10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

[x] Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the fiscal year ended September 30, 2018

or

[ ] Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from _________ to _________

Commission file number 001-34376

IEC ELECTRONICS CORP.

(Exact name of registrant as specified in its charter)

Delaware	13-3458955
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

105 Norton Street, Newark, New York 14513

(Address of principal executive offices) (Zip code)

Registrant’s telephone number, including area code: 315-331-7742

Securities registered pursuant to Section 12(b) of the Act:

Common Stock, $.01 par value	NYSE AMERICAN LLC
(Title of each class)	(Name of each exchange on which registered)

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes [ ] No [x]

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes [ ] No [x]

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [x] No [ ]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes [x] No [ ]

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨	Accelerated filer ¨
Non-accelerated filer x	Smaller reporting company x
Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the

Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ¨ No x

At March 30, 2018, the last business day of the registrant’s second quarter for the fiscal year ended September 30, 2018, the aggregate market value of the shares of common stock held by non-affiliates of the registrant was $35,707,488 (based on the closing price of the registrant’s common stock on the NYSE American on such date). Shares of common stock held by each executive officer and director and by each person and entity who beneficially owns more than 10% of the outstanding common stock have been excluded in that such person or entity may be deemed to be an affiliate for purposes of this calculation. Such exclusion should not be deemed a determination or admission by registrant that such individuals or entities are, in fact, affiliates of the registrant.

As of November 21, 2018, there were 10,255,309 shares of common stock outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of IEC Electronics Corp.’s definitive Proxy Statement to be filed with the Securities and Exchange Commission in connection with its 2019 Annual Meeting of Stockholders are incorporated by reference into Part III Items 10, 11, 12, 13 and 14 of this Form 10-K.

TABLE OF CONTENTS

		Page
PART I
Item 1.	BUSINESS	5
Item 1A.	RISK FACTORS	10
Item 1B.	UNRESOLVED STAFF COMMENTS	18
Item 2.	PROPERTIES	18
Item 3.	LEGAL PROCEEDINGS	18
Item 4.	MINE SAFETY DISCLOSURES	18
	EXECUTIVE OFFICERS OF THE REGISTRANT	19
PART II
Item 5.	MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES	19
Item 6.	SELECTED FINANCIAL DATA	20
Item 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	20
Item 7A.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	25
Item 8.	FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA	25
Item 9.	CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE	48
Item 9A.	CONTROLS AND PROCEDURES	48
Item 9B.	OTHER INFORMATION	49
PART III
Item 10.	DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE	49
Item 11.	EXECUTIVE COMPENSATION	49
Item 12.	SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS	49
Item 13.	CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE	49
Item 14.	PRINCIPAL ACCOUNTANT FEES AND SERVICES	49
PART IV
Item 15.	EXHIBITS AND FINANCIAL STATEMENT SCHEDULES	50
	SIGNATURES	53

3

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

References in this report to “IEC,” the “Company,” “we,” “our,” or “us” mean IEC Electronics Corp. and its subsidiaries except where the context otherwise requires. This Annual Report on Form 10-K for the fiscal year ended September 30, 2018 (“Form 10-K”) contains forward-looking statements. In some cases you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other similar expressions. These forward-looking statements include, but are not limited to, statements regarding future sales and operating results, future prospects, the capabilities and capacities of business operations, any financial or other guidance and all statements that are not based on historical fact, but rather reflect our current expectations concerning future results and events. The ultimate correctness of these forward-looking statements is dependent upon a number of known and unknown risks and events and is subject to various uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements.

The following important factors, among others, could affect future results and events, causing those results and events to differ materially from those views expressed or implied in our forward-looking statements: business conditions and growth or contraction in our customers’ industries, the electronic manufacturing services industry and the general economy; variability of our operating results; our ability to control our material, labor and other costs; our dependence on a limited number of major customers; the potential consolidation of our customer base; availability of component supplies; dependence on certain industries; variability and timing of customer requirements; technological, engineering and other start-up issues related to new programs and products; uncertainties as to availability and timing of governmental funding for our customers; the impact of government regulations, including FDA regulations; risks related to the accuracy of the estimates and assumptions we used to revalue our net deferred tax assets in accordance with the Tax Cuts and Jobs Act of 2017; the types and mix of sales to our customers; litigation and governmental investigations; intellectual property litigation; our ability to maintain effective internal controls over financial reporting; unforeseen product failures and the potential product liability claims that may be associated with such failures; the availability of capital and other economic, business and competitive factors affecting our customers, our industry and business generally; failure or breach of our information technology systems; and natural disasters. Any one or more of such risks and uncertainties could have a material adverse effect on us or the value of our common stock. For a further list and description of various risks, relevant factors and uncertainties that could cause future results or events to differ materially from those expressed or implied in our forward-looking statements, see the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections elsewhere in this Form 10-K and our other filings with the Securities and Exchange Commission (the “SEC”).

All forward-looking statements included in this Form-10-K are made only as of the date indicated or as of the date of this Form 10-K. We do not undertake any obligation to, and may not, publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or which we hereafter become aware of, except as required by law. New risks and uncertainties arise from time to time and we cannot predict these events or how they may affect us and cause actual results to differ materially from those expressed or implied by our forward-looking statements. Therefore, you should not rely on our forward-looking statements as predictions of future events. When considering these risks, uncertainties and assumptions, you should keep in mind the cautionary statements contained in this report and any documents incorporated herein by reference. You should read this document and the documents that we reference in this Form-10-K completely and with the understanding that our actual future results may be materially different from what we expect. All forward-looking statements attributable to us are expressly qualified by these cautionary statements.

4

PART I

Item 1. BUSINESS

Overview

IEC Electronics Corp. (“IEC,” “we,” “our,” “us,” “Company”) conducts business directly, as well as through its subsidiaries, IEC Electronics Corp-Albuquerque (“Albuquerque”), IEC Analysis & Testing Laboratory, LLC (“ATL”) and IEC California Holdings, Inc. The Rochester unit, formerly known as Celmet, operates as a division of IEC.

We are a premier provider of electronic manufacturing services (“EMS”) to advanced technology companies that produce life-saving and mission critical products for the medical, industrial, aerospace and defense sectors. We specialize in delivering technical solutions for the custom manufacturing, product configuration, and verification testing of highly engineered complex products that require a sophisticated level of manufacturing to ensure quality and performance.

Within the EMS sector, we have unique capabilities which allow our customers to rely on us to solve their complex challenges, minimize their supply chain risk and deliver full system solutions for their supply chain. These capabilities include, among others:

• Our engineering services include the design, development, and fabrication of customized stress testing platforms to simulate a product’s end application, such as thermal cycling and vibration, in order to ensure reliable performance and avoid catastrophic failure when the product is placed in service.

• Our vertical manufacturing model offers customers the ability to simplify their supply chain by utilizing a single supplier for their critical components including complex printed circuit board assembly (“PCBA”), precision metalworking, and interconnect solutions. This service model allows us to control the cost, lead time, and quality of these critical components which are then integrated into full system assemblies and minimizes our customers’ supply chain risk.

• We provide direct order fulfillment services for our customers by integrating with their configuration management process to obtain their customer orders, customize the product to the specific requirements, functionally test the product and provide verification data, and direct ship to their end customer in order to reduce time, cost, and complexity within our customer’s supply chain.

• We are the only EMS provider with an on-site laboratory that has been approved by the Defense Logistics Agency (“DLA”) for their Qualified Testing Supplier List (“QTSL”) program which deems the site suitable to conduct various QTSL and military testing standards including counterfeit component analysis. In addition, this advanced laboratory is utilized for complex design analysis and manufacturing process development to solve challenges and accelerate our customers’ time to market.

We are a 100% U.S. manufacturer which attracts customers who are unlikely to utilize offshore suppliers due to the proprietary nature of their products, governmental restrictions or volume considerations. Our locations include:

• Newark, New York - Located approximately one hour east of Rochester, New York, our Newark location is our corporate headquarters and is the largest manufacturing location providing complex circuit board manufacturing, interconnect solutions, and system-level assemblies along with an on-site material analysis laboratory for advanced manufacturing process development.

• Rochester, New York - Focuses on precision metalworking services including complex metal chassis and assemblies.

• Albuquerque, New Mexico - Specializes in the aerospace and defense markets with complex circuit board and system-level assemblies along with a state of the art analysis and testing laboratory which conducts counterfeit component analysis and complex design analysis.

We excel at complex, highly engineered products that require sophisticated manufacturing support where quality and reliability are of paramount importance. With our customers at the center of everything we do, we have created a high-intensity, rapid response culture capable of reacting and adapting to their ever-changing needs.  Our customer-centric approach offers a high degree of flexibility while simultaneously complying with rigorous quality and on-time delivery standards.

We proactively invest in areas we view as important for our continued long-term growth. All of our locations are ISO 9001:2008 certified and ITAR registered. We are Nadcap accredited and AS9100D and AS9100C certified at our Newark and Albuquerque locations, respectively, to support the stringent quality requirements of the aerospace industry. Our Newark location is ISO 13485 certified to serve the medical sector and is an approved supplier by the National Security Agency (“NSA”) under the COMSEC standard regarding communications security. Our analysis & testing laboratory in Albuquerque is ISO 17025 accredited, an IPC-approved Validation Services test Laboratory, and is the only on-site EMS laboratory that has been approved by the DLA for their QTSL program which deems the site suitable to conduct various QTSL and military testing

5

standards including counterfeit component analysis. Albuquerque also performs work per NASA-STD-8739 and J-STD-001ES space standards.

The technical expertise of our experienced workforce enables us to build some of the most advanced electronic, wire and cable, interconnect solutions, and precision metal systems sought by original equipment manufacturers (“OEMs”).

Organization

IEC Electronics Corp., a Delaware corporation, is the successor by merger in 1990 to IEC Electronics Corp., a New York corporation, which was originally organized in 1966. Our executive offices are located at 105 Norton Street, Newark, New York 14513. Our telephone number is 315-331-7742, and our Internet address is www.iec-electronics.com.

We have executed several strategic acquisitions over the past decade to advance our capability to support existing and potential customers in the EMS market.

The Electronics Contract Manufacturing Services Industry

The EMS industry specializes in providing the program management, technical support and manufacturing expertise required to take a product from the early design and prototype stages through volume production and distribution. Primarily as a response to rapid technological change and increased competition in the electronics industry, OEMs have recognized that by utilizing EMS providers they can improve their competitive position, realize an improved return on investment and concentrate on their core competencies such as research, product design and development and marketing. In addition, EMS providers allow OEMs to bring new products to market more rapidly and to adjust more quickly to fluctuations in product demand; avoid additional investment in plant, equipment and personnel; reduce inventory and other overhead costs; and determine known unit costs over the life of a contract. Many OEMs now consider EMS providers valued partners in executing their business and manufacturing strategy.

OEMs increasingly require EMS providers to provide complete turn-key manufacturing and material handling services rather than working on a consignment basis in which the OEM supplies all materials and the EMS provider supplies labor. Turn-key contracts involve design, manufacturing and engineering support, the procurement of all materials, sophisticated in-circuit and functional testing, and distribution.

IEC’s Strategy

IEC is focused on providing services for life-saving and mission critical products in the medical, industrial, aerospace and defense sectors that require a sophisticated level of manufacturing support. We offer our customers a full range of manufacturing services, combined with advanced scientific technical support to ensure their products perform for the critical applications for which they are intended. The ability to solve our customers’ technical challenges, meet their stringent quality requirements, and integrate seamlessly within their supply chain, is the value add that IEC brings.

We often engage with our customers in the early stages of product or program design, work with customers to evaluate the manufacturability and testability of their products, with the objective of enhancing quality and reducing the overall cost of ownership for our customers. Due to the highly regulated environment for many of our customers, they are seeking a long term partnership throughout the life-cycle of their product.

We are a certified small business with advanced technical capabilities. This allows us to focus on our customer’s needs and deliver solutions in a responsive manner to accelerate their time to market.

Competition

The EMS industry is highly fragmented and characterized by intense competition. We believe that the principal competitive factors in the EMS market include: technology capabilities, quality and range of services, past performance, design, cost, responsiveness and flexibility. We specialize in the custom manufacture of life-saving and mission critical products that require complex circuit boards and system-level assemblies; a wide array of cable and wire harness assemblies capable of withstanding extreme environments; and precision metal components.

We are certified to serve the military and commercial aerospace sector as well as the medical sector and we hold various accreditations. We believe we excel where quality and reliability are of paramount importance and when low-to-medium volume, high-mix production is the norm. We utilize state-of-the-art, automated circuit board assembly equipment together with a full complement of high-reliability manufacturing stress testing methods. Our customer-centric approach offers a high degree of flexibility while simultaneously complying with rigorous quality and on-time delivery standards.

6

We compete against numerous foreign and domestic companies in addition to the internal capabilities of some of our customers. Some of our competitors include Sparton Corporation, Benchmark Electronics, Inc., Plexus Corp. and Ducommun Incorporated. We may face new competitors in the future as the outsourcing industry evolves and existing or start-up companies develop capabilities similar to ours.

Products and Services

We manufacture a wide range of assemblies that are incorporated into many different products, such as aerospace and defense systems, medical devices, industrial equipment and transportation products. Our products are distributed to and through OEMs. We support multiple divisions and product lines for many of our customers and frequently manufacture successive generations of products. In some cases, we are the sole EMS contract manufacturer for the customer site or division.

Materials Management

We generally procure materials to meet specific contract requirements and are often protected by contract terms that call for reimbursement to us in the event a contract is terminated by the customer. Whether purchased by us or supplied by a customer, materials are tracked and controlled by our internal systems throughout the manufacturing process.

Availability of Components

Our revenues are principally derived from turn-key services that involve the acquisition of raw and component materials, often from a limited number of suppliers, to be manufactured in accordance with each customer’s specifications. While we believe we are well positioned with supplier relationships and procurement expertise, potential shortages of components in the world market could have a material adverse effect on our revenue levels or operating efficiencies.

Suppliers

Although we depend on a limited number of key suppliers, as a result of strategic relationships we have established with them, the Company frequently benefits from one or more of the following enhancements: reduced lead-times; competitive pricing; favorable payment terms; and preference during periods of limited supply. We have preferred supplier partnership agreements in place to support our business generally and to ensure access to custom commodities, such as printed circuit boards.

For the year ended September 30, 2018 (“fiscal 2018”), IEC obtained 26% of the materials used in production from two vendors, Avnet, Inc. and Arrow Electronics Inc. If either of these vendors were to cease supplying us with materials for any reason, we would be forced to find alternative sources of supply. A change in suppliers could cause a delay in availability of products and a possible loss of sales, which could adversely affect operating results.

Marketing and Sales

We utilize a direct sales force as well as a nationwide network of manufacturer’s representatives. Through this hybrid sales approach, we execute a focused sales strategy targeting those customers whose product profiles are aligned with our core areas of expertise. For example, we focus on customers that are developing complex, advanced technology products for a wide array of market sectors ranging from satellite communications to medical, military and ruggedized industrial products.

Typically, the demand profiles associated with these customers are in the low-to-moderate volume range with high variability in required quantities and product mix. These customers’ products often employ emerging technologies that require concentrated engineering and manufacturing support from product development through prototyping and on to volume manufacturing, which can result in significant lead times before full production and are difficult to forecast. As a result of the specialized services required, such customers rarely rely on an outsourcing model that focuses primarily on minimizing costs.

7

To reduce risk, the Company seeks a balanced distribution of business across industry sectors. As indicated in the table that follows, this can fluctuate based on end customer demands.

	Years Ended
% of Sales by Sector	September 30, 2018	September 30, 2017
Aerospace and Defense	59%	52%
Medical	22%	28%
Industrial	19%	20%
	100%	100%

Individual customers representing 10% or more of sales in fiscal 2018 included Baxter Corporation (“Baxter”) (11%), in the medical sector, and ViaSat Inc. (23%), in the aerospace and defense sector. In fiscal 2017, two customers represented 10% or more of sales, Baxter, in the medical sector, represented 14% and ViaSat, Inc. in the aerospace and defense sector represented 13%.

Three customers represented 10% or more of receivables at September 30, 2018. One customer in the aerospace and defense sector, one customer in the medical sector, and one customer in the industrial sector together accounted for 55% of the outstanding balances at September 30, 2018. Three customers represented 10% or more of receivables at September 30, 2017. Two customers in the aerospace and defense and one in the medical sector accounted for 42% of the outstanding balances at September 30, 2017.

Backlog

Our backlog at the end of fiscal 2018 was $133.7 million, which is 85.4%higher than $72.1 million at the end of fiscal 2017. Backlog consists of two categories: purchase orders and firm forecasted commitments. In addition to fulfilling orders and commitments contained in quarter-end backlog reports, we also receive and ship orders within each quarter that do not appear in the period end backlog reports. Variations in the magnitude and duration of contracts as well as customer delivery requirements may result in fluctuations in backlog from period to period. Approximately $122.3 million of our backlog at September 30, 2018 is expected to be shipped within the fiscal year ending September 30, 2019 (“fiscal 2019”), with the remainder expected to ship in future years. This compares to $66.3 million that was expected to be shipped within 12 months from year-end as of September 30, 2017, with the remainder at such time that was expected to be shipped greater than 12 months from the prior year-end.

Governmental Regulation

Our operations are subject to certain United States government regulations that control the export and import of defense-related articles and services, as well as federal, state and local regulatory requirements relating to environmental protection, waste management, and employee health and safety matters. We believe that our business is operated in substantial compliance with all applicable laws and governmental regulations. While current costs of compliance, including compliance with environmental laws, are not material, our expenses could increase if new laws, regulations or requirements were to be introduced. Some of our medical and other customers are highly regulated. Any failure to comply by customers, related to products we produce for them, can delay or disrupt their orders from us.

Employees

Employees are our single greatest resource. IEC’s total employees numbered 689, all of which are full time employees, at September 30, 2018. The Company increased by 124 employees during fiscal 2018, mainly driven by higher volumes in fiscal 2018. Some of our full-time employees are temporary employees. We make a concerted effort to engage our employees in initiatives that improve our business and provide opportunities for growth, and we believe that our employee relations are good. We have access to large and technically qualified workforces in close proximity to our operating locations in Rochester, NY and Albuquerque, NM.

Expansion of Newark, New York Manufacturing Operations

In February 2018, we announced that we will open a new state-of-the-art manufacturing facility in Newark, NY funded in part by the State of New York. The new 150,000 square foot facility will be located at the Silver Hill Technology Park and allows us to design, from the ground up, a state-of-the-art, advanced technology facility to support our operations. As part of this expansion, we intend to move our administrative offices to this location.

8

Sale-Leaseback Transaction

On November 18, 2016, we completed a sale-leaseback transaction pursuant to which our subsidiary, Albuquerque, sold certain property, including its manufacturing facility located in Albuquerque, New Mexico, to Store Capital Acquisitions, LLC (“Store Capital”) for an aggregate purchase price of approximately $5.8 million including a $120.0 thousand holdback. Proceeds from this transaction were used to pay the mortgage on such property and pay down Term Loan A, as discussed in Note 5—Credit Facilities. As part of the transaction, Albuquerque entered into a lease (the "Lease") for the property for an initial term of 15 years that may be renewed twice for five-year terms. The initial base annual rental is approximately $474.0 thousand and is subject to certain annual increases. In addition, we entered into a separate payment and performance guaranty with Store Capital Acquisitions, LLC with respect to the lease.

On May 11, 2018, we completed a sale-leaseback transaction pursuant to which we sold our manufacturing facility located in Rochester, New York (the “Rochester Property”), to Store Capital for an aggregate purchase price of approximately $2.0 million. The net book value of the assets sold was $1.2 million. The proceeds from the transaction were used to pay off the Celmet Building Term Loan and pay down a portion of Term Loan B, as discussed in Note 5—Credit Facilities. In conjunction with this purchase, the Lease was amended to include the Rochester Property. The amended Lease includes both the lease-back of the Rochester and the Albuquerque sites. The two properties are now considered one leased property for all Lease purposes. The lease term for both properties expires on May 31, 2033 and provides for renewals of two successive periods of five years each.

The sale-leaseback transactions are further described in Note 12—Capital Lease.

9

Item 1A. RISK FACTORS

We depend on a relatively small number of customers, the loss of one or more of whom may negatively affect our operating results.

A relatively small number of customers are responsible for a significant portion of our net sales. During fiscal 2018 and fiscal 2017, our five largest customers accounted for 55% and 49% of net sales, respectively. The percentage of our sales to our major customers may fluctuate from period to period, and our principal customers may also vary from year to year. Significant reduction in sales to any of our major customers, or the loss of a major customer, could have a material adverse effect on our results of operations and financial condition.

We rely on the continued growth and financial stability of our customers, including our major customers. Adverse changes in the end markets they serve can reduce demand from our customers in those markets and/or make customers in these end markets more price sensitive. Further, mergers or restructuring among our customers, or their end customers, could increase concentration or reduce total demand as the combined entities reevaluate their business and consolidate their suppliers. Future developments, particularly in those end markets that account for more significant portions of our revenues, could harm our business and our results of operations.

Because of this concentration in our customer base, we have significant amounts of trade accounts receivable from some of our customers. If one or more of our customers experiences financial difficulty and is unable to provide timely payment for the services provided, our operating results and financial condition could be adversely affected.

In addition, consolidation among our customers could intensify this concentration and adversely affect our business. In the event of consolidation among our customers, depending on which organization controls the supply chain function following the consolidation, we may not be retained as a preferred or approved supplier. In addition, product duplication could result in the termination of a product line that we currently support. While there is potential for increasing our position with the combined customer, our revenues could decrease if we are not retained as a continuing supplier. Even if we are retained as a supplier, we may also face the risk of increased pricing pressure from the combined customer because of its increased market share.

Our operating results may fluctuate from period to period.

Our annual and quarterly operating results may fluctuate significantly depending on various factors, many of which are beyond our control. These factors may include, but are not necessarily limited to:

• adverse changes in general economic conditions;

• natural disasters that may impede our operations, the operation of our customers’ business, or availability of manufacturing inputs from our suppliers;

• the level and timing of customer orders and the accuracy of customer forecasts;

• the capacity utilization of our manufacturing facilities and associated fixed costs;

• price competition;

• market acceptance of our customers’ products;

• business conditions in our customers’ end markets;

• our level of experience in manufacturing a particular product;

• changes in the mix of sales to our customers;

• variations in efficiencies achieved in managing inventories and property, plant and equipment;

• fluctuations in cost and availability of materials;

• timing of expenditures in anticipation of future orders;

• changes in cost and availability of labor and components;

• our effectiveness in managing the high reliability manufacturing process required by our customers; and

• failure or external breach of our information technology systems.

The EMS industry is affected by the United States and global economies, both of which are influenced by world events. An economic slowdown, particularly in the industries we serve, may result in our customers reducing their forecasts or delaying orders. The demand for our services could weaken, which in turn could substantially influence our sales, capacity utilization, margins and financial results.

10

The agreements governing our debt contain various covenants that may constrain the operation of our business, and our failure to comply with these covenants may have a material adverse effect on our financial condition.

The agreements and instruments governing our secured bank credit facility (the “Credit Facility”) with Manufacturers and Traders Trust Company (“M&T Bank”) and other existing debt contain various covenants that, among other things, require us to comply with certain financial covenants including maintenance of a fixed charge coverage ratio (“Financial Covenants”). The agreements and instruments governing the Credit Facility require financial and other reporting, contain limitations on revolving loan borrowings and restrict or limit our ability to:

• incur debt;

• incur or maintain liens;

• make acquisitions of businesses or entities;

• make investments, loans or advances;

• enter into guarantee agreements;

• engage in mergers, consolidations or certain sales of assets;

• engage in transactions with affiliates;

• pay dividends or engage in stock redemptions or repurchases; and

• make capital expenditures.

The Credit Facility is secured by a general security agreement covering the assets of the Company and its subsidiaries, a pledge of the Company’s equity interest in its subsidiaries, a negative pledge on the Company’s real property, and a guarantee by the Company’s subsidiaries, all of which restrict use of these assets to support other financial instruments.

To the extent we are required to seek additional waivers and/or amendments, we may continue to experience increased borrowing costs. If we are not in compliance with all of our debt covenants, and if M&T Bank chooses to exercise its remedies, M&T Bank could accelerate our primary indebtedness which could cause cross-defaults with respect to other obligations, causing a material adverse effect on our financial condition including, our inability to obtain replacement financing or continue operations. Our ability to comply with covenants contained in our Credit Facility and other existing debt may be affected by events beyond our control, including prevailing economic, financial and industry conditions.

We participate in the electronics industry, which historically produces technologically advanced products with short life cycles.

Factors affecting the electronics industry in general could seriously harm our customers and, as a result, us. These factors may include, but may not be limited to:

• the inability of our customers to adapt to rapidly changing technology and evolving industry standards, which result in short product life cycles;

• the inability of our customers to develop and market their products, some of which are new and untested;

• increased competition among our customers and their competitors, including downward pressure on pricing;

• the potential that our customers’ products may become obsolete, or the failure of our customers’ products to gain anticipated commercial acceptance; and

• periods of significantly decreased demand in our customers’ markets.

Since a significant portion of our business is defense-related, reductions or delays in U.S. defense spending may have a material adverse effect on our revenues.

During fiscal 2018 and fiscal 2017, our sales to customers serving the aerospace and defense industries approximated 59% and 52% of our sales, respectively. Because these products and services are ultimately sold to the U.S. government by our customers, these sales are affected by, among other things, the federal budget process, which is driven by numerous factors beyond our control, including geo-political, macroeconomic and political conditions. The contracts between our direct customers and their government customers are subject to political and budgetary constraints and processes, changes in short-range and long-range strategic plans, the timing of contract awards, the congressional budget authorization and appropriation processes, the government’s ability to terminate contracts for convenience or for default, as well as other risks such as contractor suspension or debarment in the event of certain violations of legal and regulatory requirements.

11

While we believe that our customers’ programs are well aligned with national defense and other priorities, shifts in domestic and international spending and tax policy, changes in security, defense and intelligence priorities, the affordability of our products and services, general economic conditions and developments, and other factors may affect a decision to fund or the level of funding for existing or proposed programs. An impasse in federal budget decision-making could lead to substantial delays or reductions in federal spending. As a result, U.S. Government funding for certain of our customers has been and could continue to be reduced, delayed or eliminated, which could significantly impact these customers’ demand for our products and services and if so this could have a material adverse effect on our business, results of operations and cash flows.

We are subject to extensive regulation and audit by the Defense Contract Audit Agency.

The accuracy and appropriateness of certain costs and expenses used to substantiate our direct and indirect costs for U.S. Government contracts are subject to extensive regulation and audit by the Defense Contract Audit Agency, an arm of the U.S. Department of Defense. Such audits and reviews could result in adjustments to our contract costs and profitability. However, we cannot ensure the outcome of any future audits and adjustments may be required to reduce net sales or profits upon completion and final negotiation of audits. If any audit or review were to uncover inaccurate costs or improper activities, we could be subject to penalties and sanctions, including termination of contracts, forfeiture of profits, suspension of payments, fines and suspension or prohibition from conducting future business with the U.S. Government. Any such outcome could have a material adverse effect on our financial results.

Our business could be negatively impacted by economic slowdowns in the medical sector.

The medical sector represented approximately 22% and 28% of our sales during fiscal 2018 and fiscal 2017, respectively. Medical device industries are intensely competitive and heavily regulated. Medical businesses must operate within an evolving regulatory and risk environment, with ongoing pricing and cost pressures, and adoption of new business models driven by scientific and technological advances. Any significant change in production rates or any restructuring by customers in this sector would likely have a material effect on our results of operations. There is no assurance that our customers will continue to buy products from us at current levels, that we will retain any or all of our existing customers or that we will be able to form new relationships with customers upon the loss of one or more of our existing customers in this market. Any material reduction in sales, consolidation or slowdowns in the medical sector could have a negative impact on our business and financial results.

Global economic and financial market conditions may have a material adverse effect on our results of operations and financial condition.

Current global economic and financial market conditions, including the onset of a global economic recession, may have a material adverse effect on our results of operations and financial condition. These conditions may also materially impact our customers and suppliers. Economic and financial market conditions that adversely affect our customers may cause them to terminate or delay existing purchase orders or to reduce the volume of products they purchase from us in the future. We may be owed significant balances from customers that operate in cyclical industries and under leveraged conditions that could impair their ability to pay amounts owed to us on a timely basis. Failure to collect a significant portion of those receivables could have a material adverse effect on our results of operations and financial condition.

Similarly, adverse changes in credit terms extended to us by our suppliers, such as shortening the required payment period for outstanding accounts payable or reducing the maximum amount of trade credit available to us could significantly affect our liquidity and thereby have a material adverse effect on our results of operations and financial condition.

If we are unable to successfully anticipate changing economic and financial market conditions, we may be unable to effectively plan for and respond to those changes, and this could have a material adverse effect on our operating results.

Tariffs imposed by the U.S. and those imposed in response by other countries, as well as rapidly changing trade relations, could have a material adverse effect on our business and results of operations.

Changes in U.S. and foreign governments’ trade policies have resulted in, and may continue to result in, tariffs on imports into and exports from the U.S. Throughout 2018, the U.S. imposed tariffs on imports from several countries, including China, Canada and the European Union. In response, China, Canada and the European Union have proposed or implemented their own tariffs on certain products and product components, including components we use, impacting our supply chain and increasing our costs of doing business. Although the majority of our supplier contracts allow us to recover tariffs, if we are unable to recover these costs, our profit margins may be negatively impacted. Continued diminished trade relations between the U.S. and other countries, including potential reductions in trade with China and others, as well as the continued escalation of tariffs, could have a material adverse effect on our financial performance and results of operations.

12

If we experience deficiencies in our internal control over financial reporting and procedures, it could have a material adverse effect on our business and on our investors’ confidence in our reported financial information, and there is no guarantee that our internal control over financial reporting and procedures will not fail in the future.

Effective internal control over financial reporting and disclosure controls and procedures are necessary for us to provide reliable financial reports and to detect and prevent fraud. In the past, we have experienced material weaknesses with our internal controls and procedures. The remedial measures we have taken may not be sufficient to regain the confidence of investors or any loss of reputation, which could in turn affect our finances and operations. We have been and may be required in the future to expend substantial funds and resources in order to rectify deficiencies in our internal controls. Our disclosure controls and internal control over financial reporting may not prevent all errors or all instances of fraud. Because of the inherent limitations in control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our business have been detected. Moreover, projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. The benefits of a control system also must be considered relative to the costs of the system and management’s judgments regarding the likelihood of potential events. There can be no assurance that any control system will succeed in achieving its goals under all possible future conditions, and as a result of these inherent limitations, misstatements due to error or fraud may occur and may or may not be detected. If there is a failure in any of our internal controls and procedures, we could face investigation or enforcement actions by the SEC and other governmental and regulatory bodies, litigation, loss of reputation and investor confidence, the inability to acquire capital, and other material adverse effects on our finances and business operations.

We are subject to ongoing obligations in connection with the SEC settlement and our failure to comply with those obligations could adversely affect our business and the liquidity of our common stock.

On June 8, 2016, we consented to the entry of a settled administrative order by the SEC (the “Administrative Order”). Pursuant to the Administrative Order, we (i) neither admitted nor denied the SEC’s findings, (ii) agreed to pay a penalty of $200,000, and (iii) agreed to cease-and-desist from committing or causing any violations or future violations of certain provisions of the Securities Exchange Act of 1934, as amended, and certain rules thereunder.

We do not expect the Administrative Order to have any direct material impact on our business and operations. However, we may suffer indirect consequences as a result of the settlement. The SEC settlement could also make it more difficult to attract and retain qualified individuals to serve on our board of directors or as executive officers. Further, if we are found to be in violation of the Administrative Order, we may be subject to additional enforcement actions or lawsuits that could lead to added penalties and consequences. The costs of such actions and of defending lawsuits could be significant and exceed the amount of our available insurance coverage. Governmental scrutiny, pending or future investigations by regulators or law enforcement agencies or legal proceedings involving us or our affiliates could have a negative impact on our reputation and on the morale and performance of employees, as well as on business retention and sales, which could adversely affect our business and results of operations.

As a result of the settlement with the SEC, we cannot invoke the “safe harbor” for the forward-looking statements provision of the Private Securities Litigation Reform Act of 1995.

As a result of the Administrative Order, we have forfeited the ability to invoke the “safe harbor” for the forward-looking statements provision of the Private Securities Litigation Reform Act of 1995. This safe harbor provided us enhanced protection from liability related to forward-looking statements if the forward-looking statements were accompanied by meaningful cautionary statements or were made without actual knowledge that they were false or misleading. Without the statutory safe harbor, it may be more difficult for us to defend against any claims based on forward-looking statements.

Start-up costs and inefficiencies related to new or transferred programs can have a material adverse effect on our operating results and may not be recoverable.

Our long term success depends in part upon our ability to support our customers as they bring new products and programs to market, or transfer programs to us. Often these products and programs have technological issues and require, or our customers desire, engineering and other changes and innovations in order to facilitate full-scale production and end-user acceptance. Although some of these programs, particularly in the defense and space industries, once mature, will likely profitably extend over many years and will be difficult to transfer to our competitors, we may have to make significant upfront investments in them that may be recovered only over the longer term. These investments may have a significant impact on our profitability in nearer term periods. Moreover, start-up costs, including the management of labor and equipment resources in connection with establishing new programs and new customer relationships; and difficulties in estimating required resources and the timing of those resources in advance of production, can adversely affect our operating results. If new programs or customer relationships

13

are terminated or delayed, this could have a material adverse effect on our operating results, particularly in the near term, as we may not recoup those start-up costs or quickly replace anticipated new program revenues.

Some of our customers may have regulatory issues that adversely affect our operating results.

Some of our larger customers are in heavily regulated industries, such as health care. If they encounter issues with their regulators related to products we manufacture for them, there may be long delays in resolving those issues or the issues may not be resolved at all, which would adversely affect our operating results.

Most of the customers in our industry do not commit to long-term production schedules, which can make it difficult for us to schedule production.

Customers may cancel their orders, change production quantities or delay production for any number of reasons that are beyond our ability to foresee or control. Although we are always seeking new opportunities, we may not be able to replace any deferred, reduced or canceled orders. Cancellations, reductions or delays by a significant customer or by a group of customers could adversely affect our operating results and working capital levels. Such cancellations, reductions or delays have occurred and may occur again. The volume and timing of sales to our customers may vary due to:

• variation in demand for our customers’ products in their end markets;

• actions taken by our customers to manage their inventory;

• product design changes by our customers; or

• changes in our customers’ manufacturing strategy.

Due in part to these factors, most of our customers do not commit to firm, long-term production schedules. Therefore, we make significant judgments based on our estimates of customer requirements, including:

• deciding on the levels of business that we will seek;

• production schedules;

• component procurement commitments;

• equipment requirements;

• personnel needs; and

• other resource requirements.

Increased competition may result in decreased demand or reduced prices for our products and services.

The EMS industry is highly fragmented and characterized by intense competition. We may be operating at a cost disadvantage compared to larger EMS providers who have greater direct buying power from component suppliers, distributors and raw material suppliers or who have lower cost structures as a result of their geographic location. As a result, other EMS providers may have a competitive advantage. Our manufacturing processes are generally not subject to significant proprietary protection, and companies with greater resources or a greater market presence may enter our market or increase their competition with us. We also expect our competitors to continue to improve the performance of their current products or services, to reduce the prices of their products or services and to introduce new products or services that may offer greater performance and improved pricing. Any of these factors may cause a decline in our sales, loss of market acceptance for our products or services, profit margin compression, or loss of market share.

We depend on a limited number of suppliers for components that are critical to our manufacturing processes. A shortage of these components or an increase in their price could interrupt our operations and adversely affect our operating results.

For fiscal 2018, IEC obtained 26% of the materials used in production from two vendors, Avnet, Inc. and Arrow Electronics, Inc. If either of these vendors were to cease supplying us with materials for any reason, we would be forced to find alternative sources of supply. A change in suppliers could cause a delay in availability of products and a possible loss of sales, which could adversely affect operating results.

Much of our net revenue is derived from turn-key manufacturing for which we provide the materials specified by our customers. Some of our customer agreements permit periodic adjustments to pricing based on increases or decreases in component prices and other factors. However, we typically bear the risk of component price increases that occur between any such re-pricing dates or, if such re-pricing is not permitted during the balance of the term of a particular customer agreement. As a result, some component price increases may have a material adverse effect on our operating results, if we cannot increase prices enough to offset increased costs or if increased prices lead to canceled orders.

14

Many of the products we manufacture require one or more components that are available from a limited number of suppliers. In response to supply shortages, some of these components are from time to time subject to allocation limits. In some cases, supply shortages or delayed deliveries could substantially curtail production of those assemblies requiring a limited-supply component, which could contribute to an increase in our inventory levels, and could delay shipments to customers and the associated revenue of all products using that component. Component shortages have been prevalent in our industry, and such shortages may recur. An increase in economic activity could result in shortages if manufacturers of components do not adequately anticipate increased order volume or if they have excessively reduced their production capabilities. World events, armed conflict, governmental regulation, natural disaster, and epidemics could also affect our supply chain, leading to an inability to obtain sufficient components on a timely basis.

In addition, due to the specialized nature of some components and our customers’ product specifications, we may be required to use sole-source suppliers for certain components. Such suppliers may encounter financial or operational difficulties that could cause delays in or the curtailment of component deliveries.

Our turn-key manufacturing services involve inventory risk.

Our turn-key manufacturing services described above involve a greater investment in inventory and a corresponding increase in risk as compared to consignment services, for which the customer provides all materials. For example, in our turn-key operations, we must frequently order parts and supplies in minimum lot sizes that may be larger than the quantity of product ultimately needed for our customers. Customers’ cancellation or reduction of orders could result in additional expense to us. If we are not reimbursed for excess inventory ordered to meet customer forecasts, we may accumulate excess inventory and/or incur return charges imposed by suppliers. In addition, component price increases and inventory obsolescence associated with turn-key orders could adversely affect our operating results.

Furthermore, we provide inventory management programs for some of our customers under which we are required to hold and manage finished goods inventories. Such inventory management programs may lead to higher finished goods inventory levels, reduced inventory turns and increased financial exposure. In cases where customers have contractual obligations to purchase managed inventories from us, we remain subject to the risk of enforcing the obligation.

Products we manufacture may contain defects in workmanship, which could result in reduced demand for our services and product liability claims against us.

We manufacture highly complex products to our customers’ specifications, often within tight tolerance ranges, and such products may contain design or manufacturing errors or defects. Defects in the products we manufacture, whether caused by customer design, workmanship, component failure or other error, may result in delayed shipments to customers or reduced or canceled customer orders, adversely affecting our reputation and may result in product liability claims against us. Even if customers or component suppliers are responsible for the defects, they may be unwilling or unable to assume responsibility for costs associated with product failure.

Security breaches and other disruptions, both physical and virtual, could compromise our information, harm customer relationships and expose us to liability, which would cause our business and reputation to suffer.

We have access to, create and store sensitive data, including intellectual property, our proprietary business information and that of our customers, and personally identifiable information of our employees. Despite our security measures, our information technology and infrastructure may be vulnerable to attacks by hackers or breached due to employee error, malfeasance or other disruptions. Cybersecurity breaches, system disruptions and failures may interrupt or delay our ability to provide services to our customers and expose our business and our customers to harm. Any such breach could compromise our networks and the information stored there could be improperly accessed, disclosed, lost or stolen. Any such access, disclosure or other loss of information could disrupt our operations and the services we provide to customers, damage our reputation or our customer relationships, impair our ability to record, process and report accurate information to our stockholders and the SEC, or result in legal claims or proceedings, any of which could adversely affect our business, financial condition, revenues and competitive position.

Our manufacturing processes and services may result in exposure to intellectual property infringement and other claims.

Providing manufacturing services can expose us to potential claims that products, designs or manufacturing processes we use infringe third party intellectual property rights. Even though many of our manufacturing services contracts generally require our customers to indemnify us for infringement claims relating to their products, including associated product specifications and designs, a particular customer may not, or may not have the resources to, assume responsibility for such claims. In addition, we may be responsible for claims that our manufacturing processes or components used in manufacturing infringe third party intellectual property rights. Infringement claims could subject us to significant liability for damages, potential

15

injunctive action, or hamper our normal operations such as by interfering with the availability of components and, regardless of merits, could be time-consuming and expensive to resolve, and have a material adverse effect on our results of operations and financial position. In the event of such a claim, we may be required to spend a significant amount of money to develop non-infringing alternatives or obtain and maintain licenses. We may not be successful in developing such alternatives or obtaining and maintaining such a license on reasonable terms or at all. Our customers may be required to or decide to discontinue products which are alleged to be infringing rather than face continued costs of defending the infringement claims, and such discontinuance may result in a significant decrease in our business.

A failure to comply with customer-driven policies and standards, including those related to social responsibility and conflict minerals, could adversely affect our business and reputation.

In addition to government regulations and industry standards, our customers may require us to comply with their own social responsibility, conflict minerals, quality or other business policies or standards, which may be more restrictive than current laws and regulations as well as our pre-existing policies, before they commence, or continue, doing business with us. Such policies or standards may be customer-driven, established by the industry sectors in which we operate or imposed by third party organizations, such as the SEC’s conflict mineral rules.

Our compliance with these policies, standards and third party certification requirements could be costly, and our failure to comply could adversely affect our operations, customer relationships, reputation and profitability. In addition, our adoption of these standards could adversely affect our cost competitiveness, ability to provide customers with required service levels and ability to attract and retain employees in jurisdictions where these standards vary from prevailing local customs and practices.

If we are unable to maintain satisfactory capacity utilization rates, our results of operations and financial condition would be adversely affected.

Given the high fixed costs of our operations, decreases in capacity utilization rates can have a significant effect on our business. Accordingly, our ability to maintain or enhance gross margins continues to depend, in part, on maintaining satisfactory capacity utilization rates. In turn, our ability to maintain satisfactory capacity utilization depends on the demand for our products, the volume of orders we receive, and our ability to offer products that meet our customers’ requirements at competitive prices. If current or future production capacity fails to match current or future customer demands, our facilities would be underutilized, our sales may not fully cover our fixed overhead expenses, and we would be less likely to achieve anticipated gross margins. If forecasts and assumptions used to support the implied fair value of goodwill or realizability of our long-lived assets including intangible assets change, we may incur significant impairment charges, which would adversely affect our results of operations and financial condition, as we have experienced.

In addition, we generally schedule our production facilities at less than full capacity to retain our ability to respond to unexpected additional quick-turn orders. However, if these orders are not received, we may forego some production and could experience continued excess capacity. If we conclude that we have significant, long-term excess capacity, we may decide to permanently close one or more of our facilities, and lay off some of our employees. Closures or lay-offs could result in our recording restructuring charges such as severance and other exit costs, and asset impairments.

If our customers choose to provide manufacturing services in-house or overseas, our results of operations could suffer.

Our business has benefited from OEMs deciding to outsource their EMS needs to us. Our future revenue growth depends, in part, on new outsourcing opportunities from OEMs. Current and prospective customers continuously evaluate our performance against other providers, including off-shore procurement opportunities. They also evaluate the potential benefits of manufacturing their products themselves. To the extent that outsourcing opportunities are not available either due to OEM decisions to produce these products themselves or to use other domestic or foreign providers, this could have a material adverse effect on our financial results and prospects.

We may not be able to maintain the engineering, technological and manufacturing capabilities required by our customers in the future.

The markets for our manufacturing and engineering services are characterized by rapidly changing technology and evolving process development. The continued success of our business will depend upon our ability to:

• hire and retain qualified engineering and technical personnel;

• maintain and enhance our technological leadership; and

• develop and market manufacturing services that meet changing customer needs.

16

Although we believe that our operations provide the assembly and testing technologies, equipment and processes that are currently required by our customers, there is no certainty that we will develop the capabilities required by our customers in the future. The emergence of new technology, industry standards or customer requirements may render our equipment, inventory or processes obsolete or uncompetitive; or we may have to acquire new assembly and testing technologies and equipment to remain competitive. The acquisition and implementation of new technologies and equipment may require significant expense or capital investment that could adversely affect our operating results, as could our failure to anticipate and adapt to our customers’ changing technological requirements.

Failure to attract and retain key personnel and other skilled employees could have a material adverse effect on our business.

Our continued success depends to a large extent on our ability to recruit, train, and retain skilled employees, particularly executive management and technical employees. The competition for these individuals is significant; hence the loss of the services of certain of these key employees or an inability to attract or retain qualified employees could negatively impact us.

Failure to comply with current and future governmental regulations related to defense, health and safety and the environment could impair our operations or cause us to incur significant expense.

We are subject to a variety of United States government regulations that control the export and import of defense-related articles and services, as well as federal, state and local regulatory requirements relating to employee occupational health and safety, and environmental and waste management regulations relating to the use, storage, discharge and disposal of hazardous materials used in our manufacturing process. To date, the cost to us of such compliance has not had a material impact on our business, financial condition or results of operations. However, violations may occur in the future as a result of human error, equipment failure or other causes. Further, we cannot predict the nature, scope or effect of environmental legislation or regulatory requirements that could be imposed in the future, or how existing or future laws or regulations will be administered or interpreted. Compliance with more stringent laws or regulations, as well as more vigorous enforcement policies of regulatory agencies, could require substantial expenditures by us and could have a material adverse effect on our business, financial condition and results of operations. If we fail to comply with any present or future regulations, we could be subject to future liabilities or the suspension of production which could have a material adverse effect on our results of operations. While we are not currently aware of any violations, such regulations could restrict our ability to expand our facilities or could require us to acquire costly equipment, or to incur other significant compliance-related expenses.

We may face heightened liability risks specific to our medical device business as a result of additional healthcare regulatory related compliance requirements and the potential severe consequences that could result from manufacturing defects or malfunctions (e.g., death or serious injury) of the medical devices we manufacture, design or test.

As a manufacturer and designer of medical devices for our customers, we have compliance requirements in addition to those relating to other areas of our business. We are required to register with the FDA and are subject to periodic inspection by the FDA for compliance with the FDA’s Quality System Regulation (“QSR”) and current Good Manufacturing Practices (“cGMP”) requirements, which require manufacturers of medical devices to adhere to certain regulations and to implement design and process manufacturing controls, quality control, labeling, handling and documentation procedures. The FDA, through periodic inspections and product field monitoring, continually reviews and rigorously monitors compliance with these QSR requirements and other applicable regulatory requirements. If any FDA inspection reveals noncompliance, and we do not address the FDA’s concerns to its satisfaction, the FDA may take action against us, including issuing a form noting the FDA’s inspection observations, a notice of violation or a warning letter, imposing fines, bringing an action against us and our officers, requiring a recall of the products we manufactured for our customers, issuing an import detention on products entering the U.S. from an offshore facility or temporarily halting operations at or shutting down a manufacturing facility. If any of these were to occur, our reputation and business could suffer.

In addition, any defects or malfunctions in medical devices we manufacture or in our manufacturing processes and facilities may result in liability claims against us, expose us to liability to pay for the recall or remanufacture of a product, or otherwise adversely affect product sales or our reputation. The magnitude of such claims could be particularly severe as defects in medical devices could cause severe harm or injuries, including death, to users of these products and others.

A failure of our information technology systems, including the implementation of our new enterprise resource planning system, could have a material adverse effect on our business.

A failure or prolonged interruption in our information technology systems, some of which are aging, or difficulties encountered in upgrading our systems or implementing new systems, that compromises our ability to meet our customers’ needs, or impairs our ability to record, process and report accurate information could have a material adverse effect on our financial condition.

17

We are in the process of implementing a financial reporting system, Epicor ERP Software (“Epicor”), as part of a multi-year plan to integrate and upgrade our systems and processes. Epicor will assist with the collection, storage, management and interpretation of data from our business activities to support future growth and to integrate significant processes. Enterprise resource planning (“ERP”) system implementations are complex and time-consuming and involve substantial expenditures on system software and implementation activities, as well as changes in business processes. As part of the Epicor implementation, certain changes to our processes and procedures have and will continue to occur.  These changes will result in changes to our internal control over financial reporting.  While Epicor is designed to strengthen our internal financial controls by automating certain manual processes and standardizing business processes and reporting across our organization, management will continue to evaluate and monitor our internal controls as each of the affected areas evolve.

Our ERP system is critical to our ability to accurately maintain books and records, record transactions, provide important information to our management and prepare our consolidated financial statements. ERP system implementations also require the transformation of business and financial processes in order to reap the benefits of the ERP system; any such transformation involves risks inherent in the conversion to a new computer system, including loss of information and potential disruption to our normal operations. Any disruptions, delays or deficiencies in the design and implementation of a new ERP system could adversely affect our ability to process orders, provide services and customer support, send invoices and track payments, fulfill contractual obligations or otherwise operate our business. Additionally, if the ERP system does not operate as intended, the effectiveness of our internal control over financial reporting could be adversely affected or our ability to assess it adequately could be further impacted.

Competition and consolidation in the electronic industry could negatively affect our business.

Consolidation could result in an increasing number of very large electronics companies offering products similar to ours in multiple sectors of the electronics industry. The growth of these large companies, with significant purchasing and marketing power, could result in increased pricing and competitive pressures for us. Accordingly, industry consolidation could harm our business. We may need to increase our efficiencies to compete and may incur additional restructuring charges.

Item 1B. UNRESOLVED STAFF COMMENTS

None.

Item 2. PROPERTIES

We own or lease properties in three locations that together house our administrative offices (“AO”), engineering (“E”), manufacturing (“M”), warehouse (“W”) and distribution (“D”) functions, as follows:

Location	Principal Use	Building SF	Owned/Leased	Lease Expiration
Newark, New York (1)	AO,E,M,W,D	235,000	Owned	N/A
Rochester, New York	AO,M,W,D	47,000	Leased	5/31/2033
Albuquerque, New Mexico	AO,E,M,W,D	72,000	Leased	5/31/2033

⁽¹⁾  Please see the disclosure regarding the expansion of our operations in Newark, NY above under “Expansion of Newark, New York Manufacturing Operations” in Part I, Item 1 of this report.

Our properties are generally in good condition and are suitable for their intended purposes. We have granted mortgages on the Newark property to secure certain of our obligations to M&T Bank.

Item 3. LEGAL PROCEEDINGS

From time to time, we may be involved in legal actions in the ordinary course of our business, but management does not believe that any such proceedings individually or in the aggregate, will have a material effect on our consolidated financial statements.

Item 4.   MINE SAFETY DISCLOSURES

Not Applicable.

18

EXECUTIVE OFFICERS OF THE REGISTRANT

Our executive officers at September 30, 2018 were as follows:

	Age
Jeffrey T. Schlarbaum	52	President and Chief Executive Officer
Thomas L. Barbato	49	Senior Vice President and Chief Financial Officer

Jeffrey T. Schlarbaum, age 52, has served as a director and as our President and Chief Executive Officer since February 2015. From February 2013 to June 2013 and from June 2014 to February 2015, Mr. Schlarbaum pursued personal interests. From June 2013 to June 2014, Mr. Schlarbaum served as Chief Operations Officer for LaserMax, Inc., a manufacturer of laser gun sights for law enforcement and the shooting sports community. From October 2010 to February 2013, Mr. Schlarbaum served as our President. Prior to that, Mr. Schlarbaum served as our Executive Vice President and President of Contract Manufacturing from October 2008 to October 2010, Executive Vice President from November 2006 to October 2008 and Vice President, Sales & Marketing from May 2004 to November 2006. Prior to joining us, Mr. Schlarbaum served in senior management roles with various contract manufacturing companies. Since July 2017, Mr. Schlarbaum also serves as a director and member of the audit committee of Lakeland Industries, Inc.

Thomas L. Barbato, age 49, has served as our Senior Vice President and Chief Financial Officer since September 2018.

Mr. Barbato has held various positions with Xerox Corporation, an American global corporation that sells print and digital document solutions, and document technology products, since 1995 most recently serving as Vice President of Finance, North America Operations, Pricing and Contracting Center of Excellence, from January 2017 to September 2018; Vice President of Finance and Chief Financial Officer, Xerox Large Enterprise Operations (LEO) U.S., from March 2014 to December 2016; Vice President of Finance Transformation and Director, Xerox Business Services, from April 2013 to March 2014; and Finance Director, Acquisition Operations Office from April 2010 to April 2013. Prior to joining Xerox Corporation, Mr. Barbato was a senior auditor with Deloitte & Touche, LLP in Rochester, New York. Mr. Barbato is a certified public accountant.

PART II

Item 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES

(a) Market Information

Our common stock trades on the NYSE American LLC (“NYSE American”) under the symbol “IEC”.

(b) Holders

As of November 21, 2018, there were approximately 186 holders of record of IEC’s common stock. This figure does not include an estimate of the indeterminate number of beneficial holders whose shares may be held of record by brokerage firms and clearing agencies.

(c) Recent sales of Unregistered Securities

None.

(d) Repurchases of IEC Securities

We did not repurchase any shares during the fourth quarter of the fiscal year ended September 30, 2018. Furthermore, certain covenants in our credit agreement with M&T Bank limit our ability to repurchase shares of our common stock.

19

Item 6. SELECTED FINANCIAL DATA

		Years Ended September 30,
		2018			2017			2016			2015			2014
(amounts in thousands, except per share data)		(a)									(b)			(b)
Net sales		$	116,922		$	96,455		$	127,010		$	126,999		$	120,837
Gross profit		14,157			11,257			20,287			16,295			13,689
Operating profit/(loss)		2,719			1,060			6,248			(1,660		)	40
Income/(loss) before income taxes		1,573			143			4,856			(3,770		)	(1,772		)
(Benefit)/provision for income taxes		(8,837		)	62			70			1			12,876
Income/(loss) from continuing operations		10,410			81			4,786			(3,771		)	(14,648		)
Loss from discontinued operations, net		—			—			—			(6,415		)	(423		)
Net income/(loss)		$	10,410		$	81		$	4,786		$	(10,186	)	$	(15,071	)
Gross margin as % of sales		12.1		%	11.7		%	16.0		%	12.8		%	11.3		%
Operating profit/(loss) as % of sales		2.3		%	1.1		%	4.9		%	(1.3		)%	—		%
Diluted net income/(loss) per common share:
	Earnings/(loss) from continuing operations	$	1.01		$	0.01		$	0.47		$	(0.37	)	$	(1.49	)
	Earnings/(loss) from discontinued operations	—			—			—			(0.64		)	(0.04		)
	Net earnings/loss	$	1.01		$	0.01		$	0.47		$	(1.01	)	$	(1.53	)
Working capital		$	20,748		$	17,194		$	19,772		$	21,866		$	24,046
Total assets		90,448			52,447			50,397			68,262			72,996
Long-term debt (excluding current portion)		16,002			14,023			16,732			28,323			28,479
Long-term capital lease obligation (excluding current portion)		7,027			5,362			—			—			—
Stockholders’ equity		25,376			14,429			13,864			8,688			17,405
(a)	Fiscal year 2018 was impacted by the income tax benefit recorded to release the majority of the valuation allowance against the net deferred income tax assets.
(b)	Fiscal years 2015 and 2014 were impacted by the 2014 restatement of our financial statements and related expenses.

Item 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The information in this Management’s Discussion and Analysis should be read in conjunction with the accompanying Consolidated Financial Statements (“Financial Statements”), the related Notes and the five-year summary of Selected Financial Data. References to “Notes” in this report are references to the Notes to the Consolidated Financial Statements unless otherwise specified. Forward-looking statements in this Management’s Discussion and Analysis are qualified by the cautionary statement preceding Item 1 of this Form 10-K and the risk factors identified in Item 1A.

20

Results of Operations

Fiscal Years Ended September 30, 2018 and 2017

A summary of selected income statement amounts during the years ended September 30, 2018 and 2017 is as follows:

	Years Ended
Income Statement Data	September 30, 2018			September 30, 2017
(in thousands)
Net sales	$	116,922		$	96,455
Gross profit	14,157			11,257
Selling and administrative expenses	11,438			10,197
Interest expense	1,146			917
Income before income taxes	1,573			143
(Benefit)/provision for income taxes	(8,837		)	62
Net income	$	10,410		$	81

A summary of sales, according to the market sector within which IEC’s customers operate, follows:

	Years Ended
% of Sales by Sector	September 30, 2018	September 30, 2017
Aerospace and Defense	59%	52%
Medical	22%	28%
Industrial	19%	20%
	100%	100%

Revenue increased21.2%, or $20.5 million, during fiscal 2018 as compared to the prior fiscal year. The increase was mainly driven by increases in sales in the aerospace and defense sector of $18.7 million and in the industrial sector of $2.6 million, partially offset by decline in the medical sector of $0.9 million.

Various increases and decreases for our aerospace and defense customers resulted in a net increase in sales of $18.7 million for fiscal 2018 compared to fiscal 2017. Programs frequently fluctuate in demand or end and are replaced by new programs. Aggregate decreases in sales from existing customers of $5.2 million were offset by increases in revenues from other existing customers of $24.3 million. We had an increase in sales of $1.6 million from six new customers. However, ending one customer relationship due to low profitability caused an additional sales decrease of $0.7 million during fiscal 2018.

The net increase in sales for the industrial market sector was $2.6 million. Increases in demand across various customers amounted to $4.3 million, with one customer representing $2.6 million due to growth in the semiconductor market. We also added two new customers with sales of $1.1 million for fiscal 2018. These increases were partially offset by one of our customers sourcing more product from an alternate source in China and who also experienced softer end market demand which decreased our sales by $2.8 million.

The net decrease of $0.9 million in sales in the medical sector was primarily due to net increases in customer demand of $1.3 million offset by reduction in volume for one legacy program of $1.5 million and the ending of programs and customer relationships of $2.3 million.

21

Gross profit increased$2.9 million from 11.7% of sales in fiscal 2017 to 12.1% of sales for fiscal 2018. The most significant impact on gross profit can be attributed to the increase in sales mix.

Selling and administrative (“S&A”) expenses increased$1.2 million and represented 9.8% of sales in fiscal 2018, compared to 10.6% of sales in the prior fiscal year. The increase in S&A expenses was primarily due to higher wage and related expenses of $0.7 million and increased consulting expenses related to the ongoing implementation of a new enterprise resource planning (“ERP”) system.

Interest expense increased by $0.2 million in fiscal 2018 compared to the prior fiscal year. The weighted average interest rate on our debt was 0.05% higher during fiscal 2018 than the prior fiscal year. In fiscal 2018, we incurred approximately $0.3 million of interest related to the capital lease obligation for the Albuquerque, New Mexico and Rochester, New York facilities. Our average outstanding debt balances increased by $2.6 million in fiscal 2018 compared to fiscal 2017 because of higher balances on the revolving credit facility and equipment line advances to fund capital purchases. Cash paid for interest on credit facility debt was approximately $0.9 million and $0.7 million for fiscal 2018 and fiscal 2017, respectively. Detailed information regarding our borrowings is provided in Note 5—Credit Facilities.

On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act significantly revises the future ongoing U.S. corporate income tax by, among other things, lowering U.S. corporate income tax rates and implementing a territorial tax system. As the Company has a September 30 fiscal year-end, the lower corporate income tax rate will be phased in, resulting in a U.S. statutory federal tax rate of approximately 24.2% for fiscal 2018, and 21% for subsequent fiscal years. The Tax Act eliminates the domestic manufacturing deduction and moves to a territorial system. In addition, previously paid federal AMT will now be refundable regardless of whether there is future income tax liability before AMT credits.

The Company has concluded that the Tax Act has caused the Company’s U.S. deferred tax assets and liabilities to be revalued. Deferred income taxes result from temporary differences between the tax basis of assets and liabilities and their reported basis in the financial statements that will result in taxable or deductible amounts in future years. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in years in which those temporary differences are expected to be recovered or settled. As changes in tax laws or rates are enacted, deferred tax assets and liabilities are revalued and any change is adjusted through the provision for income tax expense in the reporting period of the enactment. As of September 30, 2018, the Company has completed its analysis of the impact of the Tax Act under SAB 118.

For the year ended September 30, 2018, the impact of the Tax Act resulted in the Company recording a tax expense of approximately $4.7 million due to the change in the tax rate. This was offset by a corresponding decrease to the valuation allowance of approximately $5.8 million, resulting in a net tax benefit of approximately $1.0 million related to the release of the valuation allowance on the Company’s AMT credits.

As of September 30, 2018, the Company’s deferred tax assets were primarily the result of U.S. federal net operating loss carryforwards (“NOLs”) and tax credit carryforwards. A valuation allowance of $1.3 million and $15.1 million was recorded against our gross deferred tax asset balance as of September 30, 2018, and September 30, 2017, respectively. During the year ended September 30, 2018, management evaluated both positive and negative evidence to consider the reversal of the valuation allowance on the Company's net deferred income tax assets and determined in the fourth quarter of fiscal 2018 that there was sufficient positive evidence to conclude that it is more likely than not that the Company's deferred income tax assets are realizable. As a result, in the fourth quarter of fiscal 2018 the Company recorded a $7.8 million income tax benefit to release most of the valuation allowance against the Company's net deferred income tax assets.

Management performs an assessment of positive and negative evidence regarding the realization of the Company's net deferred income tax assets as required by ASC 740. For the year ended September 30, 2017, we determined that a valuation allowance was needed for all of our net deferred income tax assets, based on the required weight of positive and negative evidence under ASC 740, including consideration of the Company's three-year cumulative losses at that time.

IEC has NOLs for income tax purposes of approximately $29.7 million at September 30, 2018, expiring mainly in years 2022 through 2025 and 2031 through 2035. The Company also has additional state NOLs available in several jurisdictions in which it files.  

22

Liquidity and Capital Resources (Full Years Ended September 30, 2018 and 2017)

Capital Resources

As of September 30, 2018, there was $0.2 million of outstanding capital expenditure commitments for manufacturing equipment.  We generally fund capital expenditures with cash flow from operations, our revolving credit facility and our equipment line advances. Based on our current expectations, we believe that our projected cash flows provided by operations and potential borrowings under the revolving credit facility and equipment line advances, are sufficient to meet our working capital, debt service and capital expenditure requirements for the next twelve months.

Our cash management system provides for the funding of the disbursement accounts on a daily basis as checks are presented for payment. Under this system, outstanding checks in excess of the bank balance create a book overdraft.

Summary of Cash Flows

A summary of selected cash flow amounts for the years ended follows:

	Years Ended
Cash Flow Data	September 30, 2018			September 30, 2017
(in thousands)
Cash, beginning of year	$	—		$	845
Net cash flow provided by/(used in):
Operating activities	(203		)	1,759
Investing activities	(1,982		)	2,222
Financing activities	2,185			(4,826		)
Net cash decrease for the year	—			(845		)
Cash, end of year	$	—		$	—

Operating activities

Cash flows provided by operations, before considering changes in working capital, were $4.4 million in fiscal2018 and $2.8 million in fiscal2017. Net income of $10.4 million in fiscal 2018 improved compared to the prior year due to the income tax benefit of $1.0 million as a result of the Tax Act and a release of the deferred tax valuation allowance of $7.8 million. Net income was $0.1 million during the prior fiscal year.

Working capital used cash flows of $4.6 million and $1.1 million in fiscal2018 and fiscal2017, respectively.  The change in working capital in fiscal2018 was primarily due to an increase in accounts receivable of $7.3 million and an increase in inventory of $18.6 million. These increases were partially offset by an increase in accounts payable of $13.5 million, an increase in the book overdraft of $2.1 million and an increase in customer deposits of $6.0 million. Accounts receivable increases were primarily due to timing of revenue in the fourth quarter of fiscal 2018. The accounts payable increase in fiscal 2018 was partially due to an increase in inventory as well as the timing of payments. In both periods, the increase in inventory and customer deposits was due to securing materials for future production.

Investing activities

Cash flows used by investing activities were $2.0 million for fiscal2018 and provided $2.2 million for fiscal2017.  Cash flows used in fiscal 2018 consisted of $0.8 million of purchases of equipment and capitalized software costs resulting from the ongoing implementation of a new ERP system, partially offset by the proceeds of $1.9 million from the Rochester sale-leaseback transaction. Cash flows provided in fiscal 2017 consisted of proceeds of $5.8 million from the Albuquerque sale-leaseback transaction, partially offset by the purchases of equipment and capitalized software costs.

Financing activities

Cash flows provided by financing activities were $2.2 million in fiscal2018 and used $4.8 million for fiscal2017. During fiscal2018, net borrowings under all credit facilities were $2.5 million, with $4.2 million of net borrowings under the Revolver, as defined below, repayments of $2.9 million for term debt, and $1.2 million of new borrowings related to Equipment Line Advances. Term debt payments were more than normal principal repayments as proceeds from the Rochester sale-leaseback transaction were used to pay down term debt. During fiscal2017, net repayments under all credit facilities were $4.6 million,

23

with $4.8 million of net borrowings under the Revolver and repayments of $9.4 million for term debt, due largely to the Albuquerque sale-leaseback transaction.

Credit Facilities

At September 30, 2018, borrowings outstanding under the revolving credit facility (the “Revolver”) under the Sixth Amendment to the Fifth Amended and Restated Credit Facility Agreement (which amended the Fifth Amended and Restated Credit Facility Agreement dated as of December 14, 2015, as amended by various amendments (collectively, the “Credit Facility, as amended”) amounted to $13.0 million, and the upper limit was $22.0 million.  We believe that our liquidity is sufficient to satisfy anticipated operating requirements during the next twelve months.

The Credit Facility, as amended, contains various affirmative and negative covenants including financial covenants. As of September 30, 2018, the Company had to maintain a minimum fixed charge coverage ratio (“Fixed Charge Coverage Ratio”). The Fixed Charge Coverage Ratio compares (i) EBITDAS minus unfinanced capital expenditures minus tax expense, to (ii) the sum of interest expense, principal payments, payments on all capital lease obligations and dividends, if any (fixed charges). “EBITDAS” is defined as earnings before interest, taxes, depreciation, amortization and non-cash stock compensation expense. The Fixed Charge Coverage Ratio was initially measured for a trailing six months ended September 30, 2017 and was measured for a trailing twelve months ended September 30, 2018. The Credit Facility, as amended, also provides for customary events of default, subject in certain cases to customary cure periods, in which events, the outstanding balance and any unpaid interest would become due and payable.

Pursuant to the Credit Facility, as amended, the Fixed Charge Coverage Ratio covenant of a minimum of 1.10 was the only covenant in effect at September 30, 2018. The Fixed Charge Coverage Ratio was calculated as 1.16 at September 30, 2018.

The Company was in compliance with all financial debt covenants at September 30, 2018.

Detailed information regarding our borrowings is provided in Note 5—Credit Facilities.

Off-Balance Sheet Arrangements

IEC is not a party to any material off-balance sheet arrangements.

Critical Accounting Policies and Use of Estimates

IEC’s consolidated financial statements and accompanying notes are prepared in accordance with GAAP, as presented in the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”). In preparing financial statements, management is required to (i) determine the manner in which accounting principles are applied and (ii) make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. A discussion of the Company’s critical accounting policies follows.

Revenue recognition: Under FASB ASC 605-10 (Revenue Recognition), revenue from sales is recognized when (i) goods are shipped or title and risk of ownership have passed, (ii) the price to the buyer is fixed or determinable, and (iii) realization is reasonably assured. Service revenues are generally recognized as services are rendered or, in the case of material management contracts, in proportion to materials procured to date. Provisions for discounts and rebates to customers, estimated returns and allowances and other adjustments are recorded in the period the related sales are recognized.

Inventory reserves: FASB ASC 330-10-35 (Inventory) requires us to reduce the carrying value of inventory when there is evidence that the utility of goods will be less than cost, whether due to physical deterioration, obsolescence, changes in price levels or other causes. Inventory balances are generally reduced to the lower of cost or net realizable value by establishing offsetting balance sheet reserves.

Valuation of Deferred Income Tax Assets. We perform an assessment of positive and negative evidence regarding the realization of our net deferred income tax assets as required by FASB ASC 740 (Income Taxes)(“ASC 740”). Under ASC 740, the weight given to negative and positive evidence is commensurate only to the extent that such evidence can be objectively verified. ASC 740 also prescribes that objective historical evidence be given greater weight than subjective evidence, including our forecasts of future taxable income, which include assumptions that cannot be objectively verified. Based on our evaluation of positive evidence in fiscal 2018, we reversed the valuation allowance established in fiscal 2014 on our net deferred income tax assets. We will continue to monitor and evaluate the positive and negative evidence considered in arriving at the above conclusion, in order to assess whether such conclusion remains appropriate in future periods.

24

Income taxes: ASC 740 describes the manner in which income taxes are to be provided for in our financial statements. We are required to recognize (i) the amount of taxes payable or refundable for the current period and (ii) deferred tax assets and liabilities for the future tax consequences of events that have been reported in our financial statements or tax returns. With respect to uncertain positions that may be taken on a tax return, we recognize related tax benefits only if it is more likely than not that the position will be sustained under examination based on the technical merits of the position. We evaluate whether, based on all available evidence, our deferred income tax assets will be realizable. Valuation allowances are established when it is estimated that it is more likely than not that the tax benefit of a deferred tax asset will not be realized. The determination of income tax balances for financial statement purposes requires significant judgment and actual outcomes may vary from the amounts recorded.

Recently Issued Accounting Standards

Information with respect to recently issued accounting standards is provided in Note 1—Our Business and Summary of Significant Accounting Policies.

Item 7A.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a result of its financing activities, the Company is exposed to changes in interest rates that may adversely affect operating results.  The Company actively monitors its exposure to interest rate risk and from time to time may use derivative financial instruments to manage the impact of this risk.  The Company may use derivatives only for the purpose of managing risk associated with underlying exposures.  The Company does not trade or use instruments with the objective of earning financial gains on the interest rate nor does the Company use derivatives instruments where it does not have underlying exposure.  The Company did not have any derivative financial instruments at September 30, 2018 or September 30, 2017.

At September 30, 2018, the Company had $17.5 million of debt, all with variable interest rates. Interest rates on variable loans are based on London interbank offered rate (“LIBOR”). The credit facilities are more fully described in Note 5—Credit Facilities.  Interest rates based on LIBOR currently adjust daily, causing interest on such loans to vary from period to period.  A sensitivity analysis as of September 30, 2018, indicates that a one-percentage point increase or decrease in our variable interest rates, which represents more than a 10% change, would increase or decrease the Company’s annual interest expense by approximately $0.2 million.

The Company is exposed to credit risk to the extent of non-performance by M&T Bank under the Credit Facility, as amended.  M&T Bank’s credit rating (reaffirmed A by Fitch in September 2018) is monitored by the Company, and IEC expects that M&T Bank will perform in accordance with the terms of the Credit Facility, as amended.

Item 8.  FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The consolidated financial statements are included in this Item 8 on the pages indicated below:

	Page
Report of Independent Registered Public Accounting Firm	26
Consolidated Balance Sheets as of September 30, 2018 and 2017	27
Consolidated Statements of Operations for the years ended September 30, 2018 and 2017	28
Consolidated Statements of Changes in Stockholders’ Equity for the years ended September 30, 2018 and 2017	29
Consolidated Statements of Cash Flows for the years ended September 30, 2018 and 2017	30
Notes to Consolidated Financial Statements	31

25

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the stockholders and the Board of Directors of IEC Electronics Corp.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of IEC Electronics Corp. and subsidiaries (the "Company") as of September 30, 2018 and 2017, and the related consolidated statements of operations, changes in stockholders’ equity, and cash flows for each of the two years in the period ended September 30, 2018, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of September 30, 2018 and 2017, and the results of its operations and its cash flows for each of the two years in the period ended September 30, 2018, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ Deloitte & Touche LLP

Rochester, New York

November 29, 2018

We have served as the Company's auditor since fiscal 2017.

26

IEC ELECTRONICS CORP.

CONSOLIDATED BALANCE SHEETS

SEPTEMBER 30, 2018 and 2017

(in thousands, except share and per share data)

	September 30, 2018			September 30, 2017
ASSETS
Current assets:
Cash	$	—		$	—
Accounts receivable, net of allowance	25,168			17,887
Inventories	34,126			15,605
Other current assets	1,747			1,018
Total current assets	61,041			34,510
Property, plant and equipment, net	20,110			17,777
Deferred income taxes	8,855			—
Other long-term assets	442			160
Total assets	$	90,448		$	52,447
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt	$	1,449		$	987
Current portion of capital lease obligation	306			215
Accounts payable	28,689			13,046
Accrued payroll and related expenses	1,796			1,013
Other accrued expenses	458			444
Customer deposits	7,595			1,611
Total current liabilities	40,293			17,316
Long-term debt	16,002			14,023
Long-term capital lease obligation	7,027			5,362
Other long-term liabilities	1,750			1,317
Total liabilities	65,072			38,018
Commitments and contingencies (Note 11)
STOCKHOLDERS’ EQUITY
Preferred stock, $0.01 par value:	—			—
500,000 shares authorized; none issued or outstanding
Common stock, $0.01 par value:
Authorized 50,000,000 shares
Issued: 11,304,393 and 11,252,566 shares, respectively
Outstanding: 10,248,905 and 10,197,078 shares, respectively	102			102
Additional paid-in capital	47,326			46,789
Accumulated deficit	(20,463		)	(30,873		)
Treasury stock, at cost: 1,055,488 shares	(1,589		)	(1,589		)
Total stockholders’ equity	25,376			14,429
Total liabilities and stockholders’ equity	$	90,448		$	52,447

The accompanying notes are an integral part of these consolidated financial statements.

27

IEC ELECTRONICS CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS

YEARS ENDED SEPTEMBER 30, 2018 and 2017

(in thousands, except share and per share data)

	Years Ended
	September 30, 2018			September 30, 2017
Net sales	$	116,922		$	96,455
Cost of sales	102,765			85,198
Gross profit	14,157			11,257
Selling and administrative expenses	11,438			10,197
Operating profit	2,719			1,060
Interest expense	1,146			917
Income before income taxes	1,573			143
(Benefit)/provision for income taxes	(8,837		)	62
Net income	$	10,410		$	81
Net income per common share:
Basic	$	1.01		$	0.01
Diluted	$	1.01		$	0.01
Weighted average number of shares outstanding:
Basic	10,228,596			10,181,868
Diluted	10,320,203			10,181,868

The accompanying notes are an integral part of these consolidated financial statements.

28

IEC ELECTRONICS CORP.

CONSOLIDATED STATEMENTS of CHANGES in STOCKHOLDERS’ EQUITY

YEARS ENDED SEPTEMBER 30, 2018 and 2017

(in thousands, except share data)

	Number of Shares Outstanding		Common Stock, par $0.01		Additional Paid-In Capital			Retained (Deficit)			Treasury Stock, at cost			Total Stockholders’ Equity
Balances, October 1, 2016	10,160,128		$	102	$	46,305		$	(30,954	)	$	(1,589	)	$	13,864
Net income	—		—		—			81			—			81
Stock-based compensation	—		—		460			—			—			460
Vested restricted stock	31,559		—		—			—			—			—
Shares withheld for payment of taxes upon vesting of restricted stock	(1,825	)	—		(3		)	—			—			(3		)
Employee stock plan purchase	7,216		—		27			—			—			27
Balances, September 30, 2017	10,197,078		102		46,789			(30,873		)	(1,589		)	14,429
Net income	—		—		—			10,410			—			10,410
Stock-based compensation	—		—		489			—			—			489
Vested restricted stock	40,107				—						—			—
Shares withheld for payment of taxes upon vesting of restricted stock	(1,743	)	—		(8		)	—			—			(8		)
Exercise of stock options	1,400		—		6			—			—			6
Employee stock plan purchases	12,063		—		50			—			—			50
Balances, September 30, 2018	10,248,905		$	102	$	47,326		$	(20,463	)	$	(1,589	)	$	25,376

The accompanying notes are an integral part of these consolidated financial statements.

29

IEC ELECTRONICS CORP.

CONSOLIDATED STATEMENTS of CASH FLOWS

YEARS ENDED SEPTEMBER 30, 2018 and 2017

(in thousands)

	Years Ended
	September 30, 2018			September 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	10,410		$	81
Non-cash adjustments:
Stock-based compensation	489			460
Depreciation and amortization	2,351			2,609
Loss on sale of property, plant and equipment	—			4
Change in reserve for doubtful accounts	10			(151		)
Change in excess/obsolete inventory reserve	123			(111		)
Deferred tax benefit	(8,855		)	—
Amortization of deferred gain on sale of leaseback	(83		)	(61		)
Changes in assets and liabilities:
Accounts receivable	(7,291		)	(596		)
Inventories	(18,644		)	(110		)
Other current assets	(729		)	196
Other long-term assets	(333		)	—
Accounts payable	13,540			1,624
Change in book overdraft position	2,103			558
Accrued expenses	797			(2,437		)
Customer deposits	5,984			(145		)
Other long-term liabilities	(75		)	(162		)
Net cash flows (used in)/provided by operating activities	(203		)	1,759
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment	(3,934		)	(3,533		)
Proceeds from disposal of property, plant and equipment	5			5
Proceeds from sale-leaseback transaction	1,947			5,750
Net cash flows (used in)/provided by investing activities	(1,982		)	2,222
CASH FLOWS FROM FINANCING ACTIVITIES
Advances from revolving line of credit	62,380			46,851
Repayments of revolving line of credit	(58,153		)	(42,043		)
Borrowings under other loan agreements	1,150			—
Repayments under other loan agreements	(2,921		)	(9,396		)
Repayments under capital lease	(244		)	(173		)
Debt issuance costs	(75		)	(89		)
Proceeds from exercise of stock options	6			—
Proceeds from employee stock plan purchases	50			27
Cash paid for employee taxes upon vesting of restricted stock	(8		)	(3		)
Net cash flows provided by/(used in) financing activities	2,185			(4,826		)
Net cash decrease for the year	—			(845		)
Cash, beginning of year	—			845
Cash, end of year	$	—		$	—
Supplemental cash flow information:
Interest paid	$	1,151		$	922
Income taxes paid	7			127
Property, plant and equipment additions financed through capital lease	2,000			5,750

The accompanying notes are an integral part of these consolidated financial statements.

30

IEC ELECTRONICS CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018 and 2017

Note 1—OUR BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Our Business

IEC Electronics Corp. (“IEC,” or the “Company”) provides electronic manufacturing services (“EMS”) to advanced technology companies that produce life-saving and mission critical products for the medical, industrial, aerospace and defense sectors. The Company specializes in delivering technical solutions for the custom manufacture of complex full system assemblies by providing on-site analytical testing laboratories, custom design and test engineering services combined with a broad array of manufacturing services encompassing electronics, interconnect solutions, and precision metalworking.  As a full service EMS provider, IEC holds all appropriate certifications for the market sectors it supports including ISO 9001:2008, AS9100C, ISO 13485, Nadcap.  IEC is headquartered in Newark, NY and also has operations in Rochester, NY and Albuquerque, NM.  Additional information about IEC can be found on its web site at www.iec-electronics.com. The contents of this website are not incorporated by reference into this annual report.

Generally Accepted Accounting Principles

IEC’s financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), as set forth in the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”).

Fiscal Calendar

The Company’s fiscal year ends on September 30th and the first three quarters generally end on the Friday closest to the last day of the calendar quarter. For the fiscal year ended September 30, 2018 (“fiscal 2018”), the fiscal quarters ended on December 29, 2017, March 30, 2018 and June 29, 2018. For the fiscal year ended September 30, 2017 (“fiscal 2017”), the fiscal quarters ended on December 30, 2016, March 31, 2017 and June 30, 2017.

Consolidation

The consolidated financial statements include the accounts of IEC and its wholly-owned subsidiaries: IEC Electronics Wire and Cable, Inc. (“Wire and Cable”) which merged into IEC on December 28, 2016; IEC Electronics Corp-Albuquerque (“Albuquerque”); IEC Analysis & Testing Laboratory, LLC (“ATL”); and IEC California Holdings, Inc. The Rochester unit, formerly Celmet, operates as a division of IEC. All intercompany transactions and accounts are eliminated in consolidation.

Cash

The Company’s cash represents deposit accounts with Manufacturers and Traders Trust Company (“M&T Bank”), a banking corporation headquartered in Buffalo, NY. The Company’s cash management system provides for the funding of the disbursement accounts on a daily basis as checks are presented for payment. Under this system, outstanding checks in excess of the bank balance create a book overdraft. Book overdrafts are presented in accounts payable in the consolidated balance sheets. Changes in the book overdrafts are presented within net cash flows provided by operating activities within the consolidated statements of cash flows.

Allowance for Doubtful Accounts

The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and management’s evaluation of collectability.  Accounts are written off after all reasonable collection efforts have been exhausted and management concludes that the likelihood of collection is remote.

Inventory Valuation

Inventories are stated at the lower of cost or net realizable value under the first-in, first-out method.  The Company regularly assesses slow-moving, excess and obsolete inventory and maintains balance sheet reserves in amounts required to reduce the recorded value of inventory to the lower of cost or net realizable value.

31

Property, Plant and Equipment

Property, plant and equipment (“PP&E”) are stated at cost and are depreciated over various estimated useful lives using the straight-line method.  Maintenance and repairs are charged to expense as incurred, while renewals and improvements are capitalized.  At the time of retirement or other disposition of PP&E, cost and accumulated depreciation are removed from the accounts and any gain or loss is recorded in earnings.

Depreciable lives generally used for PP&E are presented in the table below.  Leasehold improvements are amortized over the shorter of the lease term or estimated useful life of the improvement.   

PP&E Lives	Estimated Useful Lives
	(years)
Land improvements	10
Buildings and improvements	5 to 40
Machinery and equipment	3 to 5
Furniture and fixtures	3 to 7
Software	3 to 10

Reviewing Long-Lived Assets for Potential Impairment

ASC 360-10 (Property, Plant and Equipment) requires the Company to test long-lived assets (PP&E and definitive lived assets) for recoverability whenever events or circumstances indicate that the carrying amount may not be recoverable.  If carrying value exceeds undiscounted future cash flows attributable to an asset, it is considered impaired and the excess of carrying value over fair value must be charged to earnings.  No impairment charges were recorded by IEC for long-lived assets during fiscal2018 and 2017. 

Leases

At the inception of a lease covering equipment or real estate, the lease agreement is evaluated under criteria discussed in ASC 840-10-25 (Leases).  Leases meeting one of four key criteria are accounted for as capital leases and all others are treated as operating leases.  Under a capital lease, the discounted value of future lease payments becomes the basis for recognizing an asset and a borrowing, and lease payments are allocated between debt reduction and interest.  For operating leases, payments are recorded as rent expense.  Criteria for a capital lease include (i) transfer of ownership during the lease term; (ii) existence of a bargain purchase option under terms that make it likely to be exercised; (iii) a lease term equal to 75 percent or more of the economic life of the leased property; and (iv) minimum lease payments that equal or exceed 90 percent of the fair value of the property.

Legal Contingencies

When legal proceedings are brought or claims are made against the Company and the outcome is uncertain, ASC 450-10 (Contingencies) requires the Company to determine whether it is probable that an asset has been impaired or a liability has been incurred.  If such impairment or liability is probable and the amount of loss can be reasonably estimated, the loss must be charged to earnings.

When it is considered probable that a loss has been incurred but the amount of loss cannot be estimated, disclosure but not accrual of the probable loss is required.  Disclosure of a loss contingency is also required when it is reasonably possible, but not probable, that a loss has been incurred. 

Legal Expense Accrual

The Company records legal expenses as they are incurred, based on invoices received or estimates provided by legal counsel. Future estimated legal expenses are not recorded until incurred.

Customer Deposits

Customer deposits represent amounts invoiced to customers for which the revenue has not yet been earned and therefore represent a commitment for the Company to deliver goods or services in the future. Deposits are generally short term in nature and are recognized as revenue when earned.

32

Fair Value Measurements

Under ASC 825 (Financial Instruments), the Company is required to disclose the fair value of financial instruments for which it is practicable to estimate value.  The Company’s financial instruments consist of cash, accounts receivable, accounts payable, accrued liabilities and borrowings.  IEC believes that recorded value approximates fair value for all cash, accounts receivable, accounts payable and accrued liabilities. See Note 6—Fair Value of Financial Instruments for a discussion of the fair value of IEC’s borrowings.

ASC 820 (Fair Value Measurements and Disclosures) defines fair value, establishes a framework for measurement, and prescribes related disclosures.  ASC 820 defines fair value as the price that would be received upon sale of an asset or would be paid to transfer a liability in an orderly transaction.  Inputs used to measure fair value are categorized under the following hierarchy:

Level 1: Quoted prices in active markets for identical assets or liabilities that the Company can access at the measurement date.

Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations in which all significant inputs are observable market data.

Level 3: Model-derived valuations in which one or more significant inputs are unobservable.

The Company deems a transfer between levels of the fair value hierarchy to have occurred at the beginning of the reporting period.  There were no such transfers during fiscal2018 or fiscal2017.

Revenue Recognition

The Company’s revenue is principally derived from the sale of electronic products built to customer specifications, but also from other value-added support services and repair work.  Revenue from product sales is recognized when (i) goods are shipped or title and risk of ownership have passed, (ii) the price to the buyer is fixed or determinable, and (iii) realization is reasonably assured. Service revenue is generally recognized once the service has been rendered.  For material management arrangements, revenue is generally recognized as services are rendered.  Under such arrangements, some or all of the following services may be provided: design, bid, procurement, testing, storage or other activities relating to materials the customer expects to incorporate into products that it manufactures.  Value-added support services revenue, including material management and repair work revenue, amounted to less than 5% of total revenue in fiscal2018 and fiscal2017.

Provisions for discounts, allowances, rebates, estimated returns and other adjustments are recorded in the period the related sales are recognized.

Stock-Based Compensation

ASC 718 (Stock Compensation) requires that compensation expense be recognized for equity awards based on fair value as of the date of grant.  For stock options, the Company uses the Black-Scholes pricing model to estimate grant date fair value.  Costs associated with stock awards are recorded over requisite service periods, generally the vesting period.  If vesting is contingent on the achievement of performance objectives, fair value is accrued over the period the objectives are expected to be achieved only if it is considered probable that the objectives will be achieved.  The Company also has an employee stock purchase plan (“ESPP”) that provides for the purchase of Company common stock at a discounted stock purchase price.

Income Taxes and Deferred Taxes

ASC 740 (Income Taxes) requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns, but not in both.  Deferred tax assets are also established for tax benefits associated with tax loss and tax credit carryforwards.  Such deferred tax balances reflect tax rates that are scheduled to be in effect, based on currently enacted legislation, in the years the book/tax differences reverse and tax loss and tax credit carryforwards are expected to be realized.  An allowance is established for any deferred tax asset for which realization is not likely.

ASC 740 also prescribes the manner in which a company measures, recognizes, presents, and discloses in its financial statements uncertain tax positions that the Company has taken or expects to take on a tax return.  The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the position will be sustained following examination

33

by taxing authorities, based on technical merits of the position.  The Company believes that it has no material uncertain tax positions.

Any interest incurred is reported as interest expense. Any penalties incurred are reported as tax expense. The Company’s income tax filings are subject to audit by various tax jurisdictions and current open years are the fiscal year ended September 30, 2014 through fiscal year ended September 30, 2017. The federal income tax audit for the fiscal year ended September 30, 2013 concluded during fiscal 2017 and resulted in no change to reported tax. 

Dividends

IEC does not pay dividends on its common stock as it is the Company’s current policy to retain earnings for use in the business.  Furthermore, the Company’s Fifth Amended and Restated Credit Facility Agreement, as amended, with M&T Bank includes certain restrictions on paying cash dividends, as more fully described in Note 5—Credit Facilities. 

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, income and expenses and the disclosure of contingent assets and liabilities. Significant items subject to such estimates include: allowance for doubtful accounts, excess and obsolete inventory, warranty reserves and the valuation of deferred income tax assets. Actual results may differ from management’s estimates.

Statements of Cash Flows

The Company presents operating cash flows using the indirect method of reporting under which non-cash income and expense items are removed from net income. 

Segments

The Company’s results of operations for the years endedSeptember 30, 2018 and 2017 represent a single operating and reporting segment, referred to as contract manufacturing within the EMS industry. The Company strategically directs production between its various manufacturing facilities based on a number of considerations to best meet its customers’ requirements. The Company shares resources for sales, marketing, engineering, supply chain, information services, human resources, payroll and corporate accounting functions. Consolidated financial information is available that is evaluated regularly by the chief operating decision maker in assessing performance and allocating resources.  The Company’s operations as a whole reflect the level at which the business is managed and how the Company’s chief operating decision maker assesses performance internally.

Recently Issued Accounting Standards Not Yet Adopted

FASB Accounting Standard Update (“ASU”) 2014-09, “Revenue from Contracts with Customers” (“Topic 606”) was issued May 2014 and updates the principles for recognizing revenue. This ASU will supersede most of the existing revenue recognition requirements in GAAP. Under the new standard, revenue will be recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods and services. The standard creates a five-step model that will generally require companies to use more judgment and make more estimates than under current guidance when considering the terms of contracts along with all relevant facts and circumstances. These include the identification of customer contracts and separating performance obligations, the determination of transaction price that potentially includes an estimate of variable consideration, allocating the transaction price to each separate performance obligation, and recognizing revenue in line with the pattern of transfer. Additionally, disclosures required for revenue recognition will include qualitative and quantitative information about contracts with customers, significant judgments and changes in judgments, and assets recognized from costs to obtain or fulfill a contract. Such disclosures are more extensive than what is required under existing GAAP.

The guidance is effective for the Company beginning in the first quarter of the fiscal year ending September 30, 2019 (“fiscal 2019”). The Company has identified key personnel to evaluate the guidance and approve a transition method. The Company has assessed that the impact of the new guidance may result in a change of the Company’s revenue recognition model for electronics manufacturing services from “point in time” upon physical delivery to an “over time” model and believes this transition may have a material impact on the Company’s consolidated financial statements upon adoption primarily as it recognizes an increase in contract assets for unbilled receivables with a corresponding reduction in inventories. The Company has commenced implementation in accordance with the planned effective date. The new guidance allows for two transition methods in application: (i) retrospective to each prior reporting period presented, or (ii) modified retrospective with the cumulative effect of adoption recognized on October 1, 2018, the first day of the Company’s fiscal 2019.

34

The Company primarily provides contract manufacturing services to its customers. The customer provides a design, the Company procures materials and manufactures to that design and ships the product to the customer. Revenue is derived primarily from the manufacturing of electronics components which are built to customer specifications. Revenue is recognized as the customer's components are manufactured over time. The Company has an enforceable right to payment for work completed to date and the goods do not have an alternative use once the manufacturing process has commenced. The Company records an unbilled contract asset for finished goods associated with non-cancellable customer orders. The Company also records an unbilled contract asset for revenue related to its work-in-process inventory (“WIP”) when the manufacturing process has commenced and there is a non-cancellable customer purchase order. The Company uses an input method of direct manufacturing labor inputs to measure progress towards satisfying its performance obligation associated with WIP inventory.

The Company has contractual arrangements with many of its customers which require the customer to purchase any unused inventory that the Company has purchased to fulfill that customer’s manufacturing demand. Revenue from the sale of any excess inventory to the customer is recognized at a point in time when control transfers, which is typically when title passes to the customer upon shipment. The Company also derives revenue from the sale of procured finished goods, specifically for resale. Revenue from the sales of these goods is recognized when control transfers at a point in time, which is typically when title passes to the customer. The Company also derives revenue from engineering and design services. Service revenue is recognized over time as services are performed.

The Company will adopt the new guidance under the modified retrospective approach with a cumulative adjustment increasing the opening balance of retained earnings by approximately $0.5 million to $1.0 million, net of tax. Prior periods will not be retrospectively adjusted.

FASB ASU 2016-02, “Leases” was issued in February 2016. The new guidance establishes the principles to report transparent and economically neutral information about the assets and liabilities that arise from leases. For public entities, the new guidance is effective for annual periods beginning after December 15, 2018, or the Company’s fiscal year ending September 30, 2020, and interim periods within those annual periods. Early adoption is permitted for all entities. The Company is evaluating the impact this ASU will have on its consolidated financial statements.

Note 2—ALLOWANCE FOR DOUBTFUL ACCOUNTS

A summary of activity in the allowance for doubtful accounts during the years endedSeptember 30, 2018 and 2017 is as follows:

	Years Ended
Allowance for doubtful accounts	September 30, 2018		September 30, 2017
(in thousands)
Allowance, beginning of period	$	75	$	226
Change in provision for doubtful accounts	10		(144		)
Write-offs	—		(7		)
Allowance, end of period	$	85	$	75

Note 3—INVENTORIES

A summary of inventory by category at period end is as follows:

Inventories	September 30, 2018		September 30, 2017
(in thousands)
Raw materials	$	21,323	$	8,964
Work-in-process	11,263		5,080
Finished goods	1,540		1,561
Total inventories	$	34,126	$	15,605

35

Note 4—PROPERTY, PLANT AND EQUIPMENT, NET

A summary of property, plant and equipment and accumulated depreciation at period end is as follows:

Property, Plant and Equipment	September 30, 2018			September 30, 2017
(in thousands)
Land and improvements	$	788		$	788
Buildings and improvements	7,314			8,910
Building under capital lease	7,750			5,750
Machinery and equipment	30,969			27,947
Furniture and fixtures	7,877			7,520
Construction in progress	5,360			4,968
Total property, plant and equipment, at cost	60,058			55,883
Accumulated depreciation	(39,948		)	(38,106		)
Property, plant and equipment, net	$	20,110		$	17,777

Depreciation expense during the years endedSeptember 30, 2018 and 2017 follows:

	Years Ended
	September 30, 2018		September 30, 2017
(in thousands)
Depreciation expense	$	2,358	$	2,515

Note 5—CREDIT FACILITIES

A summary of borrowings at period end is as follows:   

	Fixed/			September 30, 2018					September 30, 2017
	Variable						Interest					Interest
Debt	Rate	Date		Balance			Rate		Balance			Rate
(in thousands)
M&T credit facilities:
Revolving Credit Facility	v	5/5/2022		$	12,996		5.26	%	$	8,769		3.73	%
Term Loan B	v	5/5/2022		3,636			5.36		5,714			3.99
Celmet Building Term Loan	f	11/7/2018	1	—			—		802			4.72
Equipment Line Advances	v	12/18/2018		314			5.56		—			—
Equipment Line Term Note	v	Various	2	794			5.56		—			—
Total debt, gross				17,740					15,285
Unamortized debt issuance costs				(289		)			(275		)
Total debt, net				17,451					15,010
Less: current portion				(1,449		)			(987		)
Long-term debt				$	16,002				$	14,023

¹ The Celmet Building Term Loan was repaid in connection with the sale-leaseback transaction described in Note 12—Capital Lease. Proceeds from the transaction were also used to pay down a portion of Term Loan B.

² On July 26, 2018 and September 27, 2018, $750 thousand and $86 thousand, respectively, of Equipment Line Advances matured and were converted to an Equipment Line Term Note.

M&T Bank Credit Facilities

Effective as of August 2, 2018, the Company and M&T Bank entered into the Sixth Amendment to the Fifth Amended and Restated Credit Facility Agreement, which amended the Fifth Amended and Restated Credit Facility Agreement dated as of December 14, 2015, as amended by various amendments (collectively, the “Credit Facility, as amended”).

36

The Credit Facility, as amended, is secured by a general security agreement covering the assets of the Company and its subsidiaries, a pledge of the Company’s equity interest in its subsidiaries, a negative pledge on the Company’s real property, and a guarantee by the Company’s subsidiaries, all of which restrict use of these assets to support other financial instruments.

Individual debt facilities provided under the Credit Facility, as amended, are described below:

a) Revolving Credit Facility (“Revolver”): At September 30, 2018, up to $22.0 million is available through May 5, 2022. The maximum amount the Company may borrow is determined based on a borrowing base calculation described below.

b) Term Loan B:$14.0 million was borrowed on January 18, 2013. Principal is being repaid in 120 equal monthly installments of $117 thousand. As part of an amendment to the Credit Facility, as amended, the principal was modified from $8.0 million to $6.0 million and principal is being repaid in equal monthly installments of $71 thousand plus a balloon payment of $0.6 million. The maturity date of the loan is May 5, 2022. The proceeds of the sale-leaseback transaction described in Note 12—Capital Lease, were used to pay down a portion of the loan.

c) Celmet Building Term Loan:$1.3 million was borrowed on November 8, 2013 pursuant to an amendment to the Credit Facility, as amended. The proceeds were used to reimburse the Company’s cost of purchasing its Rochester, New York facility. Principal was being repaid in 59 equal monthly installments of $11 thousand plus a balloon payment of $672 thousand due at maturity on November 7, 2018. The loan was repaid in connection with the sale-leaseback transaction described in Note 12—Capital Lease.

d) Equipment Line Advances: Up to $1.5 million is available through May 5, 2022. Interest only is paid until maturity. Principal is due six months after borrowing or can be converted to an Equipment Line Term Loan. On September 18, 2018, $0.3 million was borrowed.

e) Equipment Line Term Note: $0.8 million was converted from an Equipment Line Advance on July 26, 2018 and is being repaid in 36 equal monthly installments of $21 thousand and matures July 26, 2021. $0.1 million was converted from an Equipment Line Advance on September 27, 2018 and is being repaid in 36 equal monthly installments of $2 thousand and matures September 29, 2021.

Borrowing Base

At September 30, 2018, under the Credit Facility, as amended, the maximum amount the Company can borrow under the Revolver was the lesser of (i) 85% of eligible receivables plus a percentage of eligible inventories (up to a cap of $8.0 million) or (ii) $22.0 million at September 30, 2018 and September 30, 2017.

At September 30, 2018, the upper limit on Revolver borrowings was $22.0 million, and $9.0 million was available. At September 30, 2017, the upper limit on Revolver borrowings was $16.0 million with $7.2 million available. Average Revolver balances amounted to $12.5 million and $6.1 million during the years endedSeptember 30, 2018 and September 30, 2017, respectively.

Interest Rates

Under the Credit Facility, as amended, variable rate debt accrues interest at LIBOR plus the applicable marginal interest rate that fluctuates based on the Company’s Fixed Charge Coverage Ratio, as defined below. At September 30, 2018, the applicable marginal interest rate was 3.00% for the Revolver and 3.25% for Term Loan B and Equipment Line Advances. At September 30, 2017, the applicable marginal interest rate was 2.50% for the Revolver and 2.75% for Term Loan B.  Changes to applicable margins and unused fees resulting from the Fixed Charge Coverage Ratio generally become effective mid-way through the subsequent quarter.

The Company incurs quarterly unused commitment fees ranging from 0.250% to 0.375% of the excess of $22.0 million over average borrowings under the Revolver. Fees incurred amounted to $23.3 thousand and $50.0 thousand during the years endedSeptember 30, 2018 and September 30, 2017, respectively. The fee percentage varies based on the Company’s Fixed Charge Coverage Ratio, as defined below.

37

Financial Covenants

The Credit Facility, as amended, contains various affirmative and negative covenants including financial covenants. As of September 30, 2018, the Company had to maintain a minimum fixed charge coverage ratio (“Fixed Charge Coverage Ratio”). The Fixed Charge Coverage Ratio compares (i) EBITDAS minus unfinanced capital expenditures minus income tax expense, to (ii) the sum of interest expense, principal payments, payments on all capital lease obligations and dividends, if any (fixed charges). “EBITDAS” is defined as earnings before interest, income taxes, depreciation, amortization and non-cash stock compensation expense. The Fixed Charge Coverage Ratio was initially measured for a trailing six months ended September 30, 2017 and was measured for a trailing twelve months ended September 30, 2018 as a minimum of 1.10 times. The Fixed Charge Coverage Ratio was the only covenant in effect at September 30, 2018. The Credit Facility, as amended, also provides for customary events of default, subject in certain cases to customary cure periods, in which the outstanding balance and any unpaid interest would become due and payable.

The Company was in compliance with all financial debt covenants at September 30, 2018.

Contractual Principal Payments

A summary of contractual principal payments under IEC’s borrowings at September 30, 2018 for the next four years taking into consideration the Credit Facility, as amended, is as follows:

Debt Repayment Schedule		Contractual Principal Payments
(in thousands)
Twelve months ended September 30,
2019		$	1,449
2020		1,136
2021		1,094
2022	(1)	14,061
		$	17,740

⁽¹⁾ Includes Revolver balance of $13.0 million at September 30, 2018, maturing on May 5, 2022.

Note 6—FAIR VALUE OF FINANCIAL INSTRUMENTS

Financial Instruments Carried at Historical Cost

The Company’s long-term debt is not quoted.  Fair value was estimated using a discounted cash flow analysis based on Level 2 valuation inputs, including borrowing rates the Company believes are currently available to it for loans with similar terms and maturities.

The Company’s debt is carried at historical cost on the consolidated balance sheet. The fair value and carrying value of the Celmet Building Term Loan at September 30, 2017 was $0.8 million. As described in Note 12—Capital Lease, the Celmet Building Term Loan was repaid on May 11, 2018.

The fair value of the remainder of the Company’s debt approximated carrying value at September 30, 2018 and September 30, 2017, as it is variable rate debt.

Note 7—WARRANTY RESERVES

IEC generally warrants its products and workmanship for up to twelve months from date of sale.  As an offset to warranty claims, the Company is sometimes able to obtain reimbursement from suppliers for warranty-related costs or losses.  Based on historical warranty claims experience and in consideration of sales trends, a reserve is maintained for estimated future warranty costs to be incurred on products and services sold through the balance sheet date. The warranty reserve is included in other accrued expenses on the consolidated balance sheet.

38

A summary of additions to and charges against IEC’s warranty reserves during the period follows: 

	Years Ended
Warranty Reserve	September 30, 2018			September 30, 2017
(in thousands)
Reserve, beginning of period	$	153		$	180
Provision	266			137
Warranty costs	(246		)	(164		)
Reserve, end of period	$	173		$	153

Note 8—STOCK-BASED COMPENSATION

The 2010 Omnibus Incentive Compensation Plan (“2010 Plan”) was approved by the Company’s stockholders at the January 2011 Annual Meeting of Stockholders.  The 2010 Plan, which is administered by the Compensation Committee of the Board of Directors, provides for the following types of awards: incentive stock options, nonqualified options, stock appreciation rights, restricted shares, restricted stock units, performance compensation awards, cash incentive awards, director stock and other equity-based and equity-related awards.  Awards are generally granted to certain members of management and employees, as well as directors.  The Company also has an employee stock purchase plan (“ESPP”), adopted in 2011, that provides for the purchase of Company common stock at a discounted stock purchase price. Under the 2010 Plan, up to 2,000,000 common shares may be issued over a term of ten years. Under the ESPP, 150,000 shares of common stock may be purchased over a term of ten years.

Stock-based compensation expense recorded under the 2010 Plan totaled $0.5 million for each of the years endedSeptember 30, 2018 and 2017, respectively. 

At September 30, 2018, there were 415,710 remaining shares available to be issued under the 2010 Plan and 100,765 remaining shares available to be purchased under the ESPP.

Expenses relating to stock options that comply with certain U.S. income tax rules are neither deductible by the Company nor taxable to the employee.  Further information regarding awards granted under the 2010 Plan and ESPP is provided below.

Stock Options

When options are granted, IEC estimates fair value using the Black-Scholes option pricing model and recognizes the computed value as compensation cost over the vesting period, which is typically four years.  The contractual term of options granted under the 2010 Plan is generally seven years.  The volatility rate is based on the historical volatility of IEC’s common stock.

Assumptions used in the Black-Scholes model and the estimated value of options granted during the years endedSeptember 30, 2018 and 2017 follows:

	Years Ended
Valuation of Options	September 30, 2018			September 30, 2017
Assumptions for Black-Scholes:
Risk-free interest rate	2.84		%	1.50		%
Expected term in years	5.5			4.0
Volatility	33		%	39		%
Expected annual dividends	none			none
Value of options granted:
Number of options granted	120,000			57,500
Weighted average fair value per share	$	1.84		$	1.19
Fair value of options granted (000s)	$	221		$	68

39

A summary of stock option activity, together with other related data, follows:

	Years Ended
	September 30, 2018				September 30, 2017
Stock Options	Number of Options		Wgtd.  Avg. Exercise Price		Number of Options		Wgtd.  Avg. Exercise Price
Outstanding, beginning of period	743,045		$	4.27	759,795		$	4.43
Granted	120,000		5.19		57,500		3.64
Exercised	(1,400	)	4.08		—		—
Forfeited	(114,000	)	4.78		(44,500	)	5.67
Expired	(10,500	)	5.24		(29,750	)	5.04
Outstanding, end of period	737,145		$	4.33	743,045		$	4.27
For options expected to vest
Number expected to vest	724,398		$	4.32	727,403		$	4.29
Weighted average remaining life, in years	4.0				4.6
Intrinsic value (000s)			$	733			$	545
For exercisable options
Number exercisable	426,358		$	4.24	332,472		$	4.40
Weighted average remaining life, in years	3.3				4.1
Intrinsic value (000s)			$	467			$	229
For non-exercisable options
Expense not yet recognized (000s)			$	343			$	416
Weighted average years to be recognized	2.8				1.8
For options exercised
Intrinsic value (000s)			$	2			$	—

Restricted (Non-vested) Stock

Certain holders of IEC restricted stock have voting and dividend rights as of the date of grant, but until vested the shares may be forfeited and cannot be sold or otherwise transferred.  At the end of the vesting period, which is typically four or five years (three years in the case of directors), holders have all the rights and privileges of any other common stockholder.  The fair value of a share of restricted stock is its market value on the date of grant and that value is recognized as stock-based compensation expense over the vesting period. 

40

A summary of restricted stock activity, together with related data, follows: 

	Years Ended
	September 30, 2018				September 30, 2017
Restricted (Non-vested) Stock	Number of Non-vested Shares		Wgtd. Avg. Grant Date Fair Value		Number of Non-vested Shares		Wgtd. Avg. Grant Date Fair Value
Outstanding, beginning of period	109,695		$	4.01	115,950		$	4.16
Granted	44,878		4.29		39,576		3.79
Vested	(40,107	)	4.11		(31,559	)	4.25
Shares withheld for payment of taxes upon vesting of restricted stock	(1,743	)	3.70		(1,825	)	4.27
Forfeited	(9,490	)	4.20		(12,447	)	4.03
Outstanding, end of period	103,233		$	4.08	109,695		$	4.01
For non-vested shares
Expense not yet recognized (000s)			$	315			$	328
Weighted average remaining years for vesting			1.7				1.7
For shares vested
Aggregate fair value on vesting dates (000s)			$	187			$	123

Stock Issued to Board Members

In addition to annual grants of restricted stock, included in the table above, board members may elect to have their meeting fees paid in the form of shares of the Company’s common stock. The Company has not paid any meeting fees in stock since May 21, 2013. 

Restricted Stock Units

Holders of IEC restricted stock units do not have voting and dividend rights as of the date of grant, and, until vested, the units may be forfeited and cannot be sold or otherwise transferred.  At the end of the vesting period, which is typically three years, holders will receive shares of the Company’s common stock and have all the rights and privileges of any other common stockholder of the Company.  The fair value of a restricted stock unit is the market value of the underlying shares of the Company’s stock on the date of grant and that value is recognized as stock compensation expense over the vesting period. 

A summary of restricted stock unit activity, together with related data, follows: 

	Years Ended
	September 30, 2018				September 30, 2017
Restricted Stock Units	Number of Non-vested Shares		Wgtd. Avg. Grant Date Fair Value		Number of Non-vested Shares	Wgtd. Avg. Grant Date Fair Value
Outstanding, beginning of period	267,999		$	4.03	112,809	$	4.64
Granted	102,864		4.28		155,190	3.58
Vested	—		—		—	—
Forfeited	(200,371	)	4.22		—	—
Outstanding, end of period	170,492		$	3.96	267,999	$	4.03
For non-vested shares
Expense not yet recognized (000s)			$	352		$	329
Weighted average remaining years for vesting			2.3			2.0

41

Note 9—INCOME TAXES

(Benefit)/provision for income taxes during the years endedSeptember 30, 2018 and 2017 follows:

	Years Ended
Income Tax Provision	September 30, 2018			September 30, 2017
(in thousands)
Current tax:
State	$	6		$	53
Federal	12			9
Deferred tax:
State	(103		)	—
Federal	5,088			—
Valuation allowance	(13,840		)	—
(Benefit)/provision for income taxes	$	(8,837	)	$	62

Differences between the federal statutory rate and IEC’s effective tax rates for fiscal 2018 and fiscal 2017 are explained by the following reconciliation.

	Years Ended
Taxes as Percent of Pretax Income	September 30, 2018		September 30, 2017
Federal statutory rate	24.2	%	34.0	%
Decrease in valuation allowance	(880.0	)	(164.4	)
Deferred tax adjustment	(21.2	)	65.8
Decrease in state deferred tax rate	(6.6	)	—
State income taxes, net of federal benefit	0.4		26.8
Rate change due to Tax Reform	316.6		—
Stock-based compensation	7.3		57.6
Non-deductible expenses	0.6		23.5
Other	(3.2	)	—
Income tax provision as percent of pretax income	(561.9	)%	43.3	%

42

The following table displays deferred tax assets by category:

	As of
	September 30, 2018			September 30, 2017
(in thousands)
Deferred tax assets:
Federal and state net operating loss carryforward	$	6,366		$	11,367
Alternative minimum tax credit carryforward	1,031			1,010
Depreciation and fixed assets	306			289
Amortization and impairment of intangibles	27			28
New York State investment tax and other credits	1,308			1,186
Inventories	382			585
Deferred gain on sale-leaseback	431			271
Other	312			412
Total before allowance	10,163			15,148
Valuation allowance	(1,308		)	(15,148		)
Deferred tax assets, net	$	8,855		$	—

On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act significantly revises the future ongoing U.S. corporate income tax by, among other things, lowering U.S. corporate income tax rates and implementing a territorial tax system. As the Company has a September 30 fiscal year-end, the lower corporate income tax rate will be phased in, resulting in a U.S. statutory federal tax rate of approximately 24.2% for fiscal 2018, and 21% for subsequent fiscal years. The Tax Act eliminates the domestic manufacturing deduction and moves to a territorial system. In addition, previously paid federal AMT will now be refundable regardless of whether there is future income tax liability before AMT credits.

The Company has concluded that the Tax Act has caused the Company’s U.S. deferred tax assets and liabilities to be revalued. Deferred income taxes result from temporary differences between the tax basis of assets and liabilities and their reported basis in the financial statements that will result in taxable or deductible amounts in future years. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in years in which those temporary differences are expected to be recovered or settled. As changes in tax laws or rates are enacted, deferred tax assets and liabilities are revalued and any change is adjusted through the provision for income tax expense in the reporting period of the enactment. As of September 30, 2018, the Company has completed its analysis of the impact of the Tax Act under SAB 118.

For the year ended September 30, 2018, the impact of the Tax Act resulted in the Company recording a tax expense of approximately $4.7 million due to the change in the tax rate. This was offset by a corresponding decrease to the valuation allowance of approximately $5.8 million, resulting in a net tax benefit of approximately $1.0 million related to the release of the valuation allowance on the Company’s AMT credits.

As of September 30, 2018, the Company’s deferred tax assets were primarily the result of U.S. federal net operating loss carryforwards (“NOLs”) and tax credit carryforwards. A valuation allowance of $1.3 million and $15.1 million was recorded against our gross deferred tax asset balance as of September 30, 2018, and September 30, 2017, respectively. During the year ended September 30, 2018, management evaluated both positive and negative evidence to consider the reversal of the valuation allowance on the Company's net deferred income tax assets and determined in the fourth quarter of fiscal 2018 that there was sufficient positive evidence to conclude that it is more likely than not that the Company's deferred income tax assets are realizable. As a result, in the fourth quarter of fiscal 2018 the Company recorded a $7.8 million income tax benefit to release most of the valuation allowance against the Company's net deferred income tax assets.

Management performs an assessment of positive and negative evidence regarding the realization of the Company's net deferred income tax assets as required by ASC 740. For the year ended September 30, 2017, we determined that a valuation allowance was needed for all of our net deferred income tax assets, based on the required weight of positive and negative evidence under ASC 740, including consideration of the Company's three-year cumulative losses at that time.

IEC has NOLs for income tax purposes of approximately $29.7 million at September 30, 2018, expiring mainly in years 2022 through 2025 and 2031 through 2035. The Company also has additional state NOLs available in several jurisdictions in which it files.

43

Recent New York state corporate tax reform has resulted in the reduction of the business income base rate for qualified manufacturers in New York state to 0% beginning in fiscal 2016 for IEC. At September 30, 2018, the Company had $1.6 million of New York State investment tax and other credit carryforwards, expiring in various years through 2031.  The credits cannot be utilized unless the New York state tax rate is no longer 0%, and as such, the Company has recorded a valuation allowance against the full amount of these credit carryforwards (net of the federal benefit).

Note 10—MARKET SECTORS AND MAJOR CUSTOMERS

A summary of sales, according to the market sector within which IEC’s customers operate, is as follows:

	Years Ended
% of Sales by Sector	September 30, 2018	September 30, 2017
Aerospace and Defense	59%	52%
Medical	22%	28%
Industrial	19%	20%
	100%	100%

Two individual customers represented 10% or more of sales for the year endedSeptember 30, 2018. One customer in the aerospace and defense sector totaled 23% and one customer in the medical sector totaled 11%. In the prior fiscal year, two individual customers represented 10% or more of sales, one customer in the medical sector totaled 14%, while the other customer in the aerospace and defense sector totaled 13%.

Three individual customers represented 10% or more of receivables and accounted for 55% of outstanding balances at September 30, 2018. At September 30, 2017, three individual customers represented 10% or more of receivables and accounted for 42% of such outstanding balances.

Credit risk associated with individual customers is periodically evaluated by analyzing the entity’s financial condition and payment history.  Customers generally are not required to post collateral.

Note 11—COMMITMENTS AND CONTINGENCIES

Litigation

From time to time, the Company may be involved in legal actions in the ordinary course of its business, but management does not believe that any such proceedings, individually or in the aggregate, will have a material adverse effect on the Company’s consolidated financial statements.

Note 12—CAPITAL LEASE

Leases

On November 18, 2016, the Company entered into a sale-leaseback agreement, pursuant to the terms of a purchase and sale agreement, with Store Capital Acquisitions, LLC, a Delaware limited liability company (the “Purchaser”), for the sale of certain property, including the manufacturing facility located in Albuquerque, New Mexico (the “Albuquerque Property”). Albuquerque (the “Seller”) completed the sale of the Albuquerque Property to the Purchaser for an aggregate purchase price of approximately $5.8 million including a $0.1 million holdback held subject to a holdback of funds agreement. The net book value of assets sold was $4.6 million and the value of the assets acquired under the lease is $5.8 million. The Company recorded a deferred gain of $1.1 million related to the transaction, which is recorded in other long-term liabilities section of the consolidated balance sheets. The proceeds from the transaction were used to pay off the Albuquerque Mortgage Loan and pay down Term Loan A. As part of the transaction, a Lease Agreement dated as of November 18, 2016 was entered into between the Seller and the Purchaser (the “Lease”). Pursuant to the Lease, the Seller is leasing the Albuquerque Property for an initial term of 15 years, with two renewal options of five years each. The initial base annual rent is approximately $0.5 million and is subject to an annual increase equal to the lesser of 2% or 1.25 times the change in the Consumer Price Index. If an event of default occurs under the terms of the Lease, among other things, all rental amounts accelerate and become due and owing, subject to certain adjustments.

On April 10, 2018, the Company entered into a purchase and sale agreement, with the Purchaser, for the sale of the Company’s manufacturing facility located in Rochester, New York (the “Rochester Property”). The Rochester Property was sold for $2.0

44

million, and the net book value of the assets sold was $1.2 million. The Company recorded a deferred gain of $0.7 million related to the transaction, which is recorded in other long-term liabilities section of the consolidated balance sheet. The proceeds from the transaction were used to pay off the Celmet Building Term Loan and pay down a portion of Term Loan B. In conjunction with this purchase, the Lease was amended to include the Rochester Property. The amended Lease includes both the lease-back of the Rochester Property and the Albuquerque Property. The lease term for both properties expires on May 31, 2033 and provides for renewals of two successive periods of 5 years each.

A summary of capital lease payments for the next five years is as follows:

Capital Lease Payment Schedule	Contractual Principal Payments
(in thousands)
Twelve months ended September 30,
2019	$	658
2020	671
2021	685
2022	698
2023 and thereafter	7,413
Total capital lease payments	10,125
Less: amounts representing interest	(2,792		)
Present value of minimum lease payment	$	7,333

Note 13—EARNINGS PER SHARE

The Company applies the two-class method to calculate and present net income per share. Certain of the Company’s restricted (non-vested) share awards contain non-forfeitable rights to dividends and are considered participating securities for purposes of computing net income per share pursuant to the two-class method. Under the two-class method, net earnings are reduced by the amount of dividends declared (whether paid or unpaid) and the remaining undistributed earnings are then allocated to common stock and participating securities, based on their respective rights to receive dividends.

Basic earnings per common share are calculated by dividing income available to common stockholders by the weighted average number of shares outstanding during each period.  Diluted earnings per common share add to the denominator incremental shares resulting from the assumed exercise of all potentially dilutive stock options, as well as unvested restricted stock and restricted stock units.  Options, restricted stock and restricted stock units are primarily held by directors, officers and certain employees. 

The Company uses the two-class method to calculate net income per share as both classes share the same rights in dividends. Therefore, basic and diluted earnings per share (“EPS”) are the same for both classes of ordinary shares.

45

A summary of shares used in the EPS calculations is as follows (in thousands except share and per share data):

	Years Ended
Earnings Per Share	September 30, 2018		September 30, 2017
Basic net income per share:
Net income	$	10,410	$	81
Less: Income attributable to non-vested shares	104		1
Net income available to common stockholders	$	10,306	$	80
Weighted average common shares outstanding	10,228,596		10,181,868
Basic net income per share	$	1.01	$	0.01
Diluted net income per share:
Net income	$	10,410	$	81
Shares used in computing basic net income per share	10,228,596		10,181,868
Dilutive effect of non-vested shares and options	91,607		—
Shares used in computing diluted net income per share	10,320,203		10,181,868
Diluted net income per share	$	1.01	$	0.01

The diluted weighted average share calculations do not include the following securities, which are not dilutive to the EPS calculations.

	Years Ended
	September 30, 2018	September 30, 2017
Anti-dilutive shares excluded	32,788	855,836

Note 14—QUARTERLY FINANCIAL DATA (UNAUDITED)

The accompanying unaudited financial information for the three month periods specified below have been prepared in accordance with GAAP for interim financial information. In the opinion of management, all adjustments required for a fair presentation of the information have been made.

46

Note that quarterly amounts are rounded separately and as a result the sum of the quarterly amounts may not equal the computed amount for the full year.

	Net Sales		Gross Profit		Net Income/(Loss)				Basic and Diluted Earnings/(Loss) Per Share
(Unaudited; in thousands, except per share data)
Fiscal Quarters
Fourth 2018	$	34,216	$	4,496	$	9,121		(a)	$	0.89
Third 2018	29,782		3,359		204				0.02
Second 2018	31,768		4,784		1,579				0.15
First 2018	21,156		1,518		(494		)		(0.05		)
Fourth 2017	$	27,623	$	3,475	$	755			$	0.07
Third 2017	26,489		3,708		794				0.08
Second 2017	21,368		2,279		(603		)		(0.06		)
First 2017	20,976		1,795		(865		)		(0.09		)

^(a)  Fourth quarter 2018 was impacted by a $7.8 million income tax benefit recorded to release the majority of the valuation allowance against the net deferred income tax assets.

47

Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

Item 9A. CONTROLS AND PROCEDURES

Conclusion regarding the effectiveness of disclosure controls and procedures

Our management, with the participation of our Chief Executive Officer (our principal executive officer) and Chief Financial Officer (our principal financial officer), evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of September 30, 2018, the end of the period covered by this Form 10-K.  Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2018, our disclosure controls and procedures were effective.

Management’s Annual Report on Internal Control over Financial Reporting

Our management, under the supervision of our Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Exchange Act Rules 13a-15(f) and 15d-15(f).  Our internal control system was designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America.  The Company’s internal control over financial reporting includes those policies and procedures that:

(i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and asset dispositions of the Company;

(ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and

(iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on financial statements.

IEC’s management does not expect that our disclosure controls and internal controls will prevent all errors and fraud. Because of inherent limitations in any such control system (e.g. faulty judgments, human error, information technology system error, or intentional circumvention), there can be no assurance that the objectives of a control system will be met under all circumstances. Moreover, projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. The benefits of a control system also must be considered relative to the costs of the system and management’s judgments regarding the likelihood of potential events. In summary, there can be no assurance that any control system will succeed in achieving its goals under all possible future conditions, and as a result of these inherent limitations, misstatements due to error or fraud may occur and may or may not be detected.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our internal control over financial reporting, as of September 30, 2018, based on the framework entitled “Internal Controls - Integrated Framework (2013)” issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this evaluation, our internal control over financial reporting was effective as of September 30, 2018.

This annual report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting because the Securities and Exchange Commission’s rules regarding such attestations do not apply to smaller reporting companies.

Changes in internal control over financial reporting

The Company is in the process of implementing a financial reporting system, Epicor ERP Software (“Epicor”), as part of a multi-year plan to integrate and upgrade our systems and processes.  The implementation has occurred in phases throughout fiscal 2017 and fiscal 2018, and is expected to be completed during fiscal 2019. 

48

As part of the Epicor implementation, certain changes to our processes and procedures have and will continue to occur.  These changes will result in changes to our internal control over financial reporting.  While Epicor is designed to strengthen our internal financial controls by automating certain manual processes and standardizing business processes and reporting across our organization, management will continue to evaluate and monitor our internal controls as each of the affected areas evolve.

During the quarter ended September 30, 2018, there have been no other changes in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Item 9B. OTHER INFORMATION

None.

PART III

Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The information required by this item is incorporated herein by reference from the captions entitled “Election of Directors - Nominees for Election as Directors,” “Section 16(a) Beneficial Ownership Reporting Compliance” and “Election of Directors - Corporate Governance and Board Matters” contained in our definitive proxy statement for the 2019 Annual Meeting of Stockholders to be filed within 120 days after the September 30, 2018 fiscal year end (the “2019 Proxy Statement”).

The information regarding our Executive Officers is found in Part I of this Form 10-K. 

Item 11. EXECUTIVE COMPENSATION

The information required by this item is incorporated herein by reference from the captions entitled “Compensation of Named Executive Officers” and “Director Compensation” contained in the 2019 Proxy Statement.

Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The information required by this item is incorporated herein by reference from the captions entitled “Security Ownership of Certain Beneficial Owners” and “Security Ownership of Management” contained in the 2019 Proxy Statement.

Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The information required by this item is incorporated herein by reference from the captions “Certain Relationships and Related Person Transactions” and “Election of Directors - Nominees for Election as Directors,” and “Election of Directors - Corporate Governance and Board Matters” contained in the 2019 Proxy Statement.

Item 14.  PRINCIPAL ACCOUNTANT FEES AND SERVICES

The information required by this item is incorporated herein by reference from the caption “Ratification of the Selection of the Company’s Independent Registered Public Accounting Firm For Fiscal 2019” contained in the 2019 Proxy Statement.

49

PART IV

Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

The following documents are filed as part of this Form 10-K:

Financial Statements

Reference is made to Item 8, “Financial Statements and Supplementary Data” of Part II of this Form 10-K. No financial statement schedules are required to be filed by Item 8 of Part II of this Form 10-K.

Exhibits

Exhibit No.	Title
3.1	Amended and Restated Certificate of Incorporation of DFT Holdings Corp. (incorporated herein by reference from Exhibit 3.1 to the Company’s Registration Statement on Form S-1, Registration No. 33-56498)
3.2	Certificate of Ownership and Merger merging IEC Electronics Corp. into DFT Holdings Corp. (incorporated herein by reference from Exhibit 3.5 to the Company’s Registration Statement on Form S-1, Registration No. 33-56498)
3.3	Certificate of Amendment of the Certificate of Incorporation of IEC Electronics Corp. (incorporated herein by reference from Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 27, 1998)
3.4	Certificate of Designation of Series A Junior Participating Preferred Stock of IEC Electronics Corp. (incorporated herein by reference from Exhibit 3.1 to the Company’s Current Report on Form 8-K/A filed August 1, 2014)
3.5	Certificate of Elimination of Series A Junior Participating Preferred Stock (incorporated herein by reference from Exhibit 3.1 to the Company’s Current Report on Form 8-K filed March 13, 2015)
3.6	Bylaws, as amended through May 12, 2016 (incorporated herein by reference from Exhibit 3.1 to the Company’s Current Report on Form 8-K filed May 18, 2016)
10.1	Fifth Amended and Restated Credit Facility Agreement dated as of December 14, 2015 between IEC Electronics Corp. and Manufacturers and Traders Trust Company (incorporated by reference from Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended January 1, 2016)
10.2	First Amendment to Fifth Amended and Restated Credit Facility Agreement dated as of June 20, 2016 by and between IEC Electronics Corp. and Manufacturers and Traders Trust Company (incorporated herein by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed June 24, 2016)
10.3	Second Amendment to Fifth Amended and Restated Credit Facility Agreement dated as of November 28, 2016 by and between IEC Electronics Corp. and Manufacturers and Traders Trust Company (incorporated herein by reference from Exhibit 10.13 to the Company’s Annual Report on Form 10-K for the year ended September 30, 2016)
10.4	Third Amendment to Fifth Amended and Restated Credit Facility Agreement dated as of May 5, 2017 (incorporated herein by reference from Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2017)
10.5	Fourth Amendment to Fifth Amended and Restated Credit Facility Agreement dated as of January 26, 2018 (incorporated herein by reference from Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 30, 2018)
10.6	Fifth Amendment to Fifth Amended and Restated Credit Facility Agreement dated as of April 20, 2018 (incorporated herein by reference from Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 30, 2018)
10.7	Sixth Amendment to Fifth Amended and Restated Credit Facility Agreement dated as of August 2, 2018 (incorporated herein by reference from Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 29, 2018)
10.8	Purchase and Sale Agreement dated as of September 30, 2016 by and between IEC Electronics Corp. - Albuquerque and Store Capital Acquisitions, LLC (incorporated herein by reference from Exhibit 10.14 to the Company’s Annual Report on Form 10-K for the year ended September 30, 2016)
10.9	Lease Agreement dated as of November 18, 2016 by and between Store Capital Acquisitions, LLC and IEC Electronics Corp. - Albuquerque (incorporated herein by reference from Exhibit 10.15 to the Company’s Annual Report on Form 10-K for the year ended September 30, 2016)

50

10.10	Securities and Exchange Commission Administrative Order (Release No. 34-78017) issued as of June 8, 2016 (incorporated herein by reference from Exhibit 10.16 to the Company’s Annual Report on Form 10-K for the year ended September 30, 2016)
10.11*	Form of Indemnification Agreement between IEC Electronics Corp. and its directors and executive officers (incorporated herein by reference from Exhibit 10.12 to the Company’s Annual Report on Form 10-K for the year ended September 30, 2015)
10.12*	IEC Electronics Corp. 2010 Omnibus Incentive Compensation Plan (incorporated herein by reference from Exhibit 10.12 to the Company’s Annual Report on Form 10-K for the year ended September 30, 2011)
10.13*	Form of Incentive Stock Option Agreement pursuant to the 2010 Omnibus Incentive Compensation Plan (incorporated herein by reference from Exhibit 10.12 to the Company’s Annual Report on Form 10-K for the year ended September 30, 2012)
10.14*	Form of Employee Restricted Stock Award Agreement pursuant to the 2010 Omnibus Incentive Compensation Plan (incorporated herein by reference from Exhibit 10.13 to the Company’s Annual Report on Form 10-K for the year ended September 30, 2012)
10.15*	Form of Director Restricted Stock Award Agreement pursuant to the 2010 Omnibus Incentive Compensation Plan (incorporated herein by reference from Exhibit 10.14 to the Company’s Annual Report on Form 10-K for the year ended September 30, 2012)
10.16*	IEC Electronics Corp. Form of Restricted Share Award Agreement Pursuant to 2010 Omnibus Incentive Plan (incorporated herein by reference from Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 30, 2018)
10.17*	IEC Electronics Corp. Form of Director Restricted Share Award Agreement Pursuant to 2010 Omnibus Incentive Compensation Plan (incorporated herein by reference from Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 30, 2018)
10.18*	Employee Stock Purchase Plan (incorporated herein by reference from Appendix A to the Company’s Proxy Statement on Schedule 14A filed on December 22, 2011)
10.19*	Employee Stock Purchase Plan Amendment 1 (incorporated herein by reference from Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 27, 2014)
10.20*	Amended and Restated Employment Agreement between IEC Electronics Corp. and W. Barry Gilbert dated as of December 16, 2013 (incorporated herein by reference from Exhibit 10.2 to the Company’s Current Report on Form 8-K filed December 19, 2013)
10.21*	Separation Agreement effective March 16, 2016 by and between the Company and W. Barry Gilbert (incorporated herein by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed March 18, 2016)
10.22*	Employment Agreement dated as of September 14, 2015 between IEC Electronics Corp. and Michael T. Williams (incorporated herein by reference from Exhibit 10.30 to the Company’s Annual Report on Form 10-K for the year ended September 30, 2015).
10.23*	Employment Agreement dated as of March 20, 2015 between IEC Electronics Corp. and Jeffrey T. Schlarbaum (incorporated herein by reference from Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 27, 2015)
10.24*	Sign-on Option Award Agreement (Inducement Grant) between IEC Electronics Corp. and Jeffrey T. Schlarbaum (incorporated herein by reference from Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 27, 2015)
10.25*	Sign-on Option Award Agreement (Pursuant to 2010 Omnibus Incentive Compensation Plan) between IEC Electronics Corp. and Jeffrey T. Schlarbaum (incorporated herein by reference from Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 27, 2015)
10.26*	Employment Agreement dated as of September 8, 2015 between IEC Electronics Corp. and Jens Hauvn (incorporated herein by reference from Exhibit 10.37 to the Company’s Annual Report on Form 10-K for the year ended September 30, 2015).
10.27*	IEC Electronics Corp. Management Deferred Compensation Plan, as amended (incorporated herein by reference from Exhibit 10.43 to the Company’s Annual Report on Form 10-K/A for the year ended September 30, 2014)
10.28*	IEC Electronics Corp. Board of Directors Deferred Compensation Plan (incorporated herein by reference from Exhibit 10.22 to the Company’s Annual Report on Form 10-K for the year ended September 30, 2009)
10.29*	Waiver of Annual Bonus for 2017 Fiscal Year dated as of March 23, 2017 between IEC Electronics Corp. and Jeffrey T. Schlarbaum (incorporated herein by reference from Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2017)
10.30*	Waiver of Annual Bonus for 2017 Fiscal Year dated as of March 23, 2017 between IEC Electronics Corp. and Michael T. Williams (incorporated herein by reference from Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2017)
10.31*	Waiver of Annual Bonus for 2017 Fiscal Year dated as of March 23, 2017 between IEC Electronics Corp. and Jens Hauvn (incorporated herein by reference from Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2017)

51

10.32*#	Employment Agreement dated as of September 4, 2018 between IEC Electronics Corp. and Thomas L. Barbato
21.1#	Subsidiaries of IEC Electronics Corp.
23.1#	Consent of Independent Registered Public Accounting Firm
31.1#	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2#	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1#	Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101	The following items from this Annual Report on Form 10-K formatted in Extensible Business Reporting Language: (i) Consolidated Balance Sheets, (ii) Consolidated Income Statements, (iii) Consolidated Statements of Changes in Stockholders’ Equity, (iv) Consolidated Statements of Cash Flows, and (v) Notes to Consolidated Financial Statements.

* Management contract or compensatory plan or arrangement.

# Filed herewith.

52

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		IEC Electronics Corp.
		(Registrant)
Dated: November 29, 2018	By:	/s/ Jeffrey T. Schlarbaum
		Jeffrey T. Schlarbaum
		President and Chief Executive Officer
		(Principal Executive Officer)

53

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature	Title	Date
/s/ Jeffrey T. Schlarbaum	President and Chief Executive Officer
Jeffrey T. Schlarbaum	(Principal Executive Officer and Director)	November 29, 2018
/s/ Thomas L. Barbato	Senior Vice President and Chief Financial Officer	November 29, 2018
Thomas L. Barbato	(Principal Financial and Accounting Officer)
/s/ Keith M. Butler	Director	November 29, 2018
Keith M. Butler
/s/ Charles P. Hadeed	Director	November 29, 2018
Charles P. Hadeed
/s/ Lynn J. Hartrick	Director	November 29, 2018
Lynn J. Hartrick
/s/ Andrew M. Laurence	Director	November 29, 2018
Andrew M. Laurence
/s/ Jeremy R. Nowak	Chairman of the Board	November 29, 2018
Jeremy R. Nowak
/s/ Michael Osborne	Director	November 29, 2018
Michael Osborne

54

EX-10.32

Exhibit 10.32

EMPLOYMENT AGREEMENT

This Employment Agreement (“Agreement”) is entered into and effective as of September 4, 2018 (“Effective Date”), between IEC Electronics Corp. (“Company”) and Thomas L. Barbato (“Executive”).

WHEREAS, the Company and the Executive wish for the Company to continue to employ the Executive upon the terms and conditions as set forth in this Agreement;

NOW, THEREFORE, in consideration of the mutual covenants and promises contained herein, and for other good and valuable consideration, the receipt and sufficiency of which the parties acknowledge mutually, the parties agree as follows:

1.Employment and Duties.

1.1Employment by the Company. The Company agrees to employ the Executive to render exclusive and full-time services in the capacity of Chief Financial Officer and Senior Vice President, subject to the control and direction of the Company’s Chief Executive Officer (“CEO”).

1.2Duties/Authority. The Executive shall be responsible for conducting the Company’s business and fiscal affairs and for the general supervision of and control over the Company’s financial assets, business interests, and agents, in each case subject to the CEO’s control and direction. The Executive’s duties shall be consistent with the duties, responsibilities, and authority generally incident to the position of CFO and shall include such other reasonably related duties as may be assigned to him from time to time by the CEO. In performing his duties, Executive agrees to abide by all bylaws, policies, practices, procedures, and rules of the Company.

1.3Corporate Opportunities. The Executive agrees that he shall not take personal advantage of any business opportunities that arise during employment that may benefit the Company. The Executive must promptly report to the CEO, for the Company’s consideration, all material facts regarding such opportunities.

2.Term of Employment. The term of this Agreement shall commence on the Effective Date and continue until terminated as provided in Section 4 below.

3.Compensation.

3.1Salary. As consideration for services rendered, the Company shall pay the Executive an annual salary of $235,000 (“Base Salary”), payable in equal installments at such intervals as are the usual custom of the Company, but not less frequently than monthly. The Executive’s Base Salary will be reviewed periodically for increases by the CEO. Unless offset pursuant to Section 3.8, Executive’s Base Salary shall not be decreased.

3.2Annual Bonus. Pursuant to the terms of the Company’s Management Incentive Plan or any successor arrangement thereto (“MIP”), the Executive shall be eligible to receive a performance bonus for each fiscal year of the Company, which shall be subject to the Executive’s continued employment with the Company and the accomplishment of the specific performance goals established by the Compensation Committee for such fiscal year (“Annual Bonus”), with a target value of at least 45% of the Executive’s Base Salary for such fiscal year. The Compensation Committee, in its sole discretion, but in consultation with the CEO, shall establish the following for the MIP for each fiscal year: (a) the applicable performance criteria and goals (“Targets”); (b) the relative weightings, if any, of the

Exhibit 10.32

Targets; and (c) the percentage of the target Annual Bonus that the Executive will be able to earn upon achievement of certain percentages of the Targets, including the percentages of performance in excess of 100% of Target in which event a higher Annual Bonus will be earned, and which may include minimum percentages below which no Annual Bonus will be earned. The calculation of the Annual Bonus shall be determined by the Compensation Committee, in its reasonable discretion following the completion of the Company’s audit for such fiscal year, and the Annual Bonus for a given fiscal year shall be paid within 15 days of the receipt by the Company of the audited financial statements for such fiscal year, but no later than the 15th day of the third month following the end of such fiscal year. If this Agreement terminates other than at the end of a fiscal year and if the Executive is entitled to a pro rata Annual Bonus for such partial fiscal year pursuant to Section 5 hereof, such pro rata Annual Bonus shall be equal to the Annual Bonus that the Executive would have received under the MIP, based on the Target for such fiscal year, multiplied by a fraction, the numerator of which shall be the number of days during such fiscal year he was so employed and the denominator of which shall be the number of days in such fiscal year (“Pro Rata Annual Bonus”). The Executive also may be entitled to the Annual Bonus for the fiscal year prior to the fiscal year in which the Executive is terminated, to the extent not yet paid (“Preceding Bonus”). The Executive shall be entitled to receive the Preceding Bonus and/or the Pro Rata Bonus, as applicable, at the time the Annual Bonus is payable pursuant to the terms of the MIP. The Annual Bonus shall, in all respects, be subject to the terms of the MIP.

3.3LTIP Incentive. The Executive will be eligible to participate in the long-term incentive award program of the Company on such terms as are established by the Compensation Committee from time to time (any such awards and any stock options granted pursuant to Section 3.4 of this Agreement, “LTIP Awards”).

3.4Sign-On Award. Promptly following the Effective Date of this Agreement and subject to the approval of the Compensation Committee, the Company shall grant to the Executive a stock option under the terms of the Company’s 2010 Omnibus Incentive Compensation Plan and applicable award agreement thereunder, to purchase up to 100,000 of the Company’s Common Stock. Unless the Compensation Committee provides otherwise, any stock option granted pursuant to this Section 3.3 shall have an exercise price per share equal to the fair market value of a share of Common Stock on the date of grant thereof, and subject to the Executive’s continued employment with the Company, shall vest and become exercisable as follows: 25% will vest upon the first anniversary of the date of grant; 25% will vest upon the second anniversary of the date of grant; 25% will vest upon the third anniversary of the date of grant; and the remaining 25% will vest upon the fourth anniversary of the date of grant.

3.5Participation in Employee Benefit Plans. The Executive shall be permitted, if and to the extent eligible, to participate in any employee welfare and health benefit plans (including, but not limited to, life insurance, health and medical, dental, and disability insurance plans) and other employee benefit plans (including, but not limited to, qualified pension plans) that are available generally to other senior executives of the Company. The Executive shall be required to comply with any conditions required for coverage by such plans and shall comply with and be entitled to benefits only in accordance with the terms and conditions of such plans as they may be amended from time to time.

3.6Expenses. The Company shall pay or reimburse the Executive for all reasonable expenses (including travel expenses) actually incurred or paid by the Executive during his employment in the performance of the Executive’s services under this Agreement. Such reimbursement shall be paid upon presentation of supporting expense statements, receipts or such other supporting information as the Company may require, and in accordance with the Company’s reimbursement policies generally applicable to other senior executives.

Exhibit 10.32

3.7Paid Time Off. The Executive shall be entitled to twenty-seven (27) days of paid time off accrued annually in accordance with the IEC policy.

3.8Clawback. In the event the Company is required to prepare an accounting restatement of its financial statements due to the Company’s material noncompliance with any financial reporting requirements under the Securities Act of 1933, as amended on the Securities Exchange Act of 1934 as amended, and the accounting restatement results from the Executive’s willful or grossly negligent conduct or from Executive’s financial dishonesty, the Executive shall reimburse or forfeit (as the case may be) any compensation received or due Executive pursuant to Sections 3.2, 3.3 and 3.4 during the three (3) year period preceding the date on which the Company is required to prepare an accounting restatement. The amount to be recovered shall be the excess of the compensation paid to the Executive pursuant to Sections 3.2, 3.3 and 3.4 based on the erroneous dates over the amount of compensation pursuant to Section 3.2, 3.3 and 3.4 that would have been paid to the Executive had it been based on the restated results, as determined by the Company’s Board of Directors (Board”). For purposes of this Section 3.8, “financial dishonesty” shall mean a material misstatement or material omission in the Company’s disclosure documents including but not limited to documents filed or furnished pursuant to the Securities Exchange Act of 1934 as amended, press releases or the Company’s disclosure documents filed under the Securities Act of 1933, as amended.

The Board will determine, in its sole discretion, the method for recouping compensation paid pursuant to Sections 3.2, 3.3 and 3.4 hereunder which may include, without limitation:

(a) requiring reimbursement of cash incentive compensation previously paid;

(b) seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer or other disposition of any equity-based awards;

(c) offsetting the recouped amount from any compensation otherwise owed by the Company to the Executive;

(d) cancelling outstanding vested or unvested equity awards; and/or

(e) taking any other remedial and recovery action permitted by law, as determined by the Board.

4.Termination or Removal from Duties.

4.1Termination Upon Death. This Agreement shall terminate automatically upon the Executive’s death.

4.2Removal from Position Upon Disability. If during the Executive’s employment, as a result of a physical or mental incapacity or infirmity, the Executive is unable to perform the essential functions of his job with or without reasonable accommodation for a period of six (6) continuous months, the Executive shall be deemed disabled (“Disability”) and the Company, by written notice to the Executive, shall have the right to remove him from his position. The Executive’s status as an inactive employee of the Company shall continue after such removal for the period of time that his Disability continues. However, the Company shall have no obligation to reinstate or otherwise continue the Executive’s employment if he should recover from his Disability and any such termination shall not constitute a termination without Cause or without Good Reason (as herein defined). The existence of a

Exhibit 10.32

Disability shall be determined by a reputable, licensed physician selected by the Company in good faith, whose determination shall be final and binding on the parties.

4.3Termination for Cause. The Company may at any time, by written notice to the Executive, terminate the Executive’s employment hereunder for Cause. For purposes hereof, the term “Cause” shall mean: (A) Executive’s conviction of or pleading guilty or no contest to a felony; (B) failure or refusal of the Executive in any material respect (i) to perform the duties of his employment or to follow the lawful and proper directives of the Board, provided such duties or directives are consistent with this Agreement and such duties or directives have been given to the Executive in writing, or (ii) to comply with the reasonable and substantial written policies, practices, standards or regulations of the Company (so long as same are not inconsistent with this Agreement) as may be established from time to time, if such failure or refusal under either clause (i) or clause (ii) continues uncured for a period of thirty (30) days after written notice thereof, specifying the nature of such failure or refusal and requesting that it be cured, is given by the Company to the Executive; (C) any willful or intentional act of the Executive committed for the purpose, or having the reasonably foreseeable effect, of injuring the Company, its business or reputation, or of improperly or unlawfully converting for the Executive’s own personal benefit any property of the Company, if such act or conduct is not cured or capable of cure within a period of thirty (30) days after written notice thereof, specifying the nature of such failure or refusal and requesting that it be cured, is given by the Company to the Executive; or (D) any violation or breach of the provisions of Section 6 of this Agreement.

4.4Termination without Cause. The Company may terminate the Executive’s employment without Cause at any time.

4.5Termination for Good Reason. With thirty (30) days’ prior written notice to the Company, Executive may terminate his employment and this Agreement for Good Reason. For purposes of this Agreement, “Good Reason” means: (A) a material change to or diminution of the Executive’s job duties; and (B) a material breach of this Agreement by the Company that is not cured within thirty (30) days’ written notice of the same to the Company. The written notice of termination for Good Reason must specify in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive’s employment under the provision so indicated, if applicable.

4.6Termination without Good Reason. With thirty (30) days’ prior written notice to the Company, Executive may terminate his employment and this Agreement without Good Reason.

Any resignation pursuant to the terms of this Section shall not constitute a breach of this Agreement by either party.

5.Rights and Obligations of the Company and the Executive Upon Termination, or Removal. Upon the termination of his employment for whatever reason, Executive shall be entitled to all salary and other benefits earned and accrued through his termination date, including any Preceding Bonus that is accrued but remains unpaid. In addition, and notwithstanding the other provisions of this Agreement, but subject to Section 8.9 and to the extent permissible by Section 409A, upon the occurrence of an event described in Section 4, the parties shall have the following rights and obligations:

5.1 Death or Disability. If the Executive’s employment is terminated by reason of the Executive’s death or Disability:

Exhibit 10.32

(A) the Company shall pay the Executive (or his estate in the event of his death), a Pro Rata Annual Bonus, which, subject to Section 8.9, shall be paid within 60 days following the date of death or Disability; and

(B) Executive (or his estate in the event of his death) shall be entitled to accelerated vesting of any outstanding LTIP Awards held by the Executive on the date of death/Disability, which, subject to Section 8.9 and to the extent permissible by Section 409A, shall be paid (if applicable) within 60 days following the date of death/Disability, and shall be entitled to exercise any stock options (if applicable) before the earlier of the stock option’s expiration date and one year following the date of death/Disability.

In the event of Executive’s Disability, his eligibility for continued enrollment in the Company’s health insurance plan shall be determined in accordance with the terms of the Company’s long-term disability policy then in effect.

5.2Termination without Cause or for Good Reason. If the Executive’s employment is terminated by the Company without Cause or by the Executive with Good Reason, the Company shall pay (unless otherwise noted, in the normal course) to the Executive or provide the following amounts or benefits:

(i) six months Base Salary (as in effect as of the date of such termination or resignation), payable in accordance with the Company’s payroll practice;

(ii) a Pro Rata Annual Bonus;

(iii) Executive shall be entitled to accelerate vesting of any outstanding LTIP Awards held by the Executive as of the date of his termination, with any options (if applicable) to be exercised before the earlier of the option expiration date and one year following the employment termination date; and

(iv) continued coverage in under the Company’s health insurance plan for a six month period following his termination date with the Company paying its share of the cost of the premiums for such period. If continued coverage under the Company’s plan would create a plan discrimination issue or is otherwise not permitted, Company will pay to the Executive the cost for the Executive to obtain comparable health insurance coverage for the applicable period less the amount of the employee share that the Executive would otherwise have had to pay under the Company’s health insurance plan (in effect at the time of termination) for such applicable period, which amount will be paid in a lump sum if permissible under Section 409A.

All payments to be provided to the Executive under this Section 5 shall be subject to the Executive’s compliance with the restrictions in Section 6 and execution, within sixty (60) days of the Executive’s termination, of a general release and waiver of claims against the Company, its officers, directors, employees and agents, in a form acceptable to the Company, from any and all liability arising from the Executive’s employment relationship with the Company (which release will include an agreement between both parties not to disparage the other) that is not revoked.

6.Confidentiality and Covenant against Competition.

6.1Non-Disclosure. The Executive shall forever hold in a fiduciary capacity for the benefit of the Company all secret or confidential information, knowledge or data relating to the Company or any of its affiliated companies, and their respective businesses, which shall have been obtained by the Executive during the Executive’s employment by the Company or any of its affiliated companies and

Exhibit 10.32

which shall not be public knowledge (other than as a result of a breach of this Section 6.1 by the Executive). The Executive shall not, without the prior written consent of the Company or except as required by law or in a judicial or administrative proceeding with subpoena powers, communicate or divulge any such information, knowledge or data to anyone other than the Company and those designated by it. The Executive understands that under the Defend Trade Secrets Act of 2016 (the “Act”), an individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (a) is made (i) in confidence to a Federal, State or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. The Executive further understand that under the Act, an individual who files a lawsuit for retaliation for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (a) files any document containing the trade secret under seal; and (b) does not disclose the trade secret, except pursuant to court order

6.2Non-Competition. The Executive will not, during the period of the Executive’s employment with the Company, and for a period of six months thereafter, directly or indirectly, (a) engage in or contribute Employee’s knowledge and abilities to or (b) be financially interested in, any entity materially engaged in any portion of the business of the Company. For purposes of this section, the Executive may not engage in, contribute to, or be financially interested in a competing business as a principal, partner, director, officer, stockholder (except as permitted below), agent, employee, consultant or otherwise. Nothing contained herein shall prevent the Executive from owning beneficially or of record not more than five percent (5%) of the outstanding equity securities of any entity whose equity securities are registered under the Securities Act of 1933, as amended, or are listed for trading on any recognizable United States or foreign stock exchange or market.

6.3Non-Solicitation of Employees. The Executive will not, during the period of the Executive’s employment with the Company, and for a period of one years after the termination of the Executive’s employment with the Company for any reason, directly or indirectly, recruit, solicit or otherwise induce or attempt to induce any employee of the Company to leave the employment of the Company, nor hire any such employee at any enterprise with which the Executive is then affiliated.

6.4Non-Solicitation of Customers. The Executive will not, during the period of the Executive’s employment with the Company, and for a period of one year after the termination of the Executive’s employment with the Company for any reason, directly or indirectly, recruit, solicit or otherwise induce or attempt to induce any business of the type performed by the Company from any current or prospective customer, or to persuade any of the Company’s customers to cease doing business or reduce the amount of business that such customer has customarily done with the Company.

6.4Enforceability of Provisions. If any restriction set forth in this Section 6 is found by any court of competent jurisdiction to be unenforceable because it extends for too long a period of time or over too great a range of activities or in too broad a geographic area, it shall be interpreted to extend only over the maximum period of time, range of activities or geographic area as to which it may be enforceable, it being understood and agreed that by the execution of this Agreement, the parties hereto regard the restrictions herein as reasonable and compatible with their respective rights.

6.5Remedy for Breach. The Executive hereby acknowledges that the provisions of this Section 6 are reasonable and necessary for the protection of the Company and its respective subsidiaries and affiliates. In addition, the Executive further acknowledges that the Company and its respective subsidiaries and affiliates will be irrevocably damaged if such covenants are not specifically enforced.

Exhibit 10.32

Accordingly, the Executive agrees that, in addition to any other relief to which the Company may be entitled, the Company will be entitled to seek and obtain injunctive relief (without the requirement of any bond) from a court of competent jurisdiction for the purposes of restraining the Executive from an actual or threatened breach of such covenants. In addition, and without limiting the Company’s other remedies, in the event of any breach by the Executive of such covenants, the Company will have no obligation to pay any of the amounts that remain payable by the Company in Section 5 of this Agreement.

7.Executive’s Representations.The Executive represents that he is not precluded from performing this employment by reason of a pre-existing contractual restriction or physical or mental disability. Upon any breach or inaccuracy of the foregoing, the terms and benefits of this Agreement shall be null and void. The Executive shall indemnify and hold harmless the Company from and against any and all claims, liabilities, damages and reasonable costs of defense and investigation arising out of any breach or inaccuracy in any of the foregoing representations.

8.Other Provisions.

8.1Withholdings. The Company may withhold from any amounts or benefits payable under this Agreement such Federal, state or local taxes required to be withheld pursuant to any applicable law or regulation and may take such other deductions only as permitted or required pursuant to law, rule or regulation.

8.2Notices. Any notice or other communication required or which may be given hereunder shall be in writing and shall be delivered personally, telecopied, or sent by certified, registered or express mail, postage prepaid, to the parties at the following addresses or at such other addresses as shall be specified by the parties by like notice, and shall be deemed given when so delivered personally, telecopied or if mailed, two days after the date of mailing, as follows:

(a)if to the Company, to it at:

IEC Electronics Corp.

105 Norton Street

Newark, New York 14513

Attention: Corporate Secretary

(b)if to the Executive, to him at:

Thomas L. Barbato

784 Hamlin Center Rd

Hamlin, NY 14464

8.3Entire Agreement. This Agreement, together with the MIP, contains the entire understanding of the Company and the Executive with respect to the subject matter hereof.

8.4Waivers and Amendments. This Agreement may not be amended or modified otherwise than by a written agreement executed by the parties hereto or their respective successors and legal representatives. No delay on the part of any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any waiver on the part of any party of any right, power or privilege hereunder, nor any single or partial exercise of any right, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, power or privilege hereunder.

Exhibit 10.32

8.5Governing Law; Jurisdiction. This Agreement shall be governed by and construed and enforced in accordance with and subject to, the laws of the State of New Yorkapplicable to agreements made and to be performed entirely within such state. The courts of New York and the United States District Courts serving the County of Monroe, New York shall have jurisdiction over the parties with respect to any dispute or controversy between them arising under or in connection with this Agreement.

8.6Assignment. This Agreement shall inure to the benefit of and shall be binding upon the Company and its successors. This Agreement is personal to the Executive and shall not be assignable by Executive otherwise than by will or the laws of descent and distribution. The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. As used in this Agreement, “Company” shall mean the Company as hereinbefore defined and any successor to its business and/or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law, or otherwise.

8.7Headings. The headings in this Agreement are for reference purposes only and shall not in any way affect the meaning or interpretation of this Agreement.

8.8Severability. If any term, provision, covenant or restriction of this Agreement, or any part thereof, is held by a court of competent jurisdiction of any foreign, federal, state, county or local government or any other governmental, regulatory or administrative agency or authority to be invalid, void, unenforceable or against public policy for any reason, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated.

8.9Section 409A. The compensation and benefits under this Agreement are intended to comply with or be exempt from the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), and the regulations promulgated and other official guidance issued thereunder (collectively, “Section 409A”), and this Agreement will be interpreted in a manner consistent with that intent. For purposes of Sections 4, 5 and 6 of this Agreement, “removal,” “termination of the Executive’s employment” and words of similar import mean, to the extent necessary to comply with Section 409A, the date that the Executive first incurs a “separation from service” within the meaning of Section 409A. Each payment under this Agreement shall be designated as a “separate payment” for purposes of Section 409A. To the extent any reimbursement provided under this Agreement is includable in the Executive’s income, such reimbursements shall be paid to the Executive not later than December 31st of the year following the year in which the Executive incurs the expense and the amount of reimbursable expenses provided in one year shall not increase or decrease the amount of reimbursable expenses to be provided in a subsequent year. To the extent that any payment or acceleration of payment under this Agreement would be considered an impermissible acceleration of payment that would result in a violation of Section 409A, the Company shall delay making such period until the earliest date on which such payment may be made without violating Section 409A. Notwithstanding anything in this Agreement to the contrary, if at the time of the Executive’s separation from service with the Company, the Executive is a “specified employee” for purposes of Section 409A, and any payment payable under this Agreement as a result of such separation from service is required to be delayed by six months pursuant to Section 409A, then the Company will make such payment on the date that is six months following the Executive’s separation from service with the Company. The amount of such payment will equal the sum of the payments that would have been paid to the Executive during the six-month period immediately following the Executive’s separation from service had the payment commenced as of such date.

Exhibit 10.32

IN WITNESS WHEREOF, the parties have executed this Employment Agreement on

September 4, 2018.

IEC ELECTRONICS CORP.

By:/s/ Jeffrey T. Schlarbaum

Jeffrey T. Schlarbaum

Chief Executive Officer

Thomas L. Barbato

By:/s/Thomas L. Barbato

Thomas L. Barbato

EX-21.1

Exhibit 21.1 

Subsidiaries of IEC Electronics Corp.

September 30, 2018

Subsidiary	State of Incorporation
IEC Electronics Corp.-Albuquerque	New Mexico
IEC Analysis & Testing Laboratory, LLC	New Mexico
IEC California Holdings, Inc.	Delaware

EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-103847, 333-122181, 333-151218, 333-174884 and 333-180041 on Form S-8 of our report dated November 29, 2018, relating to the consolidated financial statements of IEC Electronics Corp. and subsidiaries (the “Company”), appearing in this Annual Report on Form 10-K of IEC Electronics Corp. for the year ended September 30, 2018.

/s/ Deloitte & Touche LLP

Rochester, New York

November 29, 2018

EX-31.1

Exhibit 31.1

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Jeffrey T. Schlarbaum, certify that:

1. I have reviewed this Annual Report on Form 10-K for the year endedSeptember 30, 2018 of IEC Electronics Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: November 29, 2018	/s/ Jeffrey T. Schlarbaum
	Jeffrey T. Schlarbaum
	President and Chief Executive Officer
	(Principal Executive Officer)

EX-31.2

Exhibit 31.2

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Thomas L. Barbato, certify that:

1. I have reviewed this Annual Report on Form 10-K for the year endedSeptember 30, 2018 of IEC Electronics Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: November 29, 2018	/s/ Thomas L. Barbato
	Thomas L. Barbato
	Senior Vice President and Chief Financial Officer
	(Principal Financial and Accounting Officer)

EX-32.1

Exhibit 32.1

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the the Annual Report of IEC Electronics Corp. (the "Company") on Form 10-K for the fiscal year ended September 30, 2018 as filed with the Securities and Exchange Commission on the day hereof (the "Report"), I, Jeffrey T. Schlarbaum, President and Chief Executive Officer of the Company and Thomas L. Barbato, Senior Vice President and Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 29, 2018	/s/ Jeffrey T. Schlarbaum
	Jeffrey T. Schlarbaum
	President and Chief Executive Officer
	(Principal Executive Officer)

Dated: November 29, 2018	/s/ Thomas L. Barbato
	Thomas L. Barbato
	Senior Vice President and Chief Financial Officer
	(Principal Financial and Accounting Officer)

XML

Document And Entity Information - USD ($)	12 Months Ended
	Sep. 30, 2018	Nov. 21, 2018	Mar. 30, 2018
Document And Entity Information [Abstract]
Entity Registrant Name	IEC ELECTRONICS CORP
Entity Central Index Key	0000049728
Current Fiscal Year End Date	--09-30
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Entity Shell Company	false
Trading Symbol	IEC
Entity Common Stock, Shares Outstanding		10,255,309
Document Type	10-K
Amendment Flag	false
Document Period End Date	Sep. 30, 2018
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2018
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 35,707,488

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2018	Sep. 30, 2017
Current assets:
Cash	$ 0	$ 0
Accounts receivable, net of allowance	25,168	17,887
Inventories	34,126	15,605
Other current assets	1,747	1,018
Total current assets	61,041	34,510
Property, plant and equipment, net	20,110	17,777
Deferred income taxes	8,855	0
Other long-term assets	442	160
Total assets	90,448	52,447
Current liabilities:
Current portion of long-term debt	1,449	987
Current portion of capital lease obligation	306	215
Accounts payable	28,689	13,046
Accrued payroll and related expenses	1,796	1,013
Other accrued expenses	458	444
Customer deposits	7,595	1,611
Total current liabilities	40,293	17,316
Long-term debt	16,002	14,023
Long-term capital lease obligation	7,027	5,362
Other long-term liabilities	1,750	1,317
Total liabilities	65,072	38,018
STOCKHOLDERS’ EQUITY
Preferred stock, $0.01 par value: 500,000 shares authorized; none issued or outstanding	0	0
Additional paid-in capital		46,789
Accumulated deficit		(30,873)
Treasury stock, at cost: 1,055,488 shares		(1,589)
Total stockholders’ equity	25,376	14,429
Total liabilities and stockholders’ equity	$ 90,448	$ 52,447

XML

CONSOLIDATED BALANCE SHEETS [Parenthetical] - $ / shares	Sep. 30, 2018	Sep. 30, 2017
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	11,306,136	11,252,566
Common stock, shares outstanding	10,250,648	10,197,078
Treasury stock, shares	1,055,488	1,055,488

XML

CONSOLIDATED INCOME STATEMENTS - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Income Statement [Abstract]
Revenues	$ 116,922	$ 96,455
Cost of sales	102,765	85,198
Gross profit	14,157	11,257
Selling and administrative expenses	11,438	10,197
Operating profit	2,719	1,060
Interest expense	1,146	917
Income before income taxes	1,573	143
(Benefit)/provision for income taxes	(8,837)	62
Net income	$ 10,410	$ 81
Net income per common share:
Net earnings/loss (in dollars per share)	$ 0	$ 0
Net earnings/loss (in dollars per share)	$ 0	$ 0
Weighted average number of shares outstanding:
Weighted Average Number of Shares Outstanding, Basic	10,228,596	10,181,868
Diluted (in shares)	10,320,203	10,181,868

XML

CONSOLIDATED STATEMENTS of CHANGES in STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock, par $0.01	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Treasury Stock, at cost
Number of shares outstanding, beginning balance at Sep. 30, 2016		10,160,128
Beginning Balance at Sep. 30, 2016	$ 13,864	$ 102	$ 46,305	$ (30,954)	$ (1,589)
Net income	81			81
Stock-based compensation	$ 460		460
Stock granted, value, share-based compensation, gross	31,559
Restricted (non-vested) stock grants, net of forfeitures	$ 0	0	$ 0
Exercise of stock options	0
Shares withheld for payment of taxes upon vesting of restricted stock (in shares)			(1,825)
Adjustments To Additional Paid In Capital Shares With Held For Payment Of Taxes Upon Vesting Of Restricted Stock	$ (3)		$ (3)
Stock issued during period, shares, employee stock ownership plan			7,216
Stock issued during period, value, employee stock ownership plan	27		$ 27
Ending Balance at Sep. 30, 2017	$ 14,429	$ 102	46,789	(30,873)	(1,589)
Number of shares outstanding, ending balance at Sep. 30, 2017	10,197,078	10,197,078
Net income	$ 10,410			10,410
Stock-based compensation	$ 489		$ 489
Stock granted, value, share-based compensation, gross	40,107
Restricted (non-vested) stock grants, net of forfeitures	$ 0
Exercise of stock options	1,400
Shares withheld for payment of taxes upon vesting of restricted stock (in shares)			(1,743)
Adjustments To Additional Paid In Capital Shares With Held For Payment Of Taxes Upon Vesting Of Restricted Stock	$ (8)		$ (8)
Stock issued during period, shares, employee stock ownership plan			12,063
Stock issued during period, value, employee stock ownership plan	50		$ 50
Ending Balance at Sep. 30, 2018	$ 25,376	$ 102	$ 47,326	$ (20,463)	$ (1,589)
Number of shares outstanding, ending balance at Sep. 30, 2018	10,250,648	10,248,905.000

XML

CONSOLIDATED STATEMENTS of CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 10,410	$ 81
Non-cash adjustments:
Stock-based compensation	489	460
Depreciation and amortization	2,351	2,609
Loss on sale of property, plant and equipment	0	4
Change in reserve for doubtful accounts	10	(151)
Change in excess/obsolete inventory reserve	123	(111)
Deferred tax benefit	(8,855)	0
Amortization of deferred gain on sale of leaseback	(83)	(61)
Amortization of deferred gain on sale of leaseback
Accounts receivable	(7,291)	(596)
Inventories	(18,644)	(110)
Other current assets	(729)	196
Other long-term assets	(333)	0
Accounts payable	13,540	1,624
Change in book overdraft position	2,103	558
Accrued expenses	797	(2,437)
Customer deposits	5,984	(145)
Accrued expenses	(75)	(162)
Net cash flows (used in)/provided by operating activities	(203)	1,759
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment	(3,934)	(3,533)
Proceeds from disposal of property, plant and equipment	5	5
Proceeds from sale-leaseback transaction	1,947	5,750
Net cash flows (used in)/provided by investing activities	(1,982)	2,222
Borrowings under other loan agreements
Repayments under other loan agreements	62,380	46,851
Repayments under capital lease	(58,153)	(42,043)
Borrowings under other loan agreements	1,150	0
Proceeds from exercise of stock options	(2,921)	(9,396)
Repayments under capital lease	(244)	(173)
Proceeds from employee stock plan purchases	(75)	(89)
Cash paid for employee taxes upon vesting of restricted stock	6	0
Restricted (non-vested) stock grants, net of forfeitures	50	27
Cash paid for employee taxes upon vesting of restricted stock	(8)	(3)
Net cash flows provided by/(used in) financing activities	2,185	(4,826)
Net cash decrease for the year	0	(845)
Cash, beginning of year	0	845
Cash, end of year	0	0
Income taxes paid
Interest paid	1,151	922
Income taxes paid	7	127
Property, plant and equipment additions financed through capital lease	$ 2,000	$ 5,750

XML

OUR BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

OUR BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Note 1—OUR BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Our Business

IEC Electronics Corp. (“IEC,” or the “Company”) provides electronic manufacturing services (“EMS”) to advanced technology companies that produce life-saving and mission critical products for the medical, industrial, aerospace and defense sectors. The Company specializes in delivering technical solutions for the custom manufacture of complex full system assemblies by providing on-site analytical testing laboratories, custom design and test engineering services combined with a broad array of manufacturing services encompassing electronics, interconnect solutions, and precision metalworking.  As a full service EMS provider, IEC holds all appropriate certifications for the market sectors it supports including ISO 9001:2008, AS9100C, ISO 13485, Nadcap.  IEC is headquartered in Newark, NY and also has operations in Rochester, NY and Albuquerque, NM.  Additional information about IEC can be found on its web site at www.iec-electronics.com. The contents of this website are not incorporated by reference into this annual report.

Generally Accepted Accounting Principles

IEC’s financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), as set forth in the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”).

Fiscal Calendar

The Company’s fiscal year ends on September 30th and the first three quarters generally end on the Friday closest to the last day of the calendar quarter. For the fiscal year ended September 30, 2018 (“fiscal 2018”), the fiscal quarters ended on December 29, 2017, March 30, 2018 and June 29, 2018. For the fiscal year ended September 30, 2017 (“fiscal 2017”), the fiscal quarters ended on December 30, 2016, March 31, 2017 and June 30, 2017.

Consolidation

The consolidated financial statements include the accounts of IEC and its wholly-owned subsidiaries: IEC Electronics Wire and Cable, Inc. (“Wire and Cable”) which merged into IEC on December 28, 2016; IEC Electronics Corp-Albuquerque (“Albuquerque”); IEC Analysis & Testing Laboratory, LLC (“ATL”); and IEC California Holdings, Inc. The Rochester unit, formerly Celmet, operates as a division of IEC. All intercompany transactions and accounts are eliminated in consolidation.

Cash

The Company’s cash represents deposit accounts with Manufacturers and Traders Trust Company (“M&T Bank”), a banking corporation headquartered in Buffalo, NY. The Company’s cash management system provides for the funding of the disbursement accounts on a daily basis as checks are presented for payment. Under this system, outstanding checks in excess of the bank balance create a book overdraft. Book overdrafts are presented in accounts payable in the consolidated balance sheets. Changes in the book overdrafts are presented within net cash flows provided by operating activities within the consolidated statements of cash flows.

Allowance for Doubtful Accounts

The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and management’s evaluation of collectability.  Accounts are written off after all reasonable collection efforts have been exhausted and management concludes that the likelihood of collection is remote.

Inventory Valuation

Inventories are stated at the lower of cost or net realizable value under the first-in, first-out method.  The Company regularly assesses slow-moving, excess and obsolete inventory and maintains balance sheet reserves in amounts required to reduce the recorded value of inventory to the lower of cost or net realizable value.

Property, Plant and Equipment

Property, plant and equipment (“PP&E”) are stated at cost and are depreciated over various estimated useful lives using the straight-line method.  Maintenance and repairs are charged to expense as incurred, while renewals and improvements are capitalized.  At the time of retirement or other disposition of PP&E, cost and accumulated depreciation are removed from the accounts and any gain or loss is recorded in earnings.

Depreciable lives generally used for PP&E are presented in the table below.  Leasehold improvements are amortized over the shorter of the lease term or estimated useful life of the improvement.   

PP&E Lives	Estimated Useful Lives
	(years)
Land improvements	10
Buildings and improvements	5 to 40
Machinery and equipment	3 to 5
Furniture and fixtures	3 to 7
Software	3 to 10

Reviewing Long-Lived Assets for Potential Impairment

ASC 360-10 (Property, Plant and Equipment) requires the Company to test long-lived assets (PP&E and definitive lived assets) for recoverability whenever events or circumstances indicate that the carrying amount may not be recoverable.  If carrying value exceeds undiscounted future cash flows attributable to an asset, it is considered impaired and the excess of carrying value over fair value must be charged to earnings.  No impairment charges were recorded by IEC for long-lived assets during fiscal2018 and 2017. 

Leases

At the inception of a lease covering equipment or real estate, the lease agreement is evaluated under criteria discussed in ASC 840-10-25 (Leases).  Leases meeting one of four key criteria are accounted for as capital leases and all others are treated as operating leases.  Under a capital lease, the discounted value of future lease payments becomes the basis for recognizing an asset and a borrowing, and lease payments are allocated between debt reduction and interest.  For operating leases, payments are recorded as rent expense.  Criteria for a capital lease include (i) transfer of ownership during the lease term; (ii) existence of a bargain purchase option under terms that make it likely to be exercised; (iii) a lease term equal to 75 percent or more of the economic life of the leased property; and (iv) minimum lease payments that equal or exceed 90 percent of the fair value of the property.

Legal Contingencies

When legal proceedings are brought or claims are made against the Company and the outcome is uncertain, ASC 450-10 (Contingencies) requires the Company to determine whether it is probable that an asset has been impaired or a liability has been incurred.  If such impairment or liability is probable and the amount of loss can be reasonably estimated, the loss must be charged to earnings.

When it is considered probable that a loss has been incurred but the amount of loss cannot be estimated, disclosure but not accrual of the probable loss is required.  Disclosure of a loss contingency is also required when it is reasonably possible, but not probable, that a loss has been incurred. 

Legal Expense Accrual

The Company records legal expenses as they are incurred, based on invoices received or estimates provided by legal counsel. Future estimated legal expenses are not recorded until incurred.

Customer Deposits

Customer deposits represent amounts invoiced to customers for which the revenue has not yet been earned and therefore represent a commitment for the Company to deliver goods or services in the future. Deposits are generally short term in nature and are recognized as revenue when earned.

Fair Value Measurements

Under ASC 825 (Financial Instruments), the Company is required to disclose the fair value of financial instruments for which it is practicable to estimate value.  The Company’s financial instruments consist of cash, accounts receivable, accounts payable, accrued liabilities and borrowings.  IEC believes that recorded value approximates fair value for all cash, accounts receivable, accounts payable and accrued liabilities. See Note 6—Fair Value of Financial Instruments for a discussion of the fair value of IEC’s borrowings.

ASC 820 (Fair Value Measurements and Disclosures) defines fair value, establishes a framework for measurement, and prescribes related disclosures.  ASC 820 defines fair value as the price that would be received upon sale of an asset or would be paid to transfer a liability in an orderly transaction.  Inputs used to measure fair value are categorized under the following hierarchy:

Level 1: Quoted prices in active markets for identical assets or liabilities that the Company can access at the measurement date.

Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations in which all significant inputs are observable market data.

Level 3: Model-derived valuations in which one or more significant inputs are unobservable.

The Company deems a transfer between levels of the fair value hierarchy to have occurred at the beginning of the reporting period.  There were no such transfers during fiscal2018 or fiscal2017.

Revenue Recognition

The Company’s revenue is principally derived from the sale of electronic products built to customer specifications, but also from other value-added support services and repair work.  Revenue from product sales is recognized when (i) goods are shipped or title and risk of ownership have passed, (ii) the price to the buyer is fixed or determinable, and (iii) realization is reasonably assured. Service revenue is generally recognized once the service has been rendered.  For material management arrangements, revenue is generally recognized as services are rendered.  Under such arrangements, some or all of the following services may be provided: design, bid, procurement, testing, storage or other activities relating to materials the customer expects to incorporate into products that it manufactures.  Value-added support services revenue, including material management and repair work revenue, amounted to less than 5% of total revenue in fiscal2018 and fiscal2017.

Provisions for discounts, allowances, rebates, estimated returns and other adjustments are recorded in the period the related sales are recognized.

Stock-Based Compensation

ASC 718 (Stock Compensation) requires that compensation expense be recognized for equity awards based on fair value as of the date of grant.  For stock options, the Company uses the Black-Scholes pricing model to estimate grant date fair value.  Costs associated with stock awards are recorded over requisite service periods, generally the vesting period.  If vesting is contingent on the achievement of performance objectives, fair value is accrued over the period the objectives are expected to be achieved only if it is considered probable that the objectives will be achieved.  The Company also has an employee stock purchase plan (“ESPP”) that provides for the purchase of Company common stock at a discounted stock purchase price.

Income Taxes and Deferred Taxes

ASC 740 (Income Taxes) requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns, but not in both.  Deferred tax assets are also established for tax benefits associated with tax loss and tax credit carryforwards.  Such deferred tax balances reflect tax rates that are scheduled to be in effect, based on currently enacted legislation, in the years the book/tax differences reverse and tax loss and tax credit carryforwards are expected to be realized.  An allowance is established for any deferred tax asset for which realization is not likely.

ASC 740 also prescribes the manner in which a company measures, recognizes, presents, and discloses in its financial statements uncertain tax positions that the Company has taken or expects to take on a tax return.  The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the position will be sustained following examination by taxing authorities, based on technical merits of the position.  The Company believes that it has no material uncertain tax positions.

Any interest incurred is reported as interest expense. Any penalties incurred are reported as tax expense. The Company’s income tax filings are subject to audit by various tax jurisdictions and current open years are the fiscal year ended September 30, 2014 through fiscal year ended September 30, 2017. The federal income tax audit for the fiscal year ended September 30, 2013 concluded during fiscal 2017 and resulted in no change to reported tax. 

Dividends

IEC does not pay dividends on its common stock as it is the Company’s current policy to retain earnings for use in the business.  Furthermore, the Company’s Fifth Amended and Restated Credit Facility Agreement, as amended, with M&T Bank includes certain restrictions on paying cash dividends, as more fully described in Note 5—Credit Facilities. 

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, income and expenses and the disclosure of contingent assets and liabilities. Significant items subject to such estimates include: allowance for doubtful accounts, excess and obsolete inventory, warranty reserves and the valuation of deferred income tax assets. Actual results may differ from management’s estimates.

Statements of Cash Flows

The Company presents operating cash flows using the indirect method of reporting under which non-cash income and expense items are removed from net income. 

Segments

The Company’s results of operations for the years endedSeptember 30, 2018 and 2017 represent a single operating and reporting segment, referred to as contract manufacturing within the EMS industry. The Company strategically directs production between its various manufacturing facilities based on a number of considerations to best meet its customers’ requirements. The Company shares resources for sales, marketing, engineering, supply chain, information services, human resources, payroll and corporate accounting functions. Consolidated financial information is available that is evaluated regularly by the chief operating decision maker in assessing performance and allocating resources.  The Company’s operations as a whole reflect the level at which the business is managed and how the Company’s chief operating decision maker assesses performance internally.

Recently Issued Accounting Standards Not Yet Adopted

FASB Accounting Standard Update (“ASU”) 2014-09, “Revenue from Contracts with Customers” (“Topic 606”) was issued May 2014 and updates the principles for recognizing revenue. This ASU will supersede most of the existing revenue recognition requirements in GAAP. Under the new standard, revenue will be recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods and services. The standard creates a five-step model that will generally require companies to use more judgment and make more estimates than under current guidance when considering the terms of contracts along with all relevant facts and circumstances. These include the identification of customer contracts and separating performance obligations, the determination of transaction price that potentially includes an estimate of variable consideration, allocating the transaction price to each separate performance obligation, and recognizing revenue in line with the pattern of transfer. Additionally, disclosures required for revenue recognition will include qualitative and quantitative information about contracts with customers, significant judgments and changes in judgments, and assets recognized from costs to obtain or fulfill a contract. Such disclosures are more extensive than what is required under existing GAAP.

The guidance is effective for the Company beginning in the first quarter of the fiscal year ending September 30, 2019 (“fiscal 2019”). The Company has identified key personnel to evaluate the guidance and approve a transition method. The Company has assessed that the impact of the new guidance may result in a change of the Company’s revenue recognition model for electronics manufacturing services from “point in time” upon physical delivery to an “over time” model and believes this transition may have a material impact on the Company’s consolidated financial statements upon adoption primarily as it recognizes an increase in contract assets for unbilled receivables with a corresponding reduction in inventories. The Company has commenced implementation in accordance with the planned effective date. The new guidance allows for two transition methods in application: (i) retrospective to each prior reporting period presented, or (ii) modified retrospective with the cumulative effect of adoption recognized on October 1, 2018, the first day of the Company’s fiscal 2019.

The Company primarily provides contract manufacturing services to its customers. The customer provides a design, the Company procures materials and manufactures to that design and ships the product to the customer. Revenue is derived primarily from the manufacturing of electronics components which are built to customer specifications. Revenue is recognized as the customer's components are manufactured over time. The Company has an enforceable right to payment for work completed to date and the goods do not have an alternative use once the manufacturing process has commenced. The Company records an unbilled contract asset for finished goods associated with non-cancellable customer orders. The Company also records an unbilled contract asset for revenue related to its work-in-process inventory (“WIP”) when the manufacturing process has commenced and there is a non-cancellable customer purchase order. The Company uses an input method of direct manufacturing labor inputs to measure progress towards satisfying its performance obligation associated with WIP inventory.

The Company has contractual arrangements with many of its customers which require the customer to purchase any unused inventory that the Company has purchased to fulfill that customer’s manufacturing demand. Revenue from the sale of any excess inventory to the customer is recognized at a point in time when control transfers, which is typically when title passes to the customer upon shipment. The Company also derives revenue from the sale of procured finished goods, specifically for resale. Revenue from the sales of these goods is recognized when control transfers at a point in time, which is typically when title passes to the customer. The Company also derives revenue from engineering and design services. Service revenue is recognized over time as services are performed.

The Company will adopt the new guidance under the modified retrospective approach with a cumulative adjustment increasing the opening balance of retained earnings by approximately $0.5 million to $1.0 million, net of tax. Prior periods will not be retrospectively adjusted.

FASB ASU 2016-02, “Leases” was issued in February 2016. The new guidance establishes the principles to report transparent and economically neutral information about the assets and liabilities that arise from leases. For public entities, the new guidance is effective for annual periods beginning after December 15, 2018, or the Company’s fiscal year ending September 30, 2020, and interim periods within those annual periods. Early adoption is permitted for all entities. The Company is evaluating the impact this ASU will have on its consolidated financial statements.

XML

ALLOWANCE FOR DOUBTFUL ACCOUNTS

12 Months Ended

Sep. 30, 2018

Receivables [Abstract]

ALLOWANCE FOR DOUBTFUL ACCOUNTS

A summary of activity in the allowance for doubtful accounts during the years endedSeptember 30, 2018 and 2017 is as follows:

	Years Ended
Allowance for doubtful accounts	September 30, 2018		September 30, 2017
(in thousands)
Allowance, beginning of period	$	75	$	226
Change in provision for doubtful accounts	10		(144		)
Write-offs	—		(7		)
Allowance, end of period	$	85	$	75

XML

INVENTORIES

12 Months Ended

Sep. 30, 2018

Inventory Disclosure [Abstract]

INVENTORIES

A summary of inventory by category at period end is as follows:

Inventories	September 30, 2018		September 30, 2017
(in thousands)
Raw materials	$	21,323	$	8,964
Work-in-process	11,263		5,080
Finished goods	1,540		1,561
Total inventories	$	34,126	$	15,605

XML

PROPERTY, PLANT AND EQUIPMENT

12 Months Ended

Sep. 30, 2018

Property, Plant and Equipment [Abstract]

PROPERTY, PLANT AND EQUIPMENT

A summary of property, plant and equipment and accumulated depreciation at period end is as follows:

Property, Plant and Equipment	September 30, 2018			September 30, 2017
(in thousands)
Land and improvements	$	788		$	788
Buildings and improvements	7,314			8,910
Building under capital lease	7,750			5,750
Machinery and equipment	30,969			27,947
Furniture and fixtures	7,877			7,520
Construction in progress	5,360			4,968
Total property, plant and equipment, at cost	60,058			55,883
Accumulated depreciation	(39,948		)	(38,106		)
Property, plant and equipment, net	$	20,110		$	17,777

Depreciation expense during the years endedSeptember 30, 2018 and 2017 follows:

	Years Ended
	September 30, 2018		September 30, 2017
(in thousands)
Depreciation expense	$	2,358	$	2,515

XML

CREDIT FACILITIES

12 Months Ended

Sep. 30, 2018

Debt Disclosure [Abstract]

CREDIT FACILITIES

A summary of borrowings at period end is as follows:   

	Fixed/			September 30, 2018					September 30, 2017
	Variable						Interest					Interest
Debt	Rate	Date		Balance			Rate		Balance			Rate
(in thousands)
M&T credit facilities:
Revolving Credit Facility	v	5/5/2022		$	12,996		5.26	%	$	8,769		3.73	%
Term Loan B	v	5/5/2022		3,636			5.36		5,714			3.99
Celmet Building Term Loan	f	11/7/2018	1	—			—		802			4.72
Equipment Line Advances	v	12/18/2018		314			5.56		—			—
Equipment Line Term Note	v	Various	2	794			5.56		—			—
Total debt, gross				17,740					15,285
Unamortized debt issuance costs				(289		)			(275		)
Total debt, net				17,451					15,010
Less: current portion				(1,449		)			(987		)
Long-term debt				$	16,002				$	14,023

¹ The Celmet Building Term Loan was repaid in connection with the sale-leaseback transaction described in Note 12—Capital Lease. Proceeds from the transaction were also used to pay down a portion of Term Loan B.

² On July 26, 2018 and September 27, 2018, $750 thousand and $86 thousand, respectively, of Equipment Line Advances matured and were converted to an Equipment Line Term Note.

M&T Bank Credit Facilities

Effective as of August 2, 2018, the Company and M&T Bank entered into the Sixth Amendment to the Fifth Amended and Restated Credit Facility Agreement, which amended the Fifth Amended and Restated Credit Facility Agreement dated as of December 14, 2015, as amended by various amendments (collectively, the “Credit Facility, as amended”).

The Credit Facility, as amended, is secured by a general security agreement covering the assets of the Company and its subsidiaries, a pledge of the Company’s equity interest in its subsidiaries, a negative pledge on the Company’s real property, and a guarantee by the Company’s subsidiaries, all of which restrict use of these assets to support other financial instruments.

Individual debt facilities provided under the Credit Facility, as amended, are described below:

a) Revolving Credit Facility (“Revolver”): At September 30, 2018, up to $22.0 million is available through May 5, 2022. The maximum amount the Company may borrow is determined based on a borrowing base calculation described below.

b) Term Loan B:$14.0 million was borrowed on January 18, 2013. Principal is being repaid in 120 equal monthly installments of $117 thousand. As part of an amendment to the Credit Facility, as amended, the principal was modified from $8.0 million to $6.0 million and principal is being repaid in equal monthly installments of $71 thousand plus a balloon payment of $0.6 million. The maturity date of the loan is May 5, 2022. The proceeds of the sale-leaseback transaction described in Note 12—Capital Lease, were used to pay down a portion of the loan.

c) Celmet Building Term Loan:$1.3 million was borrowed on November 8, 2013 pursuant to an amendment to the Credit Facility, as amended. The proceeds were used to reimburse the Company’s cost of purchasing its Rochester, New York facility. Principal was being repaid in 59 equal monthly installments of $11 thousand plus a balloon payment of $672 thousand due at maturity on November 7, 2018. The loan was repaid in connection with the sale-leaseback transaction described in Note 12—Capital Lease.

d) Equipment Line Advances: Up to $1.5 million is available through May 5, 2022. Interest only is paid until maturity. Principal is due six months after borrowing or can be converted to an Equipment Line Term Loan. On September 18, 2018, $0.3 million was borrowed.

e) Equipment Line Term Note: $0.8 million was converted from an Equipment Line Advance on July 26, 2018 and is being repaid in 36 equal monthly installments of $21 thousand and matures July 26, 2021. $0.1 million was converted from an Equipment Line Advance on September 27, 2018 and is being repaid in 36 equal monthly installments of $2 thousand and matures September 29, 2021.

Borrowing Base

At September 30, 2018, under the Credit Facility, as amended, the maximum amount the Company can borrow under the Revolver was the lesser of (i) 85% of eligible receivables plus a percentage of eligible inventories (up to a cap of $8.0 million) or (ii) $22.0 million at September 30, 2018 and September 30, 2017.

At September 30, 2018, the upper limit on Revolver borrowings was $22.0 million, and $9.0 million was available. At September 30, 2017, the upper limit on Revolver borrowings was $16.0 million with $7.2 million available. Average Revolver balances amounted to $12.5 million and $6.1 million during the years endedSeptember 30, 2018 and September 30, 2017, respectively.

Interest Rates

Under the Credit Facility, as amended, variable rate debt accrues interest at LIBOR plus the applicable marginal interest rate that fluctuates based on the Company’s Fixed Charge Coverage Ratio, as defined below. At September 30, 2018, the applicable marginal interest rate was 3.00% for the Revolver and 3.25% for Term Loan B and Equipment Line Advances. At September 30, 2017, the applicable marginal interest rate was 2.50% for the Revolver and 2.75% for Term Loan B.  Changes to applicable margins and unused fees resulting from the Fixed Charge Coverage Ratio generally become effective mid-way through the subsequent quarter.

The Company incurs quarterly unused commitment fees ranging from 0.250% to 0.375% of the excess of $22.0 million over average borrowings under the Revolver. Fees incurred amounted to $23.3 thousand and $50.0 thousand during the years endedSeptember 30, 2018 and September 30, 2017, respectively. The fee percentage varies based on the Company’s Fixed Charge Coverage Ratio, as defined below.

Financial Covenants

The Credit Facility, as amended, contains various affirmative and negative covenants including financial covenants. As of September 30, 2018, the Company had to maintain a minimum fixed charge coverage ratio (“Fixed Charge Coverage Ratio”). The Fixed Charge Coverage Ratio compares (i) EBITDAS minus unfinanced capital expenditures minus income tax expense, to (ii) the sum of interest expense, principal payments, payments on all capital lease obligations and dividends, if any (fixed charges). “EBITDAS” is defined as earnings before interest, income taxes, depreciation, amortization and non-cash stock compensation expense. The Fixed Charge Coverage Ratio was initially measured for a trailing six months ended September 30, 2017 and was measured for a trailing twelve months ended September 30, 2018 as a minimum of 1.10 times. The Fixed Charge Coverage Ratio was the only covenant in effect at September 30, 2018. The Credit Facility, as amended, also provides for customary events of default, subject in certain cases to customary cure periods, in which the outstanding balance and any unpaid interest would become due and payable.

The Company was in compliance with all financial debt covenants at September 30, 2018.

Contractual Principal Payments

A summary of contractual principal payments under IEC’s borrowings at September 30, 2018 for the next four years taking into consideration the Credit Facility, as amended, is as follows:

Debt Repayment Schedule		Contractual Principal Payments
(in thousands)
Twelve months ended September 30,
2019		$	1,449
2020		1,136
2021		1,094
2022	(1)	14,061
		$	17,740

⁽¹⁾ Includes Revolver balance of $13.0 million at September 30, 2018, maturing on May 5, 2022.

XML

FAIR VALUE OF FINANCIAL INSTRUMENTS

12 Months Ended

Sep. 30, 2018

Fair Value Disclosures [Abstract]

FAIR VALUE OF FINANCIAL INSTRUMENTS

Financial Instruments Carried at Historical Cost

The Company’s long-term debt is not quoted.  Fair value was estimated using a discounted cash flow analysis based on Level 2 valuation inputs, including borrowing rates the Company believes are currently available to it for loans with similar terms and maturities.

The Company’s debt is carried at historical cost on the consolidated balance sheet. The fair value and carrying value of the Celmet Building Term Loan at September 30, 2017 was $0.8 million. As described in Note 12—Capital Lease, the Celmet Building Term Loan was repaid on May 11, 2018.

The fair value of the remainder of the Company’s debt approximated carrying value at September 30, 2018 and September 30, 2017, as it is variable rate debt.

XML

WARRANTY RESERVES

12 Months Ended

Sep. 30, 2018

Product Warranties Disclosures [Abstract]

WARRANTY RESERVES

IEC generally warrants its products and workmanship for up to twelve months from date of sale.  As an offset to warranty claims, the Company is sometimes able to obtain reimbursement from suppliers for warranty-related costs or losses.  Based on historical warranty claims experience and in consideration of sales trends, a reserve is maintained for estimated future warranty costs to be incurred on products and services sold through the balance sheet date. The warranty reserve is included in other accrued expenses on the consolidated balance sheet.

A summary of additions to and charges against IEC’s warranty reserves during the period follows: 

	Years Ended
Warranty Reserve	September 30, 2018			September 30, 2017
(in thousands)
Reserve, beginning of period	$	153		$	180
Provision	266			137
Warranty costs	(246		)	(164		)
Reserve, end of period	$	173		$	153

XML

STOCK-BASED COMPENSATION

12 Months Ended

Sep. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

STOCK-BASED COMPENSATION

The 2010 Omnibus Incentive Compensation Plan (“2010 Plan”) was approved by the Company’s stockholders at the January 2011 Annual Meeting of Stockholders.  The 2010 Plan, which is administered by the Compensation Committee of the Board of Directors, provides for the following types of awards: incentive stock options, nonqualified options, stock appreciation rights, restricted shares, restricted stock units, performance compensation awards, cash incentive awards, director stock and other equity-based and equity-related awards.  Awards are generally granted to certain members of management and employees, as well as directors.  The Company also has an employee stock purchase plan (“ESPP”), adopted in 2011, that provides for the purchase of Company common stock at a discounted stock purchase price. Under the 2010 Plan, up to 2,000,000 common shares may be issued over a term of ten years. Under the ESPP, 150,000 shares of common stock may be purchased over a term of ten years.

Stock-based compensation expense recorded under the 2010 Plan totaled $0.5 million for each of the years endedSeptember 30, 2018 and 2017, respectively. 

At September 30, 2018, there were 415,710 remaining shares available to be issued under the 2010 Plan and 100,765 remaining shares available to be purchased under the ESPP.

Expenses relating to stock options that comply with certain U.S. income tax rules are neither deductible by the Company nor taxable to the employee.  Further information regarding awards granted under the 2010 Plan and ESPP is provided below.

Stock Options

When options are granted, IEC estimates fair value using the Black-Scholes option pricing model and recognizes the computed value as compensation cost over the vesting period, which is typically four years.  The contractual term of options granted under the 2010 Plan is generally seven years.  The volatility rate is based on the historical volatility of IEC’s common stock.

Assumptions used in the Black-Scholes model and the estimated value of options granted during the years endedSeptember 30, 2018 and 2017 follows:

	Years Ended
Valuation of Options	September 30, 2018			September 30, 2017
Assumptions for Black-Scholes:
Risk-free interest rate	2.84		%	1.50		%
Expected term in years	5.5			4.0
Volatility	33		%	39		%
Expected annual dividends	none			none
Value of options granted:
Number of options granted	120,000			57,500
Weighted average fair value per share	$	1.84		$	1.19
Fair value of options granted (000s)	$	221		$	68

A summary of stock option activity, together with other related data, follows:

	Years Ended
	September 30, 2018				September 30, 2017
Stock Options	Number of Options		Wgtd.  Avg. Exercise Price		Number of Options		Wgtd.  Avg. Exercise Price
Outstanding, beginning of period	743,045		$	4.27	759,795		$	4.43
Granted	120,000		5.19		57,500		3.64
Exercised	(1,400	)	4.08		—		—
Forfeited	(114,000	)	4.78		(44,500	)	5.67
Expired	(10,500	)	5.24		(29,750	)	5.04
Outstanding, end of period	737,145		$	4.33	743,045		$	4.27
For options expected to vest
Number expected to vest	724,398		$	4.32	727,403		$	4.29
Weighted average remaining life, in years	4.0				4.6
Intrinsic value (000s)			$	733			$	545
For exercisable options
Number exercisable	426,358		$	4.24	332,472		$	4.40
Weighted average remaining life, in years	3.3				4.1
Intrinsic value (000s)			$	467			$	229
For non-exercisable options
Expense not yet recognized (000s)			$	343			$	416
Weighted average years to be recognized	2.8				1.8
For options exercised
Intrinsic value (000s)			$	2			$	—

Restricted (Non-vested) Stock

Certain holders of IEC restricted stock have voting and dividend rights as of the date of grant, but until vested the shares may be forfeited and cannot be sold or otherwise transferred.  At the end of the vesting period, which is typically four or five years (three years in the case of directors), holders have all the rights and privileges of any other common stockholder.  The fair value of a share of restricted stock is its market value on the date of grant and that value is recognized as stock-based compensation expense over the vesting period. 

A summary of restricted stock activity, together with related data, follows: 

	Years Ended
	September 30, 2018				September 30, 2017
Restricted (Non-vested) Stock	Number of Non-vested Shares		Wgtd. Avg. Grant Date Fair Value		Number of Non-vested Shares		Wgtd. Avg. Grant Date Fair Value
Outstanding, beginning of period	109,695		$	4.01	115,950		$	4.16
Granted	44,878		4.29		39,576		3.79
Vested	(40,107	)	4.11		(31,559	)	4.25
Shares withheld for payment of taxes upon vesting of restricted stock	(1,743	)	3.70		(1,825	)	4.27
Forfeited	(9,490	)	4.20		(12,447	)	4.03
Outstanding, end of period	103,233		$	4.08	109,695		$	4.01
For non-vested shares
Expense not yet recognized (000s)			$	315			$	328
Weighted average remaining years for vesting			1.7				1.7
For shares vested
Aggregate fair value on vesting dates (000s)			$	187			$	123

Stock Issued to Board Members

In addition to annual grants of restricted stock, included in the table above, board members may elect to have their meeting fees paid in the form of shares of the Company’s common stock. The Company has not paid any meeting fees in stock since May 21, 2013. 

Restricted Stock Units

Holders of IEC restricted stock units do not have voting and dividend rights as of the date of grant, and, until vested, the units may be forfeited and cannot be sold or otherwise transferred.  At the end of the vesting period, which is typically three years, holders will receive shares of the Company’s common stock and have all the rights and privileges of any other common stockholder of the Company.  The fair value of a restricted stock unit is the market value of the underlying shares of the Company’s stock on the date of grant and that value is recognized as stock compensation expense over the vesting period. 

A summary of restricted stock unit activity, together with related data, follows: 

	Years Ended
	September 30, 2018				September 30, 2017
Restricted Stock Units	Number of Non-vested Shares		Wgtd. Avg. Grant Date Fair Value		Number of Non-vested Shares	Wgtd. Avg. Grant Date Fair Value
Outstanding, beginning of period	267,999		$	4.03	112,809	$	4.64
Granted	102,864		4.28		155,190	3.58
Vested	—		—		—	—
Forfeited	(200,371	)	4.22		—	—
Outstanding, end of period	170,492		$	3.96	267,999	$	4.03
For non-vested shares
Expense not yet recognized (000s)			$	352		$	329
Weighted average remaining years for vesting			2.3			2.0

XML

INCOME TAXES

12 Months Ended

Sep. 30, 2018

Income Tax Disclosure [Abstract]

INCOME TAXES

(Benefit)/provision for income taxes during the years endedSeptember 30, 2018 and 2017 follows:

	Years Ended
Income Tax Provision	September 30, 2018			September 30, 2017
(in thousands)
Current tax:
State	$	6		$	53
Federal	12			9
Deferred tax:
State	(103		)	—
Federal	5,088			—
Valuation allowance	(13,840		)	—
(Benefit)/provision for income taxes	$	(8,837	)	$	62

Differences between the federal statutory rate and IEC’s effective tax rates for fiscal 2018 and fiscal 2017 are explained by the following reconciliation.

	Years Ended
Taxes as Percent of Pretax Income	September 30, 2018		September 30, 2017
Federal statutory rate	24.2	%	34.0	%
Decrease in valuation allowance	(880.0	)	(164.4	)
Deferred tax adjustment	(21.2	)	65.8
Decrease in state deferred tax rate	(6.6	)	—
State income taxes, net of federal benefit	0.4		26.8
Rate change due to Tax Reform	316.6		—
Stock-based compensation	7.3		57.6
Non-deductible expenses	0.6		23.5
Other	(3.2	)	—
Income tax provision as percent of pretax income	(561.9	)%	43.3	%

The following table displays deferred tax assets by category:

	As of
	September 30, 2018			September 30, 2017
(in thousands)
Deferred tax assets:
Federal and state net operating loss carryforward	$	6,366		$	11,367
Alternative minimum tax credit carryforward	1,031			1,010
Depreciation and fixed assets	306			289
Amortization and impairment of intangibles	27			28
New York State investment tax and other credits	1,308			1,186
Inventories	382			585
Deferred gain on sale-leaseback	431			271
Other	312			412
Total before allowance	10,163			15,148
Valuation allowance	(1,308		)	(15,148		)
Deferred tax assets, net	$	8,855		$	—

On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act significantly revises the future ongoing U.S. corporate income tax by, among other things, lowering U.S. corporate income tax rates and implementing a territorial tax system. As the Company has a September 30 fiscal year-end, the lower corporate income tax rate will be phased in, resulting in a U.S. statutory federal tax rate of approximately 24.2% for fiscal 2018, and 21% for subsequent fiscal years. The Tax Act eliminates the domestic manufacturing deduction and moves to a territorial system. In addition, previously paid federal AMT will now be refundable regardless of whether there is future income tax liability before AMT credits.

The Company has concluded that the Tax Act has caused the Company’s U.S. deferred tax assets and liabilities to be revalued. Deferred income taxes result from temporary differences between the tax basis of assets and liabilities and their reported basis in the financial statements that will result in taxable or deductible amounts in future years. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in years in which those temporary differences are expected to be recovered or settled. As changes in tax laws or rates are enacted, deferred tax assets and liabilities are revalued and any change is adjusted through the provision for income tax expense in the reporting period of the enactment. As of September 30, 2018, the Company has completed its analysis of the impact of the Tax Act under SAB 118.

For the year ended September 30, 2018, the impact of the Tax Act resulted in the Company recording a tax expense of approximately $4.7 million due to the change in the tax rate. This was offset by a corresponding decrease to the valuation allowance of approximately $5.8 million, resulting in a net tax benefit of approximately $1.0 million related to the release of the valuation allowance on the Company’s AMT credits.

As of September 30, 2018, the Company’s deferred tax assets were primarily the result of U.S. federal net operating loss carryforwards (“NOLs”) and tax credit carryforwards. A valuation allowance of $1.3 million and $15.1 million was recorded against our gross deferred tax asset balance as of September 30, 2018, and September 30, 2017, respectively. During the year ended September 30, 2018, management evaluated both positive and negative evidence to consider the reversal of the valuation allowance on the Company's net deferred income tax assets and determined in the fourth quarter of fiscal 2018 that there was sufficient positive evidence to conclude that it is more likely than not that the Company's deferred income tax assets are realizable. As a result, in the fourth quarter of fiscal 2018 the Company recorded a $7.8 million income tax benefit to release most of the valuation allowance against the Company's net deferred income tax assets.

Management performs an assessment of positive and negative evidence regarding the realization of the Company's net deferred income tax assets as required by ASC 740. For the year ended September 30, 2017, we determined that a valuation allowance was needed for all of our net deferred income tax assets, based on the required weight of positive and negative evidence under ASC 740, including consideration of the Company's three-year cumulative losses at that time.

IEC has NOLs for income tax purposes of approximately $29.7 million at September 30, 2018, expiring mainly in years 2022 through 2025 and 2031 through 2035. The Company also has additional state NOLs available in several jurisdictions in which it files.

Recent New York state corporate tax reform has resulted in the reduction of the business income base rate for qualified manufacturers in New York state to 0% beginning in fiscal 2016 for IEC. At September 30, 2018, the Company had $1.6 million of New York State investment tax and other credit carryforwards, expiring in various years through 2031.  The credits cannot be utilized unless the New York state tax rate is no longer 0%, and as such, the Company has recorded a valuation allowance against the full amount of these credit carryforwards (net of the federal benefit).

XML

MARKET SECTORS AND MAJOR CUSTOMERS

12 Months Ended

Sep. 30, 2018

Risks and Uncertainties [Abstract]

MARKET SECTORS AND MAJOR CUSTOMERS

A summary of sales, according to the market sector within which IEC’s customers operate, is as follows:

	Years Ended
% of Sales by Sector	September 30, 2018	September 30, 2017
Aerospace and Defense	59%	52%
Medical	22%	28%
Industrial	19%	20%
	100%	100%

Two individual customers represented 10% or more of sales for the year endedSeptember 30, 2018. One customer in the aerospace and defense sector totaled 23% and one customer in the medical sector totaled 11%. In the prior fiscal year, two individual customers represented 10% or more of sales, one customer in the medical sector totaled 14%, while the other customer in the aerospace and defense sector totaled 13%.

Three individual customers represented 10% or more of receivables and accounted for 55% of outstanding balances at September 30, 2018. At September 30, 2017, three individual customers represented 10% or more of receivables and accounted for 42% of such outstanding balances.

Credit risk associated with individual customers is periodically evaluated by analyzing the entity’s financial condition and payment history.  Customers generally are not required to post collateral.

XML

LITIGATION

12 Months Ended

Sep. 30, 2018

Commitments and Contingencies Disclosure [Abstract]

LITIGATION

Litigation

From time to time, the Company may be involved in legal actions in the ordinary course of its business, but management does not believe that any such proceedings, individually or in the aggregate, will have a material adverse effect on the Company’s consolidated financial statements.

XML

CAPITAL LEASE (Notes)

12 Months Ended

Sep. 30, 2018

Leases [Abstract]

Capital Lease

Note 12—CAPITAL LEASE

Leases

On November 18, 2016, the Company entered into a sale-leaseback agreement, pursuant to the terms of a purchase and sale agreement, with Store Capital Acquisitions, LLC, a Delaware limited liability company (the “Purchaser”), for the sale of certain property, including the manufacturing facility located in Albuquerque, New Mexico (the “Albuquerque Property”). Albuquerque (the “Seller”) completed the sale of the Albuquerque Property to the Purchaser for an aggregate purchase price of approximately $5.8 million including a $0.1 million holdback held subject to a holdback of funds agreement. The net book value of assets sold was $4.6 million and the value of the assets acquired under the lease is $5.8 million. The Company recorded a deferred gain of $1.1 million related to the transaction, which is recorded in other long-term liabilities section of the consolidated balance sheets. The proceeds from the transaction were used to pay off the Albuquerque Mortgage Loan and pay down Term Loan A. As part of the transaction, a Lease Agreement dated as of November 18, 2016 was entered into between the Seller and the Purchaser (the “Lease”). Pursuant to the Lease, the Seller is leasing the Albuquerque Property for an initial term of 15 years, with two renewal options of five years each. The initial base annual rent is approximately $0.5 million and is subject to an annual increase equal to the lesser of 2% or 1.25 times the change in the Consumer Price Index. If an event of default occurs under the terms of the Lease, among other things, all rental amounts accelerate and become due and owing, subject to certain adjustments.

On April 10, 2018, the Company entered into a purchase and sale agreement, with the Purchaser, for the sale of the Company’s manufacturing facility located in Rochester, New York (the “Rochester Property”). The Rochester Property was sold for $2.0 million, and the net book value of the assets sold was $1.2 million. The Company recorded a deferred gain of $0.7 million related to the transaction, which is recorded in other long-term liabilities section of the consolidated balance sheet. The proceeds from the transaction were used to pay off the Celmet Building Term Loan and pay down a portion of Term Loan B. In conjunction with this purchase, the Lease was amended to include the Rochester Property. The amended Lease includes both the lease-back of the Rochester Property and the Albuquerque Property. The lease term for both properties expires on May 31, 2033 and provides for renewals of two successive periods of 5 years each.

A summary of capital lease payments for the next five years is as follows:

Capital Lease Payment Schedule	Contractual Principal Payments
(in thousands)
Twelve months ended September 30,
2019	$	658
2020	671
2021	685
2022	698
2023 and thereafter	7,413
Total capital lease payments	10,125
Less: amounts representing interest	(2,792		)
Present value of minimum lease payment	$	7,333

XML

Earnings (Loss) Per Share (Notes)

12 Months Ended

Sep. 30, 2018

Earnings Per Share [Abstract]

Earnings Per Share

	Years Ended
	September 30, 2018	September 30, 2017
Anti-dilutive shares excluded	32,788	855,836

XML

QUARTERLY FINANCIAL DATA (UNAUDITED)

12 Months Ended

Sep. 30, 2018

Quarterly Financial Information Disclosure [Abstract]

QUARTERLY FINANCIAL DATA (UNAUDITED)

The accompanying unaudited financial information for the three month periods specified below have been prepared in accordance with GAAP for interim financial information. In the opinion of management, all adjustments required for a fair presentation of the information have been made.

Note that quarterly amounts are rounded separately and as a result the sum of the quarterly amounts may not equal the computed amount for the full year.

	Net Sales		Gross Profit		Net Income/(Loss)				Basic and Diluted Earnings/(Loss) Per Share
(Unaudited; in thousands, except per share data)
Fiscal Quarters
Fourth 2018	$	34,216	$	4,496	$	9,121		(a)	$	0.89
Third 2018	29,782		3,359		204				0.02
Second 2018	31,768		4,784		1,579				0.15
First 2018	21,156		1,518		(494		)		(0.05		)
Fourth 2017	$	27,623	$	3,475	$	755			$	0.07
Third 2017	26,489		3,708		794				0.08
Second 2017	21,368		2,279		(603		)		(0.06		)
First 2017	20,976		1,795		(865		)		(0.09		)

^(a)  Fourth quarter 2018 was impacted by a $7.8 million income tax benefit recorded to release the majority of the valuation allowance against the net deferred income tax assets.

XML

OUR BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Generally Accepted Accounting Principles

Generally Accepted Accounting Principles

IEC’s financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), as set forth in the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”).

Fiscal Calendar

Fiscal Calendar

The Company’s fiscal year ends on September 30th and the first three quarters generally end on the Friday closest to the last day of the calendar quarter. For the fiscal year ended September 30, 2018 (“fiscal 2018”), the fiscal quarters ended on December 29, 2017, March 30, 2018 and June 29, 2018. For the fiscal year ended September 30, 2017 (“fiscal 2017”), the fiscal quarters ended on December 30, 2016, March 31, 2017 and June 30, 2017.

Consolidation

Consolidation

Cash and Cash Equivalents

Cash

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts

The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and management’s evaluation of collectability.  Accounts are written off after all reasonable collection efforts have been exhausted and management concludes that the likelihood of collection is remote.

Inventory Valuation

Inventory Valuation

Inventories are stated at the lower of cost or net realizable value under the first-in, first-out method.  The Company regularly assesses slow-moving, excess and obsolete inventory and maintains balance sheet reserves in amounts required to reduce the recorded value of inventory to the lower of cost or net realizable value.

Property, Plant and Equipment

Property, Plant and Equipment

Property, plant and equipment (“PP&E”) are stated at cost and are depreciated over various estimated useful lives using the straight-line method.  Maintenance and repairs are charged to expense as incurred, while renewals and improvements are capitalized.  At the time of retirement or other disposition of PP&E, cost and accumulated depreciation are removed from the accounts and any gain or loss is recorded in earnings.

Depreciable lives generally used for PP&E are presented in the table below.  Leasehold improvements are amortized over the shorter of the lease term or estimated useful life of the improvement.   

PP&E Lives	Estimated Useful Lives
	(years)
Land improvements	10
Buildings and improvements	5 to 40
Machinery and equipment	3 to 5
Furniture and fixtures	3 to 7
Software	3 to 10

Reviewing Long-Lived Assets for Potential Impairment

Reviewing Long-Lived Assets for Potential Impairment

Legal Contingencies

Legal Contingencies

When legal proceedings are brought or claims are made against the Company and the outcome is uncertain, ASC 450-10 (Contingencies) requires the Company to determine whether it is probable that an asset has been impaired or a liability has been incurred.  If such impairment or liability is probable and the amount of loss can be reasonably estimated, the loss must be charged to earnings.

When it is considered probable that a loss has been incurred but the amount of loss cannot be estimated, disclosure but not accrual of the probable loss is required.  Disclosure of a loss contingency is also required when it is reasonably possible, but not probable, that a loss has been incurred. 

Customer Deposits

Customer Deposits

Customer deposits represent amounts invoiced to customers for which the revenue has not yet been earned and therefore represent a commitment for the Company to deliver goods or services in the future. Deposits are generally short term in nature and are recognized as revenue when earned.

Fair Value Measurements

Fair Value Measurements

Under ASC 825 (Financial Instruments), the Company is required to disclose the fair value of financial instruments for which it is practicable to estimate value.  The Company’s financial instruments consist of cash, accounts receivable, accounts payable, accrued liabilities and borrowings.  IEC believes that recorded value approximates fair value for all cash, accounts receivable, accounts payable and accrued liabilities. See Note 6—Fair Value of Financial Instruments for a discussion of the fair value of IEC’s borrowings.

ASC 820 (Fair Value Measurements and Disclosures) defines fair value, establishes a framework for measurement, and prescribes related disclosures.  ASC 820 defines fair value as the price that would be received upon sale of an asset or would be paid to transfer a liability in an orderly transaction.  Inputs used to measure fair value are categorized under the following hierarchy:

Level 1: Quoted prices in active markets for identical assets or liabilities that the Company can access at the measurement date.

Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations in which all significant inputs are observable market data.

Level 3: Model-derived valuations in which one or more significant inputs are unobservable.

The Company deems a transfer between levels of the fair value hierarchy to have occurred at the beginning of the reporting period.

Revenue Recognition

Revenue Recognition

The Company’s revenue is principally derived from the sale of electronic products built to customer specifications, but also from other value-added support services and repair work.  Revenue from product sales is recognized when (i) goods are shipped or title and risk of ownership have passed, (ii) the price to the buyer is fixed or determinable, and (iii) realization is reasonably assured. Service revenue is generally recognized once the service has been rendered.  For material management arrangements, revenue is generally recognized as services are rendered.  Under such arrangements, some or all of the following services may be provided: design, bid, procurement, testing, storage or other activities relating to materials the customer expects to incorporate into products that it manufactures.  Value-added support services revenue, including material management and repair work revenue, amounted to less than 5% of total revenue in fiscal2018 and fiscal2017.

Provisions for discounts, allowances, rebates, estimated returns and other adjustments are recorded in the period the related sales are recognized.

Stock-Based Compensation

Stock-Based Compensation

ASC 718 (Stock Compensation) requires that compensation expense be recognized for equity awards based on fair value as of the date of grant.  For stock options, the Company uses the Black-Scholes pricing model to estimate grant date fair value.  Costs associated with stock awards are recorded over requisite service periods, generally the vesting period.  If vesting is contingent on the achievement of performance objectives, fair value is accrued over the period the objectives are expected to be achieved only if it is considered probable that the objectives will be achieved.  The Company also has an employee stock purchase plan (“ESPP”) that provides for the purchase of Company common stock at a discounted stock purchase price.

Legal Expense Accrual

Legal Expense Accrual

The Company records legal expenses as they are incurred, based on invoices received or estimates provided by legal counsel. Future estimated legal expenses are not recorded until incurred.

Income Taxes and Deferred Taxes

Income Taxes and Deferred Taxes

ASC 740 (Income Taxes) requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns, but not in both.  Deferred tax assets are also established for tax benefits associated with tax loss and tax credit carryforwards.  Such deferred tax balances reflect tax rates that are scheduled to be in effect, based on currently enacted legislation, in the years the book/tax differences reverse and tax loss and tax credit carryforwards are expected to be realized.  An allowance is established for any deferred tax asset for which realization is not likely.

ASC 740 also prescribes the manner in which a company measures, recognizes, presents, and discloses in its financial statements uncertain tax positions that the Company has taken or expects to take on a tax return.  The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the position will be sustained following examination by taxing authorities, based on technical merits of the position.  The Company believes that it has no material uncertain tax positions.

Any interest incurred is reported as interest expense. Any penalties incurred are reported as tax expense. The Company’s income tax filings are subject to audit by various tax jurisdictions and current open years are the fiscal year ended September 30, 2014 through fiscal year ended September 30, 2017. The federal income tax audit for the fiscal year ended September 30, 2013 concluded during fiscal 2017 and resulted in no change to reported tax. 

Earnings Per Share

Dividends

Dividends

IEC does not pay dividends on its common stock as it is the Company’s current policy to retain earnings for use in the business.  Furthermore, the Company’s Fifth Amended and Restated Credit Facility Agreement, as amended, with M&T Bank includes certain restrictions on paying cash dividends, as more fully described in Note 5—Credit Facilities. 

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, income and expenses and the disclosure of contingent assets and liabilities. Significant items subject to such estimates include: allowance for doubtful accounts, excess and obsolete inventory, warranty reserves and the valuation of deferred income tax assets. Actual results may differ from management’s estimates.

Statements of Cash Flows

tatements of Cash Flows

The Company presents operating cash flows using the indirect method of reporting under which non-cash income and expense items are removed from net income. 

Recently Issued Accounting Standards

Recently Issued Accounting Standards Not Yet Adopted

FASB Accounting Standard Update (“ASU”) 2014-09, “Revenue from Contracts with Customers” (“Topic 606”) was issued May 2014 and updates the principles for recognizing revenue. This ASU will supersede most of the existing revenue recognition requirements in GAAP. Under the new standard, revenue will be recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods and services. The standard creates a five-step model that will generally require companies to use more judgment and make more estimates than under current guidance when considering the terms of contracts along with all relevant facts and circumstances. These include the identification of customer contracts and separating performance obligations, the determination of transaction price that potentially includes an estimate of variable consideration, allocating the transaction price to each separate performance obligation, and recognizing revenue in line with the pattern of transfer. Additionally, disclosures required for revenue recognition will include qualitative and quantitative information about contracts with customers, significant judgments and changes in judgments, and assets recognized from costs to obtain or fulfill a contract. Such disclosures are more extensive than what is required under existing GAAP.

The guidance is effective for the Company beginning in the first quarter of the fiscal year ending September 30, 2019 (“fiscal 2019”). The Company has identified key personnel to evaluate the guidance and approve a transition method. The Company has assessed that the impact of the new guidance may result in a change of the Company’s revenue recognition model for electronics manufacturing services from “point in time” upon physical delivery to an “over time” model and believes this transition may have a material impact on the Company’s consolidated financial statements upon adoption primarily as it recognizes an increase in contract assets for unbilled receivables with a corresponding reduction in inventories. The Company has commenced implementation in accordance with the planned effective date. The new guidance allows for two transition methods in application: (i) retrospective to each prior reporting period presented, or (ii) modified retrospective with the cumulative effect of adoption recognized on October 1, 2018, the first day of the Company’s fiscal 2019.

The Company primarily provides contract manufacturing services to its customers. The customer provides a design, the Company procures materials and manufactures to that design and ships the product to the customer. Revenue is derived primarily from the manufacturing of electronics components which are built to customer specifications. Revenue is recognized as the customer's components are manufactured over time. The Company has an enforceable right to payment for work completed to date and the goods do not have an alternative use once the manufacturing process has commenced. The Company records an unbilled contract asset for finished goods associated with non-cancellable customer orders. The Company also records an unbilled contract asset for revenue related to its work-in-process inventory (“WIP”) when the manufacturing process has commenced and there is a non-cancellable customer purchase order. The Company uses an input method of direct manufacturing labor inputs to measure progress towards satisfying its performance obligation associated with WIP inventory.

The Company has contractual arrangements with many of its customers which require the customer to purchase any unused inventory that the Company has purchased to fulfill that customer’s manufacturing demand. Revenue from the sale of any excess inventory to the customer is recognized at a point in time when control transfers, which is typically when title passes to the customer upon shipment. The Company also derives revenue from the sale of procured finished goods, specifically for resale. Revenue from the sales of these goods is recognized when control transfers at a point in time, which is typically when title passes to the customer. The Company also derives revenue from engineering and design services. Service revenue is recognized over time as services are performed.

The Company will adopt the new guidance under the modified retrospective approach with a cumulative adjustment increasing the opening balance of retained earnings by approximately $0.5 million to $1.0 million, net of tax. Prior periods will not be retrospectively adjusted.

FASB ASU 2016-02, “Leases” was issued in February 2016. The new guidance establishes the principles to report transparent and economically neutral information about the assets and liabilities that arise from leases. For public entities, the new guidance is effective for annual periods beginning after December 15, 2018, or the Company’s fiscal year ending September 30, 2020, and interim periods within those annual periods. Early adoption is permitted for all entities. The Company is evaluating the impact this ASU will have on its consolidated financial statements.

XML

Earnings (Loss) Per Share (Policies)

12 Months Ended

Sep. 30, 2018

Earnings Per Share [Abstract]

Earnings Per Share, Policy [Policy Text Block]

XML

OUR BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Property, Plant and Equipment

Depreciable lives generally used for PP&E are presented in the table below.  Leasehold improvements are amortized over the shorter of the lease term or estimated useful life of the improvement.   

PP&E Lives	Estimated Useful Lives
	(years)
Land improvements	10
Buildings and improvements	5 to 40
Machinery and equipment	3 to 5
Furniture and fixtures	3 to 7
Software	3 to 10

XML

ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)

12 Months Ended

Sep. 30, 2018

Receivables [Abstract]

Allowance for Credit Losses on Financing Receivables

A summary of activity in the allowance for doubtful accounts during the years endedSeptember 30, 2018 and 2017 is as follows:

	Years Ended
Allowance for doubtful accounts	September 30, 2018		September 30, 2017
(in thousands)
Allowance, beginning of period	$	75	$	226
Change in provision for doubtful accounts	10		(144		)
Write-offs	—		(7		)
Allowance, end of period	$	85	$	75

XML

INVENTORIES (Tables)

12 Months Ended

Sep. 30, 2018

Inventory Disclosure [Abstract]

Schedule of Inventory, Current

A summary of inventory by category at period end is as follows:

Inventories	September 30, 2018		September 30, 2017
(in thousands)
Raw materials	$	21,323	$	8,964
Work-in-process	11,263		5,080
Finished goods	1,540		1,561
Total inventories	$	34,126	$	15,605

XML

PROPERTY, PLANT AND EQUIPMENT (Tables)

12 Months Ended

Sep. 30, 2018

Property, Plant and Equipment [Abstract]

Fixed Assets Schedule And Accumulated Depreciation Disclosure

A summary of property, plant and equipment and accumulated depreciation at period end is as follows:

Property, Plant and Equipment	September 30, 2018			September 30, 2017
(in thousands)
Land and improvements	$	788		$	788
Buildings and improvements	7,314			8,910
Building under capital lease	7,750			5,750
Machinery and equipment	30,969			27,947
Furniture and fixtures	7,877			7,520
Construction in progress	5,360			4,968
Total property, plant and equipment, at cost	60,058			55,883
Accumulated depreciation	(39,948		)	(38,106		)
Property, plant and equipment, net	$	20,110		$	17,777

Depreciation expense during the years endedSeptember 30, 2018 and 2017 follows:

	Years Ended
	September 30, 2018		September 30, 2017
(in thousands)
Depreciation expense	$	2,358	$	2,515

XML

CREDIT FACILITIES (Tables)

12 Months Ended

Sep. 30, 2018

Debt Disclosure [Abstract]

Schedule of Debt

A summary of borrowings at period end is as follows:   

	Fixed/			September 30, 2018					September 30, 2017
	Variable						Interest					Interest
Debt	Rate	Date		Balance			Rate		Balance			Rate
(in thousands)
M&T credit facilities:
Revolving Credit Facility	v	5/5/2022		$	12,996		5.26	%	$	8,769		3.73	%
Term Loan B	v	5/5/2022		3,636			5.36		5,714			3.99
Celmet Building Term Loan	f	11/7/2018	1	—			—		802			4.72
Equipment Line Advances	v	12/18/2018		314			5.56		—			—
Equipment Line Term Note	v	Various	2	794			5.56		—			—
Total debt, gross				17,740					15,285
Unamortized debt issuance costs				(289		)			(275		)
Total debt, net				17,451					15,010
Less: current portion				(1,449		)			(987		)
Long-term debt				$	16,002				$	14,023

¹ The Celmet Building Term Loan was repaid in connection with the sale-leaseback transaction described in Note 12—Capital Lease. Proceeds from the transaction were also used to pay down a portion of Term Loan B.

² On July 26, 2018 and September 27, 2018, $750 thousand and $86 thousand, respectively, of Equipment Line Advances matured and were converted to an Equipment Line Term Note.

Schedule of Debt Covenant

Schedule of Maturities of Long-term Debt

A summary of contractual principal payments under IEC’s borrowings at September 30, 2018 for the next four years taking into consideration the Credit Facility, as amended, is as follows:

Debt Repayment Schedule		Contractual Principal Payments
(in thousands)
Twelve months ended September 30,
2019		$	1,449
2020		1,136
2021		1,094
2022	(1)	14,061
		$	17,740

⁽¹⁾ Includes Revolver balance of $13.0 million at September 30, 2018, maturing on May 5, 2022.

XML

WARRANTY RESERVES (Tables)

12 Months Ended

Sep. 30, 2018

Product Warranties Disclosures [Abstract]

Schedule of Product Warranty Liability

A summary of additions to and charges against IEC’s warranty reserves during the period follows: 

	Years Ended
Warranty Reserve	September 30, 2018			September 30, 2017
(in thousands)
Reserve, beginning of period	$	153		$	180
Provision	266			137
Warranty costs	(246		)	(164		)
Reserve, end of period	$	173		$	153

XML

STOCK-BASED COMPENSATION (Tables)

12 Months Ended

Sep. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

Assumptions used in the Black-Scholes model and the estimated value of options granted during the years endedSeptember 30, 2018 and 2017 follows:

	Years Ended
Valuation of Options	September 30, 2018			September 30, 2017
Assumptions for Black-Scholes:
Risk-free interest rate	2.84		%	1.50		%
Expected term in years	5.5			4.0
Volatility	33		%	39		%
Expected annual dividends	none			none
Value of options granted:
Number of options granted	120,000			57,500
Weighted average fair value per share	$	1.84		$	1.19
Fair value of options granted (000s)	$	221		$	68

Changes in Number of Options Outstanding with Other Related Data

A summary of stock option activity, together with other related data, follows:

	Years Ended
	September 30, 2018				September 30, 2017
Stock Options	Number of Options		Wgtd.  Avg. Exercise Price		Number of Options		Wgtd.  Avg. Exercise Price
Outstanding, beginning of period	743,045		$	4.27	759,795		$	4.43
Granted	120,000		5.19		57,500		3.64
Exercised	(1,400	)	4.08		—		—
Forfeited	(114,000	)	4.78		(44,500	)	5.67
Expired	(10,500	)	5.24		(29,750	)	5.04
Outstanding, end of period	737,145		$	4.33	743,045		$	4.27
For options expected to vest
Number expected to vest	724,398		$	4.32	727,403		$	4.29
Weighted average remaining life, in years	4.0				4.6
Intrinsic value (000s)			$	733			$	545
For exercisable options
Number exercisable	426,358		$	4.24	332,472		$	4.40
Weighted average remaining life, in years	3.3				4.1
Intrinsic value (000s)			$	467			$	229
For non-exercisable options
Expense not yet recognized (000s)			$	343			$	416
Weighted average years to be recognized	2.8				1.8
For options exercised
Intrinsic value (000s)			$	2			$	—

Changes in Number of Restricted Non-vested Stock Outstanding with Other Related Data

A summary of restricted stock activity, together with related data, follows: 

	Years Ended
	September 30, 2018				September 30, 2017
Restricted (Non-vested) Stock	Number of Non-vested Shares		Wgtd. Avg. Grant Date Fair Value		Number of Non-vested Shares		Wgtd. Avg. Grant Date Fair Value
Outstanding, beginning of period	109,695		$	4.01	115,950		$	4.16
Granted	44,878		4.29		39,576		3.79
Vested	(40,107	)	4.11		(31,559	)	4.25
Shares withheld for payment of taxes upon vesting of restricted stock	(1,743	)	3.70		(1,825	)	4.27
Forfeited	(9,490	)	4.20		(12,447	)	4.03
Outstanding, end of period	103,233		$	4.08	109,695		$	4.01
For non-vested shares
Expense not yet recognized (000s)			$	315			$	328
Weighted average remaining years for vesting			1.7				1.7
For shares vested
Aggregate fair value on vesting dates (000s)			$	187			$	123

XML

INCOME TAXES (Tables)

12 Months Ended

Sep. 30, 2018

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax Expense (Benefit)

rovision for income taxes during the years endedSeptember 30, 2018 and 2017 follows:

	Years Ended
Income Tax Provision	September 30, 2018			September 30, 2017
(in thousands)
Current tax:
State	$	6		$	53
Federal	12			9
Deferred tax:
State	(103		)	—
Federal	5,088			—
Valuation allowance	(13,840		)	—
(Benefit)/provision for income taxes	$	(8,837	)	$	62

Schedule of Effective Income Tax Rate Reconciliation

Differences between the federal statutory rate and IEC’s effective tax rates for fiscal 2018 and fiscal 2017 are explained by the following reconciliation.

	Years Ended
Taxes as Percent of Pretax Income	September 30, 2018		September 30, 2017
Federal statutory rate	24.2	%	34.0	%
Decrease in valuation allowance	(880.0	)	(164.4	)
Deferred tax adjustment	(21.2	)	65.8
Decrease in state deferred tax rate	(6.6	)	—
State income taxes, net of federal benefit	0.4		26.8
Rate change due to Tax Reform	316.6		—
Stock-based compensation	7.3		57.6
Non-deductible expenses	0.6		23.5
Other	(3.2	)	—
Income tax provision as percent of pretax income	(561.9	)%	43.3	%

Schedule of Deferred Tax Assets by Category

The following table displays deferred tax assets by category:

	As of
	September 30, 2018			September 30, 2017
(in thousands)
Deferred tax assets:
Federal and state net operating loss carryforward	$	6,366		$	11,367
Alternative minimum tax credit carryforward	1,031			1,010
Depreciation and fixed assets	306			289
Amortization and impairment of intangibles	27			28
New York State investment tax and other credits	1,308			1,186
Inventories	382			585
Deferred gain on sale-leaseback	431			271
Other	312			412
Total before allowance	10,163			15,148
Valuation allowance	(1,308		)	(15,148		)
Deferred tax assets, net	$	8,855		$	—

XML

MARKET SECTORS AND MAJOR CUSTOMERS (Tables)

12 Months Ended

Sep. 30, 2018

Risks and Uncertainties [Abstract]

Schedules of Concentration of Risk, by Risk Factor

A summary of sales, according to the market sector within which IEC’s customers operate, is as follows:

	Years Ended
% of Sales by Sector	September 30, 2018	September 30, 2017
Aerospace and Defense	59%	52%
Medical	22%	28%
Industrial	19%	20%
	100%	100%

XML

CAPITAL LEASE (Tables)

12 Months Ended

Sep. 30, 2018

Leases [Abstract]

Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]

A summary of capital lease payments for the next five years is as follows:

Capital Lease Payment Schedule	Contractual Principal Payments
(in thousands)
Twelve months ended September 30,
2019	$	658
2020	671
2021	685
2022	698
2023 and thereafter	7,413
Total capital lease payments	10,125
Less: amounts representing interest	(2,792		)
Present value of minimum lease payment	$	7,333

XML

Earnings (Loss) Per Share (Tables)

12 Months Ended

Sep. 30, 2018

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

A summary of shares used in the EPS calculations is as follows (in thousands except share and per share data):

	Years Ended
Earnings Per Share	September 30, 2018		September 30, 2017
Basic net income per share:
Net income	$	10,410	$	81
Less: Income attributable to non-vested shares	104		1
Net income available to common stockholders	$	10,306	$	80
Weighted average common shares outstanding	10,228,596		10,181,868
Basic net income per share	$	1.01	$	0.01
Diluted net income per share:
Net income	$	10,410	$	81
Shares used in computing basic net income per share	10,228,596		10,181,868
Dilutive effect of non-vested shares and options	91,607		—
Shares used in computing diluted net income per share	10,320,203		10,181,868
Diluted net income per share	$	1.01	$	0.01

The diluted weighted average share calculations do not include the following securities, which are not dilutive to the EPS calculations.

	Years Ended
	September 30, 2018	September 30, 2017
Anti-dilutive shares excluded	32,788	855,836

XML

QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)

12 Months Ended

Sep. 30, 2018

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information

	Net Sales		Gross Profit		Net Income/(Loss)				Basic and Diluted Earnings/(Loss) Per Share
(Unaudited; in thousands, except per share data)
Fiscal Quarters
Fourth 2018	$	34,216	$	4,496	$	9,121		(a)	$	0.89
Third 2018	29,782		3,359		204				0.02
Second 2018	31,768		4,784		1,579				0.15
First 2018	21,156		1,518		(494		)		(0.05		)
Fourth 2017	$	27,623	$	3,475	$	755			$	0.07
Third 2017	26,489		3,708		794				0.08
Second 2017	21,368		2,279		(603		)		(0.06		)
First 2017	20,976		1,795		(865		)		(0.09		)

XML

OUR BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant and Equipment (Details)	12 Months Ended
	Sep. 30, 2017
Land improvements
Property, Plant and Equipment [Line Items]
Estimated Useful Lives	10 years
Buildings and improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives	5 years
Buildings and improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives	40 years
Machinery and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives	3 years
Machinery and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives	5 years
Furniture and fixtures | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives	3 years
Furniture and fixtures | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives	7 years
Software | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives	3 years
Software | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives	7 years

XML

OUR BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)	12 Months Ended
	Sep. 30, 2018 USD ($) criteria	Sep. 30, 2017
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Impairment charges | $	$ 0
Capital leases, number of key criteria | criteria	4
Capital lease criteria, lease term to economic life, ratio	75.00%
Capital lease criteria, minimum lease payments to fair value, ratio	90.00%
Material Management
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Maximum percentage of total revenue	5.00%	5.00%

XML

OUR BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details) - shares	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Accounting Policies [Abstract]
Weighted Average Number of Shares Outstanding, Basic	10,228,596	10,181,868
Diluted shares	10,320,203	10,181,868
Anti-dilutive shares excluded	32,788	855,836

XML

ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Allowance for doubtful accounts
Allowance, beginning of period	$ 75	$ 226
Change in provision for doubtful accounts	10	(144)
Write-offs	0	(7)
Allowance, end of period	$ 85	$ 75

XML

INVENTORIES (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Sep. 30, 2017
Inventory Disclosure [Abstract]
Inventory, Raw Materials, Net of Reserves	$ 21,323	$ 8,964
Work-in-process	11,263	5,080
Finished goods	1,540	1,561
Inventory, Net	$ 34,126	$ 15,605

XML

PROPERTY, PLANT AND EQUIPMENT - Summary of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Sep. 30, 2017
Property, Plant and Equipment [Abstract]
Land and improvements	$ 788	$ 788
Buildings and improvements	7,314	8,910
Building under capital lease	7,750	5,750
Machinery and equipment	30,969	27,947
Furniture and fixtures	7,877	7,520
Construction in progress	5,360	4,968
Total property, plant and equipment, at cost	60,058	55,883
Accumulated depreciation	(39,948)	(38,106)
Property, plant and equipment, net	$ 20,110	$ 17,777

XML

PROPERTY, PLANT AND EQUIPMENT - Depreciation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 2,358	$ 2,515

XML

CREDIT FACILITIES - Schedule of Debt (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Long-term Debt, Gross	$ 17,740	$ 15,285
Unamortized debt issuance costs	(289)	(275)
Total debt, net	17,451	15,010
Less: current portion	(1,449)	(987)
Long-term debt	$ 16,002	$ 14,023
Term Loan A
Interest rate terms	Fixed Interest Rate
Term Loan B
Date	May 05, 2022
Interest Rate	5.3637%	3.99%
Long-term Debt, Gross	$ 3,636	$ 5,714
Interest rate terms	Variable Interest Rate
Albuquerque Mortgage Loan
Interest rate terms	Variable Interest Rate
Celmet Building Term Loan
Date	Nov. 07, 2018
Interest Rate	0.00%	4.72%
Long-term Debt, Gross	$ 0	$ 802
Interest rate terms	Fixed Interest Rate
Albuquerque Industrial Revenue Bond
Interest rate terms	Fixed Interest Rate
Equipment Line Advances [Member]
Date	Dec. 18, 2018
Interest Rate		0.00%
Total debt, net	$ 314	$ 0
Equipment Line Advances Term Note [Member]
Interest Rate		0.00%
Total debt, net	$ 794	$ 0
Revolving Credit Facility
Date	May 05, 2022
Interest Rate	5.2605%	3.73%
Long-term Debt, Gross	$ 12,996	$ 8,769
Total debt, net	$ 13,000
Interest rate terms	Variable Interest Rate

XML

CREDIT FACILITIES - Narrative (Details) - USD ($)	1 Months Ended		12 Months Ended
	Nov. 30, 2013	Jan. 31, 2013	Sep. 30, 2018	Sep. 30, 2017	Nov. 08, 2013	Jan. 18, 2013
Debt Instrument [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity			$ 9,000,000	$ 7,200,000
Long-term debt			17,451,000	15,010,000
Credit Agreement 2013 | Term Loan B
Debt Instrument [Line Items]
Long-term line of credit						$ 14,000,000
Repayment monthly installments		120 equal monthly installments
Line of credit facility, periodic payment, principal		$ 117,000
Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 22,000,000.0
Maturity date			May 05, 2022
Maximum borrowing capacity as percent of eligible receivables			85.00%
Maximum borrowing capacity based on eligible inventory			$ 8,000,000.0
Current borrowing capacity			22,000,000.0	16,000,000
Average borrowing capacity			12,500,000	$ 6,100,000
Commitment fee amount			$ 22,000,000
Interest rate, stated percentage			5.2605%	3.73%
Long-term debt			$ 13,000,000
Revolving Credit Facility | Minimum
Debt Instrument [Line Items]
Unused capacity, commitment fee percentage			0.25%
Revolving Credit Facility | Maximum
Debt Instrument [Line Items]
Unused capacity, commitment fee percentage			0.375%
Revolving Credit Facility | Credit Agreement 2013
Debt Instrument [Line Items]
Commitment fee amount			$ 23,300	$ 50,000
Celmet Building Term Loan | Credit Agreement 2013
Debt Instrument [Line Items]
Long-term line of credit					$ 1,300,000
Repayment monthly installments	59 equal monthly installments
Debt instrument, periodic payment, principal	$ 11,000

XML

CREDIT FACILITIES - Contractual Principal Payments (Details) - USD ($) $ in Thousands		Sep. 30, 2018	Sep. 30, 2017
Debt Instrument [Line Items]
2017		$ 1,449
2018		1,136
2019	[1]	1,094
2020		14,061
Long-term Debt, Gross		17,740	$ 15,285
Long-term debt		17,451	15,010
Revolving Credit Facility
Debt Instrument [Line Items]
Long-term Debt, Gross		12,996	$ 8,769
Long-term debt		$ 13,000

[1] Includes Revolver balance of $13.0 million at September 30, 2018, maturing on May 5, 2022.

XML

FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Sep. 30, 2017
Carrying Value	$ 17,451	$ 15,010
Celmet Building Term Loan
Fair Value	$ 800

XML

WARRANTY RESERVES (Details) - Warranty Reserves - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Warranty Reserve
Reserve, beginning of period	$ 153	$ 180
Provision	266	137
Warranty costs	(246)	(164)
Reserve, end of period	$ 173	$ 153

XML

STOCK-BASED COMPENSATION - Narrative (Details) $ in Millions	12 Months Ended
	Sep. 30, 2018 USD ($) shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation | $	$ 0.5
Shares available to be issued (in shares)	100,765
Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	4 years
2010 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum number of common shares that may be issued	2,000,000
Common shares, issuance term	10 years
Shares available to be issued (in shares)	415,710
2010 Plan | Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award expiration period	7 years
Vesting One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	4 years
Vesting Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	5 years

XML

STOCK-BASED COMPENSATION - Valuation Assumptions (Details) - USD ($)	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Assumptions for Black-Scholes:
Risk-free interest rate	2.84%	1.50%
Expected term in years	5 years 6 months	4 years
Volatility	33.00%	39.00%
Expected annual dividends	$ 0	$ 0
Value of options granted:
Number of options granted (in shares)	120,000	57,500
Weighted average fair value per share (in dollars per share)	$ 1.84	$ 1.19
Fair value of options granted (000s)	$ 221,000	$ 68,000

XML

STOCK-BASED COMPENSATION - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Number of Options
Outstanding, beginning of period (in shares)	743,045	759,795
Granted (in shares)	120,000	57,500
Exercised (in shares)	(1,400)	0
Forfeited (in shares)	114,000	(44,500)
Expired (in shares)	(10,500)	(29,750)
Outstanding, end of period (in shares)	737,145	743,045
Wgtd. Avg. Exercise Price
Outstanding, beginning of period (in dollars per share)	$ 4.27	$ 4.43
Granted (in dollars per share)	5.19	3.64
Exercised (in dollars per share)	4.08	0.00
Forfeited (in dollars per share)	4.78	5.67
Expired (in dollars per share)	5.24	5.04
Outstanding, end of period (in dollars per share)	$ 4.33	$ 4.27
For options expected to vest
Number expected to vest (in shares)	724,398	727,403
Number expected to vest (in dollars per share)	$ 4.32	$ 4.29
Weighted average remaining term, in years	4 years 4 days	4 years 7 months
Intrinsic value (000s)	$ 733	$ 545
For exercisable options
Number exercisable (in shares)	426,358	332,472
Number exercisable (in dollars per share)	$ 4.24	$ 4.40
Weighted average remaining term, in years	3 years 3 months 8 days	4 years 1 month
Intrinsic value (000s)	$ 467	$ 229
For non-exercisable options
Expense not yet recognized (000s)	$ 343	$ 416
Weighted average years to be recognized	2 years 9 months 29 days	1 year 10 months 3 days
For options exercised, Intrinsic value (000s)	$ 2	$ 0

XML

STOCK-BASED COMPENSATION - Changes in Non-Vested Options Outstanding (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2016
Number of Options
Granted (in shares)	120,000	57,500
Wgtd. Avg. Grant Date Fair Value
Granted (in dollars per share)	$ 1.84	$ 1.19
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	170,492	267,999
Number of Options
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 4.28	$ 3.58
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	102,864	155,190
Wgtd. Avg. Grant Date Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 3.96	$ 4.03
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	0	0
Vested (in dollars per share)	$ 0.00	$ 0.00
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	$ 4.22	$ 0.00
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	(200,371)	0
Non-vested | Restricted Stock Units (RSUs) [Member]
Wgtd. Avg. Grant Date Fair Value
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options	$ 352	$ 329
Employee Service Share Based Compensation Non Vested Shares Total Compensation Not Yet Recognized Period For Recognition	2 years 3 months 22 days	2 years
Vested | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number		267,999	112,809
Wgtd. Avg. Grant Date Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value		$ 4.03	$ 4.64

XML

STOCK-BASED COMPENSATION - Summary of Restricted Stock Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Wgtd. Avg. Grant Date Fair Value
Granted (in shares)	120,000	57,500
Restricted Stock Units (RSUs) [Member]
Number of Non-vested Shares
Outstanding, beginning of period (in shares)	267,999
Granted (in shares)	102,864	155,190
Vested (in shares)	0	0
Forfeited (in shares)	(200,371)	0
Outstanding, end of period (in shares)	170,492	267,999
Wgtd. Avg. Grant Date Fair Value
Outstanding, beginning of period (in dollars per share)	$ 4.03
Granted (in dollars per share)	4.28	$ 3.58
Vested (in dollars per share)	0.00	0.00
Forfeited (in dollars per share)	4.22	0.00
Outstanding, end of period (in dollars per share)	$ 3.96	$ 4.03
Vested | Restricted Stock Units (RSUs) [Member]
Number of Non-vested Shares
Outstanding, beginning of period (in shares)	267,999	112,809
Outstanding, end of period (in shares)		267,999
Wgtd. Avg. Grant Date Fair Value
Outstanding, beginning of period (in dollars per share)	$ 4.03	$ 4.64
Outstanding, end of period (in dollars per share)		$ 4.03
Non-vested | Restricted Stock Units (RSUs) [Member]
For non-vested shares
Expense not yet recognized (000s)	$ 352	$ 329
Weighted average remaining years for vesting	2 years 3 months 22 days	2 years
Non-vested | Restricted Stock
Number of Non-vested Shares
Outstanding, beginning of period (in shares)	109,695	115,950
Granted (in shares)	44,878	39,576
Vested (in shares)	(40,107)	(31,559)
Shares withheld for payment of taxes upon vesting of restricted stock (in shares)	(1,743)	(1,825)
Forfeited (in shares)	9,490	(12,447)
Outstanding, end of period (in shares)	103,233	109,695
Wgtd. Avg. Grant Date Fair Value
Outstanding, beginning of period (in dollars per share)	$ 4.01	$ 4.16
Granted (in dollars per share)	4.29	3.79
Vested (in dollars per share)	4.11	4.25
Shares withheld for payment of taxes upon vesting of restricted stock (in dollars per share)	3.70	4.27
Forfeited (in dollars per share)	4.20	4.03
Outstanding, end of period (in dollars per share)	$ 4.08	$ 4.01
For non-vested shares
Expense not yet recognized (000s)	$ 315	$ 328
Weighted average remaining years for vesting	1 year 8 months 12 days	1 year 8 months 20 days
For shares vested
Aggregate fair value on vesting dates (000s)	$ 187	$ 123

XML

INCOME TAXES - Provision For/(Benefit From) (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Current tax:
State	$ 6	$ 53
Federal	12	9
Deferred tax:
State	(103)	0
Federal	5,088	0
Deferred Tax Assets, Valuation Allowance	(13,840)	0
Valuation allowance	$ (8,837)	$ 62

XML

INCOME TAXES - Effective Tax Rate Reconciliation (Details)	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Income Tax Disclosure [Abstract]
Federal statutory rate	24.20%	34.00%
Decrease in valuation allowance	(880.00%)	(164.40%)
Deferred tax adjustment	(21.20%)	65.80%
Decrease in state deferred tax rate	(6.60%)	0.00%
State income taxes, net of federal benefit	0.40%	26.80%
Rate change due to Tax Reform	316.60%	0.00%
Stock-based compensation	7.30%	57.60%
Non-deductible expenses	0.60%	23.50%
Other	(3.20%)	0.00%
Income tax provision as percent of pretax income	(561.90%)	43.30%

XML

INCOME TAXES - Deferred Income Taxes (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Sep. 30, 2017
Income Tax Disclosure [Abstract]
Federal and state net operating loss carryforward	$ 6,366	$ 11,367
Alternative minimum tax credit carryforward	1,031	1,010
Depreciation and fixed assets	306	289
Amortization and impairment of intangibles	27	28
New York State investment tax and other credits	1,308	1,186
Inventories	382	585
Deferred Tax Assets, Deferred Gain on Sale Leaseback Transaction	431	271
Other	312	412
Total before allowance	10,163	15,148
Valuation allowance	(1,308)	(15,148)
Deferred tax assets, net	$ 8,855	$ 0

XML

INCOME TAXES - Narrative (Details) $ in Millions	Sep. 30, 2018 USD ($)
Internal Revenue Service (IRS)
Operating loss carryforwards	$ 29.7

XML

MARKET SECTORS AND MAJOR CUSTOMERS - Summary of Sales by Sector (Details) - Sales Revenue	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Concentration Risk [Line Items]
Percentage of sales by sector	100.00%	100.00%
Aerospace and Defense
Concentration Risk [Line Items]
Percentage of sales by sector	59.00%	52.00%
Medical
Concentration Risk [Line Items]
Percentage of sales by sector	22.00%	28.00%
Industrial
Concentration Risk [Line Items]
Percentage of sales by sector	19.00%	20.00%

XML

MARKET SECTORS AND MAJOR CUSTOMERS - Narrative (Details) - Customer Concentration Risk - customer	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Sales
Concentration Risk [Line Items]
Concentration risk, number of customers	2	2
Sales | Medical
Concentration Risk [Line Items]
Concentration risk, percentage	23.00%	14.00%
Sales | Medical | Customer One
Concentration Risk [Line Items]
Concentration risk, number of customers	1
Sales | Aerospace and Defense
Concentration Risk [Line Items]
Concentration risk, percentage	11.00%	13.00%
Accounts Receivable
Concentration Risk [Line Items]
Concentration risk, number of customers	3	3
Concentration risk, percentage	55.00%	42.00%

XML

CAPITAL LEASE Additional Information (Details) $ in Millions	Apr. 10, 2018 USD ($)	Nov. 18, 2016 USD ($) renewal_option
Operating Leased Assets [Line Items]
Lessor, Sales-type Lease, Renewal Term		5 years
Sale Leaseback Transaction, Gross Proceeds, Investing Activities	$ 2.0	$ 5.8
Sale Leaseback Transaction, Holdback Amount		0.1
Sale Leaseback Transaction, Net Book Value	1.2	4.6
Sale Leaseback Transaction, Value of Assets Acquired		$ 5.8
Lessee, Operating Lease, Term of Contract		15 years
Lessee Leasing Arrangements, Operating Leases, Number of Lease Renewal Options | renewal_option		2
Sale Leaseback Transaction, Annual Rental Payments, Year One		$ 0.5
Sale Leaseback Transaction, Deferred Gain, Gross	$ 0.7
Lessor, Sales-type Lease, Number of Renewal Options | renewal_option		2
Other Noncurrent Liabilities [Member]
Operating Leased Assets [Line Items]
Sale Leaseback Transaction, Deferred Gain, Net		$ 1.1
Maximum
Operating Leased Assets [Line Items]
Sale Leaseback Transaction, Annual Rental Payments Increase, Percent		2.00%
Minimum
Operating Leased Assets [Line Items]
Sale Leaseback Transaction, Consumer Price Index Multiplier		1.25

XML

CAPITAL LEASE - Summary of future capital lease payments (Details)	Sep. 30, 2018 USD ($)
Leases [Abstract]
Capital Leases, Future Minimum Payments Due, Next Twelve Months	$ 658,027
Capital Leases, Future Minimum Payments Due in Two Years	671,188
Capital Leases, Future Minimum Payments Due in Three Years	684,611
Capital Leases, Future Minimum Payments Due in Four Years	698,304
Capital Leases, Future Minimum Payments Due in Year Five and Thereafter	7,412,557
Capital Leases, Future Minimum Payments Due	10,124,687
Capital Leases, Future Minimum Payments, Interest Included in Payments	(2,792,149)
Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments	$ 7,332,538

XML

Earnings (Loss) Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Sep. 30, 2018	Jun. 29, 2018	Mar. 30, 2018	Dec. 29, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 30, 2016	Sep. 30, 2018	Sep. 30, 2017
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net income	$ 9,121	$ 204	$ 1,579	$ (494)	$ 755	$ 794	$ (603)	$ (865)	$ 10,410	$ 81
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic									104	1
Net Income (Loss) Available to Common Stockholders, Basic									$ 10,306	$ 80
Weighted Average Number of Shares Outstanding, Basic									10,228,596	10,181,868
Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends									91,607	0
Net earnings/loss (in dollars per share)	$ 0	$ 0.02	$ 0.15	$ (0.05)	$ 0.07	$ 0.08	$ (0.06)	$ (0.09)	$ 0	$ 0
Net Income (Loss) Attributable to Parent, Diluted									$ 10,410	$ 81
Diluted shares									10,320,203	10,181,868
Diluted Earnings/ (Loss) Per Share (in dollars per share)									$ 0	$ 0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount									32,788	855,836

XML

QUARTERLY FINANCIAL DATA (UNAUDITED) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Sep. 30, 2018	Jun. 29, 2018	Mar. 30, 2018	Dec. 29, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 30, 2016	Sep. 30, 2018	Sep. 30, 2017
Quarterly Financial Information Disclosure [Abstract]
Revenues	$ 34,216	$ 29,782	$ 31,768	$ 21,156	$ 27,623	$ 26,489	$ 21,368	$ 20,976	$ 116,922	$ 96,455
Gross Profit	4,496	3,359	4,784	1,518	3,475	3,708	2,279	1,795	14,157	11,257
Net income	$ 9,121	$ 204	$ 1,579	$ (494)	$ 755	$ 794	$ (603)	$ (865)	$ 10,410	$ 81
Net earnings/loss (in dollars per share)	$ 0	$ 0.02	$ 0.15	$ (0.05)	$ 0.07	$ 0.08	$ (0.06)	$ (0.09)	$ 0	$ 0
Diluted Earnings/ (Loss) Per Share (in dollars per share)									$ 0	$ 0